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Introduction  
 
1. 'Omics' sciences 
 
Life as we know is characterized by a myriad organisms 
with which we share the planet. Every organism possesses a genome that contains the 
biological information needed to construct and maintain a living example of that 
organism. The initial product of genome expression is the transcriptome, a collection 
of RNA molecules derived from those protein-coding genes whose biological 
information is required by the cell at a particular time. The transcriptome is maintained 
by the process called transcription, in which individual genes are copied into RNA 
molecules. The second product of genome expression is the proteome, the cell‟s 
repertoire of proteins, which specifies the nature of the biochemical reactions that the 
cell is able to carry out (Fig. 1.1). The proteins that make up the proteome are 
synthesized by translation of the individual RNA molecules present in the 
transcriptome. 
 
 
 
Figure 1.1. Correlation between 'omics' sciences. 
 
All known biological processes are controlled by direct and specific molecular 
interactions involving DNA, RNA, proteins, metals and small molecules as well as 
biological membranes. The whole set of molecular interactions between biological 
entities in cells and organisms is called interactome, a word originally coined in 1999 
by a group of French scientists.
1
 Describing the contents, structure, function and 
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behavior of the interactome provides a link at the functional level between the genome, 
the proteome and the transcriptome worlds of different organisms. The structure and 
dynamic characterization of the interactome represents one of the major scientific 
challenges of the 21th century.  
 
1.2. Historical basis 
 
Genome sequencing has revolutionized all fields of life sciences. The 
development of genome sequencing technologies resulted in a wealth of sequence 
information, culminating, in 2001, in the completion  of the first map of the human 
genome.
1,2
 At present, genome sequences for thousands of organisms are available and 
the amount of data is increasing. From the genome sequences, it is possible to deduce 
the primary structure of essentially all of the proteins that a living organism can 
produce. The steps forward the genome sequencing are the analysis of the primary 
sequence data of essentially all of the proteins that a living organism can produce and 
afterwards the comprehension of the molecular bases of living processes trough the 
interactome comprehension. The most important interaction that the interactome takes 
into account comprise protein-DNA, protein-membrane, protein-small ligand, protein-
metal and protein-protein interactions. The last three interactions are object of the 
present research work.  
 
 
1.2.1. Biorecognition  
 
Molecular recognition or biorecognition is at the heart of all biological processes. 
How it works is still a partially unknown and lots of questions are still not completely 
answered. One thing is clear: in all these cases a combination of noncovalent 
interactions are involved, namely ionic, hydrogen bonding and hydrophobic 
interactions. In addition, shape complementarity appears to play a pivotal role in the 
process of biorecognition.
3
 Scientists are trying to understand how these forces are 
involved or affect a particular system, through which means to obtain a better 
understanding of the biorecognition process. For this purpose, many methods are 
available, including X-ray crystallography, Nuclear Magnetic Resonance spectroscopy 
(NMR), neutron diffraction, mass spectroscopy calorimetry and Cryo-electron 
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microscopy (cryo-EM).
4
 Currently, the best approach to study and understand 
biorecognition is to determine the three-dimensional structure experimentally via X-ray 
crystallographic methods or NMR
5
. Alternative theoretical approaches, e.g., 
bioinformatics-based computational methods, still depend largely on previously 
determined structures
6
. 
 
 
1.2.2. Protein-Ligand Interactions  
 
The biological function of a protein often depends on its interaction with ligand 
molecules. This is the case for enzyme-substrate, hormone receptor-hormone, cell 
surface antigen-receptor and for the ion channels-neurotransmitters interactions. It is 
clear that understanding biological function requires a precise knowledge of the protein-
ligand recognition events at an atomic level. Therefore, many studies have been 
performed in order to accurately characterize such processes.  
Of special interest are certainly protein-ligand interactions involved in the 
development of several diseases, such as HIV or cancer. Understanding the principles of 
such protein-ligand interactions allows the development of drug candidates able to 
inhibit the complex formation.  
The identification of such drug candidates is time consuming and consists in 
several steps. At first, it is necessary to map the protein-ligand interaction of interest. 
Due to improvements in the techniques for structure determination, such as X-ray 
crystallography and NMR spectroscopy, and thanks to the large-scale structure-
determination projects driven by genomics consortia, the number of 3D structures is 
increasing rapidly. When the 3D structure of the complex is not available, 
computational modeling approaches give a good response. Indeed in the case of protein-
natural ligand complexes, it has been often found that the small molecules bind most 
readily to the deepest clefts on the protein surface.
7
 Once the binding site of the target 
protein in complex with the substrate is known, the common strategy is strategy is to 
employ in silico approaches for the initial screening of a compound database (>10
6
) to 
predict those that should bind the target protein in the region of interest.  
In principle, there are several ways to construct novel ligands designed for a 
particular target that could subsequently become lead candidates. One approach is to 
build up a drug candidate, with typical molecular weight of 500 Daltons, from screening 
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a database of typically 1000-15000 compounds composed of smaller molecules 
(fragments) with molecular weight < 300 Daltons and good aqueous solubility.  
Computational “hits” from this virtual screening will need to be validated 
experimentally trough biochemical assays or in vitro screenings. X-ray crystallography 
or NMR spectroscopy screenings it's possible to obtain information on the binding area 
of the ligands. A relatively small  number (e.g. 1%) of top-ranking selective binders can 
be selected from this screening.  
Often, a second screen is carried out to find a second fragment that will bind in 
close proximity to the first fragment. Use of a second screen has an advantage in that 
binding of the first fragment may select for a particular conformation of the target that 
can enable binding of a particular second fragment that would not have been found in 
the absence of the first. Individually, the fragments may bind to the target with Kd 
values of only 10
-4
 to 10
-3
 M. However, by covalently linking the fragments, the 
additivity of the binding enthalpy and the favorable entropic contribution may pay off in 
a big way. In fact, sub-micromolar bi-dentate compounds can be found that are 
generally novel in structure.  
Typically, the iterative loop of computational screening and structure 
determination (Fig. 1.2), is carried until the chemical leads affinity higher than the 
natural ligand's one. Once identified the lead compounds, it's necessary to test them in 
vivo by biochemical assays and cell based assays in order to prove the real drug's 
functionality.
7,8
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Figure 1.2. NMR spectroscopy can provide critical information at early stages of  
hit validation and identification. NMR measurements for binding studies can represent a 
key step to eliminate false positives from high-throughput (HTS) campaigns, to validate 
putative hits from in silico screens or to identify novel scaffolds in fragment-based 
programmes. NMR and X-ray crystallography can also provide unique information to 
subsequently guide hit-to-lead optimization. ADME-tox, absorption, distribution, 
metabolism, excretion and toxicity are preliminary tests for the candidate identification. 
 
Beyond the protein-ligand interaction inhibition, it's necessary to mention the 
protein-protein interaction inhibition trough the development of candidate drugs able 
to bind the target protein in the same region of the partner. This topic is discussed in 
Chapter 2. The ability to identify the sites of a protein that can bind with high affinity to 
small, drug like compounds has been an important goal in drug design. The general lack 
of small molecule starting points for drug design, the typical flatness of the interface, 
the difficulty of distinguishing real from artefactual binding, and the size and character 
of typical small molecule libraries make the things difficult. Natural small molecules 
known to bind at protein-protein interfaces are rare, whereas drug friendly enzymes 
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often have small molecule substrates that can serve as templates for designing 
antagonists. One way to obtain a small molecule starting point for a protein-protein 
interface has been to map the epitope of one of the proteins onto a small peptide or 
peptidomimetic. The shape of a typical protein-protein interface adds to the difficulty of 
drug discovery.  
Approximately 700-1500 Å
2
 of surface area is buried on each side of the 
interface,
9
 and the binding  surfaces are relatively flat.
10,11
 Therefore, the X-ray 
structures of protein-protein pairs do not usually show small, deep cavities that look like 
small molecule binding sites. However, it might not be necessary for a small molecule 
to cover the entire protein binding surface, because the subset of the interface that 
contributes to high affinity binding (the „hot spot‟) is often much smaller.12-14 In 
addition, for many protein-protein interactions, the apparent complementarity between 
the two surfaces involves a significant degree of protein flexibility and adaptivity.
15
 
Moreover, there might be binding site conformations, that are well-suited to small 
molecule binding, but not visible in a single crystal structure.
16-18
  
 
 
1.2.3. Protein-Metal ion Interactions 
 
Life has developed taking advantage of the minerals present in the earth. 
Therefore it is not surprising that living beings have developed the capability to use 
inorganic elements to perform specific physiological functions. More than 20 metals are 
essential for most species to carry out their function and they are involved in a lot of 
processes such as charge balance and electrolytic conductivity (Na, K), signaling (Ca), 
electron transfer (Fe, Cu), redox catalysis (Fe, Co, Ni, Cu), energy storage (Na, K, Fe) 
and biomineralization (Ca, Mg, Fe, Cu).  
Some metals like Fe, Cu or Zn are strongly associated with proteins and form the 
so called metallo-proteins or metallo-enzymes, because, as enzymes usually do, they 
function as biological catalysts. Some others, like the non transition metal ions Na
+
, K
+
, 
Mg
2+
 or Ca
2+ 
form complexes with proteins with a significantly smaller affinity 
constant. These latter systems are considered metal-protein complexes.  
In multicellular organisms, sodium and calcium are found mostly outside the 
cellular compartment (extracellular), while potassium and magnesium are largely 
intracellular. Calcium and magnesium are often metal activators in proteins to which 
Introduction 
7 
they bind with relatively low affinity. Under appropriate circumstances, these metal ions 
induce conformational changes in the protein upon binding and in doing so they may 
transmit a signal e.g. the firing of neurons by rapid influx of sodium ions across a cell 
membrane or the regulation of intracellular functions by calcium binding proteins such 
as calmodulin. 
Owing to the great advances in research we now know the structures of many 
components of the systems that biology has adapted through evolution to perform these 
essential functions. One of the most common system that nature adopts to associate a 
metal with a protein is the so called a metal cofactor. A third of all proteins contain 
metals. A cofactor is a chemical entity that is associated with a biological 
macromolecule and is necessary for the protein's biological function. For this reason the 
metal cofactor is usually called prosthetic group, indicating its ability to help the 
macromolecule to carry out its function. Typically metal cofactors catalyze reactions or 
help provide the required geometry of a protein. 
Beside directly incorporating a variety of metal ions into proteins, the nature has 
also selected other inorganic ligands for the metal centre such as the iron-sulfur clusters 
and tetrapyrroles. These prosthetic groups are largely used in electron transfer proteins 
and redox enzymes as their redox potential can opportunely be tuned over large ranges. 
Some metal ions are found deeply buried within proteins. Such metal ions are 
usually structural in function. Their interaction with the protein helps insure the optimal 
protein structure and contributes to the stability and appropriate behavior necessary to 
perform the physiological function. For example, the Zn
2+
 ions in Zn fingers which are 
transcription factors necessary for the adoption of the proper shape of the protein, 
allowing its interaction with DNA. It is not currently known if the zinc ion plays more 
than a structural role in this proteins i.e. if the Zn
2+
 concentrations are also used in some 
manner to regulate gene expression.  
Beyond the biocoordination chemistry that generally focuses the attention on 
interactions between metals and ligands at the level of the coordination sphere, the 
biological process that produces minerals, called biomineralization, is an important 
subject (nowadays largely studied) that will be examine in Chapter 4. The research aims 
of biomineralization consist in the characterization of the structure and composition of 
the biomineral, in the comprehension of the functional properties of biominerals and 
elucidation of the process through which protein control the synthesis, construction and 
organization of inorganic mineral-based materials. 
Introduction 
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1.2.4. Protein-Protein Interactions  
 
Complete sequencing of genomes has indicated that a living organism can contain 
tens of thousands of protein-protein interactions (PPIs), which form a web of intricate 
communication networks.
19,20
 PPIs are known to be the major components of a wide 
variety of cellular events such as the transport machinery across biological membranes, 
packaging of chromatin, muscle contraction, signal transduction and regulation of gene 
expression, just to name a few. Anomalous PPIs are implicated in a big number of 
diseases; monitoring them serves as tools to reveal the molecular basis of such diseases. 
The structural characterization of a PPI is a topic that will be discussed in Chapter 3.  
It is now clear that many proteins interact with multiple partners, either 
simultaneously or separately, depending on availability and environment. The ability to 
bind multiple partners forms the basis of network complexity, which in turn is related to 
the extent of evolution of a particular organism. 
The systematic identification of interactions for a given proteome was proposed as 
an informative functional strategy.
21,22
 At the beginning, interactions involved in 
biological processes were characterized individually. This was a reductionist approach 
that suffered from a lack of information about time, space, and context in which the 
interactions occur in vivo. Further, a combined experimental and computational 
approach, was developed with the aim of building PPI maps.  
The first global experimental analyses of PPIs was made on model organisms 
(yeast Saccharomyces cerevisiae and worm Caenorhabditis elegans)
23
 using the yeast 
two-hybrid technique
24
. In parallel, a series of computational bioinformatic methods 
have been designed to predict PPIs. Yeast, worm and fly
25-28
 PPIs were analyzed with 
this method. On the basis of experimental and computational analyses 28000 PPIs are 
estimated for yeast
19,29
. The big goal is to fully understand human molecular 
mechanisms of PPIs. Human proteome may have an order of magnitude more 
complexes than the yeast cell and the number of different complexes across all relevant 
genomes may be several times larger still.  
An interdisciplinary approach that includes in vivo and in vitro techniques has 
been developed for this purpose.
30
 Among the in vivo methods to identify PPIs network 
it is worth mentioning: 
 the yeast two hybrid technique; 
Introduction 
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 the Protein-fragment Complementation Assay (PCA), also known as 
bimolecular fluorescence complementation assay;
31
 
 fluorescence resonance energy transfer (FRET); 
while between those in vitro the most important are:  
 the protein affinity chromatography, where the target protein is coupled 
to a matrix under controlled conditions and used to select ligand proteins; 
 the immunoprecipitation, where cell lysates are generated, antibody is 
added, the protein-antibody complex precipitates, the complex washed, 
and complexed proteins are eluted and analyzed;  
 the microarrays where different proteins or specific DNA binding 
sequences immobilized on microchips are able to selectively bind protein 
partners or RNA fragments;  
 the library based methods used to screen large libraries for genes or 
fragments of genes whose products may interact with a protein of interest; 
 computational prediction of protein–protein interactions; 
Concerning the biophysical techniques used to study PPIs the most important are 
light scattering, fluorescence spectroscopy, surface plasmon resonance and calorimetry, 
while the structure of macromolecular complexes can be solved with atomic resolution 
by X-ray crystallography and NMR spectroscopy depending on the strength of the 
complex, and with lower resolution but with less limitations due to the size of the 
complex by cryo-electron microscopy (cryo-EM).  
The strength of a PPI can be described by the equilibrium dissociation constant 
(Kd = [P] [L]/[PL] where [P], [L] and [PL] are the equilibrium concentrations of protein, 
ligand and complexed state, respectively). The range of Kd values observed in 
biologically relevant processes is extremely wide and can span over twelve orders of 
magnitude [16]. Despite this large difference in affinity, all protein–protein interactions 
maintain a high degree of specificity for their partners. The PPIs are often broadly 
classified as weak, or strong. Decades of extensive studies have provided significant 
understanding of a large fraction of PPIs in living cells; however, the vast majority of 
these belong to the strong category (Kd < 10
-6
 M).
32
 The weak PPIs, especially those 
with Kd > 10
-4
 M, are poorly understood, despite the fact they might be crucial for 
mediating many important cellular events, such as transient and rapid assembly and/or 
reassembly of protein complexes for multi-component enzyme regulation, signal 
transduction turnover, etc..
32
 One reason for the slow progress of studies on many weak 
Introduction 
10 
PPIs is the technical difficulty in characterizing them, especially those with Kd > 10
-4
 
M, because they usually do not result in a sufficient amount of complexes that can be 
directly detected in vitro or in vivo by conventional methods. NMR has been known for 
years as one of the most sensitive tools for examining weak but functionally important 
protein-target interactions at physiological conditions, which are normally undetectable 
by most biochemical methods.
33,34
  
 
 
1.3. NMR as unique technique for weak interaction study 
 
NMR is a powerful and reliable method for studying such interactions. In 
particular it's an ideal technique for studying weak and transient interactions which are 
ubiquitous in the crowded environment of a cell, but generally ignored by other 
approaches. The unique potential of NMR for studying transient protein complexes that 
interact weakly has been demonstrated in the past years. Unprecedented new insight 
was gained for various multi-domain proteins that play crucial roles in intra- and extra-
cellular signaling,
35
 the regulation of gene expression,
36
 chaperone-protein complexes in 
kinase folding [Sreeramulu et al Schwalbe JBC 2008 kinase chaperone], and on metal 
mediated transient protein-protein interactions,
37
 to name a few. Moreover, has been 
recently demonstrated the utility and the potential of monitoring the course of events in 
protein-protein interactions; for example the protein phosphorylation in living cells can 
be followed in real time.
38
 In many cases, structural analysis by X-ray crystallography 
was not possible since crystallization failed or the crystallized protein constructs were 
strongly influenced by crystal packing. In others, although X-ray was successful in 
providing a structural view, NMR was necessary to relate it to the functional details of 
the post-translational regulatory mechanism.  
The unique strengths of NMR for these studies (can be summarized as) that are 
not  matched but are very complementary to other structural biology techniques are: 
 mapping binding interfaces for protein-protein interactions and 
characterizing the competition and cooperativity of interactions; 
 determining the structures and dynamics of (large) multicomponent 
protein complexes using NMR solution data, also by employing 
multidisciplinary hybrid approaches. NMR is unique in that it provides 
structural information for individual components (or domains) in a multi-
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component system and in that it can follow the changes in dynamics upon 
complex formation; 
 studying transient and weak interactions, which are critical for the 
regulation of cellular processes; 
 applications of NMR to the study of protein-protein and protein-nucleic 
acid complexes of medical importance includes the analysis of misfolded, 
partially folded or intrinsically disordered proteins.  
Complementary methods, like X-ray crystallography, SAXS, electron 
microscopy, cryo-EM and mass spectrometry are increasingly used together with NMR 
spectroscopy. 
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Targeting S100B-p53 binding 
interface with small molecules 
 
2. Summary 
 
In this chapter is reported the NMR screening of fragment libraries targeting the 
human S100B-p53 interaction site. This is a project in collaboration with Siena Biotech, 
a company that focuses its research in discovering new drugs for therapeutic 
intervention against neurodegenerative diseases and oncology. S100B represents an 
interesting pharmaceutical target because interacting with p53 it's able to inhibit its 
tumor suppressor activity. The identification of small molecule compounds able to bind 
S100B preventing S100B-p53 complex formation, restores p53 dependent tumor 
activity in cancer. Siena Biotech scientists performed the in silico screening that led to 
the identification of 280 novel prospective ligands for S100B. In CERM we carried out 
an in vitro screening by solution NMR that revealed specific binding at the p53 
interaction site for a set of these compounds and confirmed their potential for further 
rational optimization. The X-ray structure determined for one of the binders revealed 
key intermolecular interactions paving the way for structure-based ligand optimization. 
 
 
2.2. S100B 
 
Calcium is a universal, intracellular second messenger that plays a regulatory role 
in processes or events such as the conduction and transmission of the nerve impulse, 
muscle contraction, cell motility, cell growth and differentiation, gene expression, 
cross-talk between different enzyme systems, apoptosis and necrosis.
1
 Cells evolved 
classes of intracellular Ca(II)-binding proteins that act to regulate the levels of cytosolic 
Ca(II) and/or to transduce the intracellular Ca(II) signal.
2
 The EF-hand protein family
3
 
is one of such classes of calcium-binding proteins displaying several modes of calcium 
signaling via interaction with target proteins.
4
 The EF-hand  calcium-binding motif is a 
helix-loop-helix motif that was discovered first in the crystal structure of parvalbumin 
and found again in calmodulin and troponin C.
5
 One important subclass of EF-hand 
calcium-binding proteins is the S100 protein family whose name refers to their 
Chapter 
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solubility in a 100%-saturated solution of ammonium sulfate.
6
 This family of low-
molecular-weight (20-24 kDa) dimeric proteins comprises approximately 25 members 
which are expressed in a cell-specific manner and have been implicated roles in such as 
cellular growth and  differentiation, cell-cycle regulation, and cytoskeletal function and 
structure.
7-9
 
Of these, S100B has been one of the most intensely studied and well 
characterized. First isolated from brain in 1965 by Moore,
6
 S100B has subsequently 
been found in a variety of other tissues and has been shown to be highly conserved 
through a variety of species.
10
 
 
 
2.2.1. Structure 
 
In 1996, the three-dimensional structures of the calcium-free (apo) forms of rat
11
 
and bovine S100B
12
 were determined by solution NMR. Two years later, the first three-
dimensional solution structure of human Ca(II)-S100B was also determined.
13
 The 
comparison of this structure with those of rat and bovine proteins allows a detailed 
analysis of the calcium-induced conformational changes of S100B.  
S100B is a symmetrical non-covalent homodimer in which the two monomers, of 
91 amino acids each, are packed together in an antiparallel fashion. Each monomer in 
Ca-S100B is comprised of four -helices (I, Leu3-Tyr17; II, Ser30-Glu39; III, Val52-
Glu58; IV, Phe70-Phe88), three loops (I, Ser18-His25 (L1); II, Leu40-Glu49 (H); III, 
Asp61-Gly66 (L2)) and two short antiparallel -strands (I, Lys26-Lys28; II, Glu67-
Asp69) (Fig. 2.1). 
 
 
 
Figure 2.1 Amino acidic sequence of the humanS100B. 
Protein-ligand interaction 
16 
Each S100B monomer is formed by two helix-loop-helix EF-hand calcium-
binding motifs joined by a flexible linker region (Fig. 2.2). In Ca-S100B the N-
terminal-pseudo-EF-hand, also called low affinity (Kd = 200 mM) calcium-binding 
site, consists of the helix I, the calcium-binding loop L1 and -strands I, and the helix 
II; while the C-terminal-canonical-EF-hand, known as the high-affinity (Kd = 7–50 
mM) calcium binding site comprises the helix III, the calcium-binding loop L2 and -
strands II, and the helix IV.
14-16
 A linker region (hinge loop, H) connects helix II–III. 
Helix IV is followed by a C-terminal extension (Fig. 2.2). The two monomeric S100B 
subunits form a compact, globular, non-covalent homodimer in solution. The dimer 
interface primarily involves hydrophobic interactions between helices I of different 
monomers and helices IV of different monomers. Contacts between helices I of 
different monomers extend nearly the entire length of each helix (Glu2–Val13) (Fig. 
2.2).  
 
Figure 2.2. Schematic representation of the secondary structure of an S100 
protein.  
 
Comparing the NMR structures of human Ca(II)-S100B, rat and bovine apo-
S100B, some structural differences are evident. The N-terminal helix-loop-helix region 
in Ca(II)–S100B (residues Val8–Glu39) is very similar to that of apo- rat and bovine 
S100B (Fig. 2.3a), while the C-terminal calcium-binding loop in S100B undergoes a 
dramatic change in conformation compared to that of rat apo- and bovine S100B (Fig. 
2.3b). The superimposition of the entire calcium binding loop (Asp61–Glu72) and the 
same region of helix IV (Phe73–Phe76) for human Ca(II)–S100B, rat and bovine apo-
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S100B reveals a reorientation of the  sheet and helix IV in Ca(II)-S100B compared to 
both rat apo-S100B (backbone pairwise rmsd ~4.06 Å) and bovine apo-S100B 
(backbone pairwise rmsd ~5.03 Å). The cause for this difference can be attributed to the 
first six residues of the calcium-binding loop. More specifically, rearrangement of the 
C-terminal loop in Ca(II)–S100B upon calcium binding brings the side chains of Asp61 
and Asp63 into a more appropriate geometry to coordinate calcium. This 
conformational change is propagated through helix III, which becomes more 
perpendicular to helix IV as a consequence of a remarkable change of the inter helical 
angle between these two helices.
13,17-19
 Owing to this change, the hinge region swings 
out. As a result of these structural changes, a cleft forms in each monomer, which is 
defined by residues in the hinge region, helices III and IV and the C-terminal extension, 
and is buried in apo-S100B monomer. Residues defining this cleft are believed to be 
important for the Ca(II)-dependent recognition of S100 target proteins. 
 
 
 
Figure 2.3. Comparison of the EF-hands of human Ca(II)–S100B, rat apo S100B 
and Ca(II)–calbindin.20 (a) The N-terminal pseudo EF-hand in Ca(II)–S100B (green) 
and rat apo S100B (magenta), superimposed (N, C and CO atoms) with the analogous 
residues in the pseudo EF-hand of Ca(II)–calbindin (white). (b) The superposition (N, 
C and CO atoms) of the C-terminal EF-hands of Ca(II)–S100B (green) and rat apo 
S100B (magenta) with the analogous residues of Ca(II)–calbindin (white).  
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The hinge region and the C-terminal extension play a critical role in the 
interaction of S100B with several target proteins.
21-24
 Thus, upon Ca(II) binding, each 
S100B monomer opens up to accommodate a target protein, and the dimer can bind 
target proteins on opposite sides. By this mechanism a S100B dimer functionally cross-
links two homologous or heterologous target proteins (Fig. 2.4). Given the positions of 
the helices of one monomer relative to those of the other monomer (particularly helices 
I and IV and I' and IV') (Fig. 2.4), helix I' might participate in the formation of each of 
the two binding surfaces on a given S100 dimer.
25
 This would explain why most S100 
members form dimers; one S100 monomer is not enough for binding a target protein or, 
alternatively, target protein binding to S100 occurs with reduced strength.
10
 
 
 
Figure 2.4. Schematic representation of the putative mode of interaction of an 
S100 dimer with target proteins. A can be equal or different from B. 
 
The exposure to the solvent of hydrophobic regions in Ca(II)-S100B gives rise to 
the S100B association and precipitation at high ionic strength. Indeed, it was shown that 
calcium-binding to  S100B has a strong salt dependence. In particular, S100B self-
association occurs in the presence of calcium at higher ionic strengths, which gives rise 
to extensive broadening of NMR signals.
15,16,16,17
 This observation is consistent with the 
increased exposure of hydrophobic residues in Ca(II)–S100B as suggested by 
fluorescence and absorption studies.
17
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2.2.2. Function 
 
Most S100 proteins are generally expressed and distributed in a cell-definite 
fashion, indicating a conserved biological role. In this setting S100B is mainly 
concentrated in the nervous system and in adipose tissue.  
S100B has been widely associated with the pathology of degenerative 
neurological disorders including Down syndrome, Alzheimer’s disease, temporal lobe 
epilepsy, and brain damage after cardiac arrest.
26,27
 Functionally, S100B regulates 
several cellular functions like protein phosphorylation, protein degradation, calcium 
homeostasis, cell locomotion, transcription factors, stimulation of enzymes activity, 
regulation of receptor function and cell proliferation and differentiation via interaction 
with transcription factors in the nucleus.
10,27
 
In general, low levels of S100B have trophic effects, and higher levels are toxic, 
resulting in uncontrolled cell growth.
8,28,29
 Increased levels of S100B are found in 
astrocytic tumors,
30
 T cell leukemia,
31
 renal cell tumors,
32
 malignant mature T cells,
33
 
and rat renal cell tumor lines.
32
 In addition, elevated S100B levels have prognostic value 
for assessing the progression of malignant melanoma including recurrence of disease, 
disease progression to more advanced stages, and metastatic potential of the melanoma 
in the later stages leading to the suggestion that S100B may have a role in this 
neuropathological disease.
34-36
 
Since S100B undergoes a calcium-sensitive conformational change, it's able to 
interact with a variety of other target proteins; up to now more than 20 known partners. 
For example, calcium-binding to S100B regulates interactions with tubulin
37
 and glial 
fibrillary acidic protein (GFAP),
38
 which are important for cellular architecture, inhibits 
the phosphorylation of neuromodulin,
39
 myristoylated alanine-rich C kinase substrate 
(MARCKS)
40
 and tau proteins
41
 through interaction with the substrate, and binds the C-
terminus of p53 inhibiting its tumor suppressor function.
23,42
 In this study I will focus 
the attention on the S100B-p53 interaction. 
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2.2.3. Interaction: S100B-p53 
 
The p53 protein plays an important role in preventing cancer development. This 
protein has been called the “guardian of the genome” 43 as it prevents inappropriate cell 
proliferation and maintains genome integrity following genotoxic stress.
44,45
 Presently, 
p53 is known to play a key role in practically all types of human cancers, and the 
mutation or loss of the p53 gene can be identified in more than 50% of all human cancer 
cases worldwide.  
Wild-type p53 protein contains 393 amino acids and is composed of several 
structural and functional domains (Fig. 2.4):  
i) the N-terminus containing an amino-terminal domain (residues 1-42) and a 
proline-rich region (residues 61-94), required for trans-activation activity, 
ii) the central core domain (residues 102-292), able to bind DNA,  
ii) the C-terminus containing a tetramerization domain (residues 324-355), and a 
regulatory domain (residues 363-393), required for trans-activation activity.
44,46,47
 
 
 
 
Figure 2.5. Schematic representation of the p53 structure. 
 
p53 is inactive in normal, unstressed cells, but becomes active under various 
intracellular and extracellular stimuli, such as DNA damage, heat shock and oncogene 
overexpression. The p53 activation is regulated by post-translational mechanisms such 
as phosphorylation, acetylation, and prolyl isomeration,
48,49
 or by PPI.
50
 The latter 
mechanism promotes p53 structural changes and modulates its DNA binding domain 
affinity to DNA. In addition, tetramerization was found to be relevant in p53 
activation,
51
 p53 binds to its DNA response elements most efficiently as a tetramer, then 
Protein-ligand interaction 
21 
a monomer. The p53 active form bound to DNA induces the expression of downstream 
genes and thereby arrests cell cycle, repairs damaged DNA, or induces apoptosis.
52
  
The majority of cancer-associated p53 mutations cluster within the DNA binding 
domain and disrupt the p53-DNA binding activity.
43
 However, recent studies have 
identified mutations also within the tetramerization domain that are associated with 
cancer.
53
 
S100B is able to bind the C-terminus of p53 and inhibit its tumor suppressor 
function. Evidence for S100B-p53 interaction in vivo comes from co-
immunoprecipitation experiments with S100B performed in human primary malignant 
melanoma cancer cells.
42
 Upon binding p53, S100B inhibits phosphorylation of the 
tumor suppressor at the C-terminus and disrupts the p53 tetramers,
21,54
 two steps 
required for p53 transcriptional activity.
55,56
 Thus, high levels of S100B in cancer cells 
such as malignant melanoma likely contribute to uncontrolled cell growth by down-
regulating p53.
57
  
The interaction between S100B and p53 is a calcium dependent process.
21,58
. A 
comparison of the 3D structures of calcium-free S100B (apo-S100B), calcium-bound 
S100B (holo-S100B), and holo-S100B bound to a peptide derived from the C-terminal 
negative regulatory domain illustrates the details of the  calcium-dependent S100B-p53 
interaction.
23
 Specifically, calcium binding to S100B causes a conformational 
rearrangement, upon which several residues form a hydrophobic patch and become 
solvent-exposed and available for interaction with the target polypeptide (Fig. 2.6).
59
 
In particular, several hydrophobic residues on helix III, helix IV, and loop II are 
exposed due to a large conformational change in the second EF-hand domain of S100B 
(Fig. 2.6). Are these newly exposed residues that form a mini-hydrophobic patch on 
holo-S100B and participate in the S100B-p53 binding interface (Fig. 2.6). In the 
absence of calcium, these same hydrophobic residues are buried in the core of the 
S100B subunit, and p53 cannot bind S100B, even at mM concentrations
21
 (Fig. 2.6).  
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Figure 2.6. Diagram illustrating the Ca(II)-dependent conformational change in 
S100B necessary to bind target proteins. In the ribbon diagrams of S100B, subunits are 
shown in red and blue, and the target protein is shown in green. Residues that have 
intermolecular correlations between S100B and the target protein are colored yellow on 
one subunit of S100B in each ribbon diagram to illustrate the Ca(II)-dependent 
conformational change necessary to expose the target protein binding site on S100B. 
 
The key interactions between the two partner proteins have been identified by 
NMR via the solution structure of rat S100B in complex with the C-terminal negative 
regulatory domain of p53 (residues 367-388) as involving 21 residues from in helices  
and IV and the hinge loop of S100B (Fig. 2.7).
23
 Among these residues, the most 
important in terms of interaction are Leu44, Glu45, Val52, Val56, Met79, Val80, Glu86 
and Phe87 whose protons are shown in blue in Figure 2.7. 
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Figure 2.7. Positioning of side chain residues in the p53 peptide-S100B complex. 
Ribbon diagram displaying the side chains involved in the hydrophobic binding pocket.  
 
The same region was identified to bind TRTK-12,
60
 a twelve-residue peptide 
derived from the actin capping protein CapZ with sub-micromolar affinity for S100B 
(Kd = 200-300 nM).
61
 The residue involved in the interaction are Leu40, Leu44, Glu45 
and Ile47,  from the hinge loop, Val52, Lys55, Val56 and T59, from the helix 3 and 
Met79, Val80 and Ala83 from the helix 4 (Fig. 2.8).  
 
 
 
Figure 2.8. Side-chains of S100B and TRTK-12 that are involved in the peptide–
protein interface. 
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There is no sequence similarity between p53 and TRTK-12 peptides, which in fact 
occupies the hydrophobic pocket of S100B a in a different orientation with respect to 
TRTK-12 (Fig. 2.9).  
 
 
 
Figure 2.9. Side-chains of S100B and TRTK-12 that are involved in the peptide–
protein interface. 
 
The availability of high-resolution structural information of bond form of S100B 
provides the possibility of applying structure-based approaches to identify small 
molecule compounds that bind to this hydrophobic patch on holo-S100B and inhibit the 
calcium-dependent S100B-p53 interaction. There are a many studies concerning this 
topic: Weber and coworkers
62
 identified few small molecules binding human S100B 
using a NMR-based screening, while Arendt et al. identified inhibitors of the highly 
homologous bovine protein with a similar methodology.
63
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2.3. Aim of the project 
 
In the present study we have performed an in vitro screening of virtual hits, 
selected by an in silico screening performed by Siena Biotech, with the aim to identify 
suitable scaffolds for the development of inhibitors of PPIs of human S100B. The 
challenge of targeting PPIs resides on the large and flat contact surface area for the 
complex between the two partner proteins (~1500-3000 Å
2
).
64
 The lack of well-defined 
binding sites and “druggable” cavities represents a major issue for planning in silico 
virtual screening experiments.
65
 Identification of 'hot spots' is a non trivial task,
66
 
moreover the small molecule may bind trapping protein conformations not represented 
in the “frozen” X-ray structure.  
Siena Biotech used the frames present in the available NMR structures for in 
silico screening, in order to consider the various conformations of both target and/or 
ligand as a model for system flexibility and compound selection. 
A set of selected virtual hits were then screened in CERM by NMR studies and 
led to the identification of a number of weak (Kd in the range of 0.1-1.4 mM) S100B 
ligands, characterized by novel chemo types. The X-ray structure of the complex 
between S100B and one of the identified fragments was determined as starting point for 
structure-based drug design. 
 
 
2.4. Methods 
 
NMR is a powerful tool for assessing interactions between protein and ligands. 
Over recent years NMR has gained importance as a versatile tool for industrial drug 
research. Its greatest potential in this field lies in the information that it can reveal about 
intermolecular interactions at various levels.
67
 NMR screening exploits the fact that 
many NMR observables change even upon temporary binding because of global and 
local effects. One example of application is the qualitative screening of pharmaceutical 
libraries to assess binding.  NMR experiments, such as the 
1
H NMR relaxation 
measurements, are sensitive to the overall molecular motion of test compounds, which 
is very different for free versus bound ligands. Thus, these simple approaches can be 
used to validate ligand binding and/or to identify potential ligands in mixtures of test 
compounds. Another approach is the chemical shift mapping, where interacting residues 
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can be identified and mapped on the surface of a known protein structure. Indeed, a 
simple parameter, the NMR chemical shift, is highly sensitive to the exact environment 
of the nucleus and therefore yields information about whether a small molecule binds to 
a target protein, what parts of the small molecule are interacting and to which part of the 
macromolecular target the small molecule is bound. A further application could be the 
modeling and sometimes the determination of the three-dimensional structure of a 
protein–ligand complex. The variety of readily measurable NMR parameters allows 
several applications of NMR in drug discovery, including assessing target druggability, 
pharmacophore identification, hit validation, hit optimization and potentially structure-
based drug design. 
The advantages offered by NMR for drug research can be summarized as follow: 
1. NMR can detect the weakest ligand-target interactions of any method so far and 
thus can discover initial hits with even mM dissociation constants. 
2. NMR is a universal screening technique that, unlike bioassays, requires no 
knowledge of a protein’s function and therefore no target-specific setup.  
3. NMR concomitantly enables a determination of binding constants.  
4. NMR spectrally separates individual components, allowing the direct screening 
of mixtures from natural sources or combinatorial chemistry. 
5. NMR gives structural information for both target and ligand with atomic 
resolution for the subsequent optimization of weak initial hits into strongly binding drug 
candidates.  
 
 
2.4.1. NMR ligand-based screening 
 
Does a compound bind to the target protein? The NMR ligand-based screening 
experiments answer this question. The exquisite sensitivity of ligand NMR parameters 
in the bound and free states constitutes the basis for all ligand-based techniques.  
The typical implementation of ligand-based methods compares the NMR 
parameters of a mixture of compounds in the presence and absence of the target 
molecule. This approach renders the molecular weight of the receptor molecule not 
subject to size limitations.  In fact, the most powerful ligand-based approaches become 
more sensitive when dealing with larger receptors. Additionally, ligand observation 
bypasses the need to produce milligram quantities of isotope labeled protein. Depending 
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on the approach, less than 1 mg of unlabeled protein is required for these experiments. 
An obvious disadvantage of ligand-based approaches is the inability to localize the 
binding site of the small molecule hits on the receptor. 
One of the most utilized techniques is the WaterLOGSY (Water-Ligand Observed 
by Gradient SpectroscopY) experiment.
68
 
 
 
2.4.1.1. WaterLOGSY 
 
The WaterLOGSY
69
 technique represents a powerful method for primary 
screening in the identification of compounds interacting with macromolecules. In the 
WaterLOGSY experiment the bulk water magnetization selectively perturbed is 
partially transferred to the free ligand via the ligand–protein complex. The occurring 
transfer of magnetization is therefore water → receptor → ligand (Fig. 2.10). 
 
 
 
 
Figure 2.10: Magnetization transfer mechanisms underlying WaterLOGSY. 
Magnetization transfer from bulk water to ligand occurs via labile receptor protons 
within and remote from the ligand-binding site as well as from long-lived water 
molecules within the binding pocket. 
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Inverted water magnetization can be transferred to the bound ligands via three 
simultaneous pathways.  
 One pathway involves direct 1H-1H cross-relaxation between the bound 
ligand and “bound” water molecules at the binding site. Such water 
molecules are bound in the sense that their residence times on the surface 
of the receptor exceeds the receptor rotational correlation time. As a result, 
the rate constants governing dipole-dipole intermolecular cross-relaxation 
between the bound ligand and water molecules are negative and tend to 
bring the ligand magnetization to the same inverted state as that of the 
water.  
 A second pathway is direct cross-relaxation with exchangeable receptor 
NH and OH protons within the binding site. Chemical exchange of these 
protons with those of bulk water inverts their magnetization. These 
NH/OH then propagate inversion to the bound ligand protons via 
intermolecular dipole-dipole cross-relaxation. 
 The third pathway involves indirect cross-relaxation with remote 
exchangeable NH/OH protons via spin diffusion. The inverted 
magnetization is then relayed to other non labile spins via spin diffusion.  
The bound ligand interacts directly or indirectly with inverted water spins via 
dipole-dipole interactions with sufficiently long rotational correlation times c to yield 
negative cross-relaxation rates. By contrast, nonbinders’ dipolar-dipolar interactions 
with water have much shorter c, leading to positive cross-relaxation rates. As a 
consequence, binders and nonbinders display WaterLOGSY peak intensities of opposite 
sign, thus providing an easy means to discriminate between them (Fig. 2.11). Therefore, 
the WaterLOGSY technique allows binding compounds to pick up the bulk water 
inversion while residing in the receptor binding site.  
Another mechanism exists for the transfer of magnetization to free ligands, which 
is via chemical exchange of bulk water with exchangeable ligand protons, and 
consequent intermolecular ligand dipole-dipole cross relaxation. This effect has the 
potential to complicate interpretation of data but can be easily correct by collecting 
control WaterLOGSY spectra for free ligands. 
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Figure 2.11. Water-LOGSY spectrum of the free ligand (red) and of the ligand in 
the presence of a protein (blue). The signals belonging to the binding ligand are 
highlighted in magenta. 
 
The major aspects of the Water-LOGSY technique are summarized in Table 2.1. 
 
                                Water-LOGSY 
Large protein          
(>30 kDa) 
    Yes 
Small protein          
(<10 kDa) 
    No 
Amount of protein (nM) 
at 500 MHz       ≈ 25 
Kd tight binding     100 pM 
Kd weak binding     ≈ 10 mM 
 
 
Table 2.1. Water-LOGSY major characteristics. 
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2.4.2. NMR protein-based screening 
 
Where is the ligand localized on the protein surface? The NMR target-
observed screening answers this question. Observation on the target is neither restricted 
by the ligands’ size nor by an upper affinity limit. It also immediately reveals different 
binding sites, enables direct distinction between specific and unspecific binding and 
provides a wealth of structural information for ligand optimization. This information, 
however, can only be extracted if the spectral assignments for the target are known. 
Inherent limitations often preclude observation on the large target molecule, although 
relaxation-optimized techniques combined with appropriate extent of sample 
deuteration may be of benefit. The most used protein based technique is based on the 
chemical shift perturbation. 
 
 
2.4.2.1. Chemical shift perturbations 
 
One of the advantages of  NMR spectroscopy is its ability to efficiently map the 
interaction surface of a protein with ligands.
70
 This is based on the fact that the chemical 
shift of a particular nucleus is a very sensitive function of changes in its chemical 
environment.  
The most used NMR mapping technique is based on Chemical Shift Perturbations 
(CSPs). This procedure exploits differences in chemical shift between free and bound 
protein in 
15
N-
1
H and two-dimensional correlation spectra of the labeled target upon 
titration of a unlabeled ligand. The interaction causes environmental changes on the 
protein interfaces and, hence, affects the chemical shifts of the nuclei in this area (Fig. 
2.12A). The quantification of the chemical shift variation for each protein residue upon 
binding of the ligand requires the calculation of an average weighted 
1
H-
15
N chemical 
shift difference following the equation:
71
 
 
 (NH) = 
     
2
1521
2
5/NH  
     (2.1) 
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The average weighted CSP values for each backbone amide are usually plotted as 
a function of the residue number, thus providing the so called Garrett plot, as 
exemplified in Figure 2.12B. The analysis of the plot provides a per-residue 
characterization  of the protein-ligand interface (Fig. 2.12C), thus allowing the study of 
local effects that are associated with ligand binding and the identification of the binding 
area on the protein. This procedure is of course possible only if the assignment of 
backbone amide resonances is available. One drawback of CSPs is the possible 
reflection of indirect effects linked to structural changes induced by ligand binding. 
 
 
 
Figure 2.12. Theoretical example of chemical shift mapping. (A) Superimposition 
of 
15
N–1H HSQC (Heteronuclear Single-Quantum Coherence)72 spectra of protein 
without ligand (black cross-peaks) and protein with ligand (red cross-peaks). (B) 
15
N 
and 
1
H weighted chemical shift changes between protein without ligand and with ligand 
are plotted against the amino acid sequence of protein. (C) Residues of the protein that 
have been most shifted by binding to lactose are highlighted in red and orange. (D) The 
fractional change in protein HSQC weighted chemical shifts is plotted against the 
concentration of the ligand.  
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CSPs also allows quantification of the kinetics, specificity, stoichiometry, and 
binding affinities. Plotting the  (NH) of each residue as function of the ligand 
concentration (mM) and fitting the curve with the function 2.2, it is possible to calculate 
the dissociation constant (Kd) (Fig. 2.12D). 
 
xK
Bx
y
d 
       (2.2) 
 
where B is the limit value  (NH) corresponding to the maximum concentration 
of the protein in complex with the ligand, y =  (NH) and x represents the ligand 
concentration (mM). 
The chemical shift approach is arguably one of the most robust, reliable and 
reproducible ligand binding assays currently available. However, although shift 
perturbation measurements reveal which residues are located at an intermolecular 
interface, they do not in themselves provide information about the relative orientation of 
the two partners. X-ray crystallography or NMR spectroscopy provide such 
information. The following data represents an example of a combined NMR-X-ray 
approach where solution NMR was used to screen potential ligands and to identify their 
binding areas on the protein surface, while crystallography provided structural 
information on the complex. 
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2.5. Results  
 
2.5.1. Virtual screening 
 
The fragment library that Siena Biotech scientists used for virtual screening 
purposes was generated starting from a data (6 M compounds) of commercially 
available compounds. The collection was filtered by the rule of three (molecular weight 
<300, Hydrogen Bond Acceptor (HBA) and Hydrogen Bond Donor (HBD) < 3).
73
 
Undesired and reactive groups, e.g., acyl chlorides, azides, aldehydes, hydrazones, etc. 
were also removed from the collection. Furthermore, an insolubility model
74
 was 
applied in order to filter out potentially insoluble compounds. The resulting set of 
123,000 fragments was submitted to virtual screening.  
Three complementary in silico approaches 280 compounds were selected. 
 
 
2.5.2. NMR screening 
 
NMR screening of the 280 compounds selected by in silico approaches was 
performed using ligand-based WaterLOGSY experiments.
68,75
 123 molecules showed 
peak intensity variation > 20% in the presence of protein and were classified in different 
classes of ligand strength on the basis of the observed signal intensity changes. Peak 
intensity variations <20% were considered not meaningful and typical for non 
interacting molecules; reduction of the original signal intensity in the 20-60% range was 
taken as an indication of a weak binder; strong reduction or absence (i.e. variations in 
intensity in the 60-100% range) of the signals was taken as an indication that the 
molecule is a medium affinity ligand; peak intensities of opposite sign with respect to 
the original spectrum were considered typical for strong binders. Based on the extent of 
the observed effect, therefore, 11 molecules could be classified as strong binders, 15 as 
medium-strength binders, and 97 as weak binders. The strong and medium binders were 
used to titrate 
15
N-labelled protein samples in 
15
N-HSQC spectra. In all cases, fast 
exchange between free and bound forms was observed on the NMR chemical shift time 
scale. Following the chemical shift perturbations (equation (2.1)) of the backbone amide 
signals during the titration with the organic compounds, it was possible to identify the 
binding area. Based on this type of analysis, 5 selective binders were identified, with 
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average chemical shift variations ≥ 0.03 ppm. The five molecules correspond to three 
different scaffolds, as summarized in the first column of Table 2.2.  
 
Molecular FormulaLibrary code  MW 
Estimated Kd (mM) 
 
Ligand Efficiency 
(kcal mol-1) 
Min-Max 
205A
[a]
 
263.7 0.5-1.0 0.25-0.23 
684A
[b]
 
280.3 0.6-1.2 0.21-0.19 
683A
[c]
 
280.3 0.1-0.5 0.26-0.21 
728A
[b]
 
280.3 0.1-1.0 0.26-0.19 
829
[d]
 
290.4 0.6-1.4 0.22-0.19 
[a] Compound selected via docking (S100B-TRTK12)   
[b] Compound selected via structure-based pharmacophore approach (S100B-TRTK12)  
[c] Compound selected via ligand-based pharmacophore  
[d] Compound selected via structure-based pharmacophore (S100B-p53). 
 
Table 2.2. NMR screening results. 
 
For these ligands estimates of Kd were obtained plotting the weighted average 
chemical shifts variations of perturbed residues as a function of the concentration of the 
added ligand and found to be in the 0.1-1.4 mM range (Table 2.2). Calculated ligand 
efficiencies for these compounds are somewhat smaller than the minimal 0.3 kcal mol
-1
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OH
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threshold value
76
 and the number of non-hydrogen atoms is relatively high (18-21 non-
hydrogen atoms). Nevertheless they still fall in a class suitable for optimization. For 
example, a remarkable improvement in ligand efficiency from 0.26 to 0.37 kcal mol
-1
 
has been reported upon addition of two non-hydrogen atoms to a compound of 31 non-
hydrogen atoms.
77
 Structural information on the binding mode is expected to help for an 
efficient progression of their optimization.
78
 This goal was here pursued by a combined 
NMR/X-ray approach. 
A detailed analysis of the chemical shift perturbations in 
15
N-HSQC spectra  
reveals that there is common binding region for all 5 ligands, defined by the hinge loop, 
the C-terminal part of the helix 4 and the helix 3 (Fig. 2.13), that corresponds to the 
broad interaction area with p53.  
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Figure 2.13. Plots of the weighted average 
1
H and 
15
N chemical shift variation 
(Garrett values) for the most relevant compounds. 
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In order to better prove that binding of our ligands really involves spots at the 
target protein-protein binding area, the high affinity TRTK-12 peptide was used as test 
compound, to verify that its binding is able to displace the lower affinity small 
molecules. Binding of TRTK-12 to S100B results in the disappearance of a number of 
resonances in the 
1
H-
15
N HSQC spectrum of the isolated protein, and growth of new 
signals (Fig. 2.14A).  
 
 
 
Figure 2.14. (A) Superimposition of the 
15
N-HSQC spectra of S100B (black 
trace) and S100B-TRTK-12 complex in the 1:1 ratio (green trace). (B) Superimposition 
of the 
15
N-HSQC spectra of S100B (black trace) and S100B-SEN205A complex 1:5 
ratio (red trace). (C) Superimposition of the 
15
N-HSQC spectra of the S100B-TRTK-12 
complex, 1:1 ratio (green trace) and the S100B-SEN205A complex at a 1:5 ratio (red 
trace). (D) Superimposition of the 
15
N-HSQC spectra of the S100B-TRTK-12 complex 
at a 1:1 ratio (green trace) and S100B-SEN205A complex titrated with TRTK12 at a 
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1:5:1 ratio (magenta). Very low intensity peaks are below the displayed threshold in 
some of the spectra. 
 
This behavior is typical for a slow exchange regime, on the NMR chemical shift 
time scale, between free and bound protein forms. Slow exchange on the chemical shift 
NMR time scale is consistent with the much larger affinity of TRTK-12 for S100B with 
respect to our ligands. Consistently, maximum chemical shift differences between 
resonances (calculated according to equation (2.1)) of the same residue in the free and 
TRTK-12-bound state are larger (0.3 ppm) than the chemical shift variations measured 
in the presence of small ligands (0.18 ppm).  
Residues changing their position in the NMR spectrum of S100B bound to TRTK-
12 are many and clustered in the p53 interaction area, constituted by the hinge loop and 
part of the helices , IV and I (Fig. 2.9). The large number of involved residues 
indicates a wide contact area between the peptide and the protein. The ensemble of 
residues affected by TRTK-12 binding invariably includes those experiencing chemical 
perturbations in the presence of our ligands. This fact already indicates that binders 
resulting from our screening are indeed targeting spots at the S100B/TRTK-12 
interaction surface. Competitive displacement of our ligands upon addition of TRTK-12 
was demonstrated for three molecules representative of the three identified scaffolds 
i.e., SEN205A, SEN683A, and SEN829. The complex between SEN205A and S100B 
was obtained using a 5-fold excess of the small molecule with respect to the 
concentration of the monomeric S100B (Fig. 2.14B). Addition of TRTK-12 to this 
solution induces formation of a new species, in slow-exchange with the pre-existing 
one. Addition of 0.5 equivalents of TRTK-12 is sufficient to fully displace the small 
molecule. Upon addition of 1 equivalent of TRTK-12 a spectral fingerprint identical to 
that of the 1:1 S100B/TRTK-12 adduct (Fig. 2.14D) is obtained. Therefore, TRTK-12 
displaces SEN205A from its binding site and substitutes it. The same behavior was 
obtained for SEN683A, and SEN829 and is reported in Figure 2.15 and 2.16. 
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Figure 2.15. (A) Superimposition of the 
15
N-HSQC spectra of S100B (black 
trace) and S100B-SEN683A complex, 1:4 ratio (red trace). (B) Superimposition of the 
15
N-HSQC spectra of the S100B-TRTK-12 complex, 1:1 ratio (green trace) and the 
S100B-SEN683A complex,1:4 ratio (red trace). (C) Superimposition of the 
15
N-HSQC 
spectra of the S100B-TRTK-12 complex, 1:1 ratio (green trace) and S100B-SEN683A 
complex titrated with TRTK12 in the 1:4:1 ratio (magenta). Very low intensity peaks 
are below the displayed threshold in some of the spectra. 
 
 
 
Figure 2.16. (A) Superimposition of the 
15
N-HSQC spectra of S100B (black 
trace) and S100B-SEN829 complex, 1:2 ratio (red trace). (B) Superimposition of the 
15
N-HSQC spectra of the S100B-TRTK-12 complex, 1:1 ratio (green trace) and the 
S100B-SEN829 complex, 1:2 ratio (red trace). (C) Superimposition of the 
15
N-HSQC 
spectra of the S100B-TRTK-12 complex, 1:1 ratio (green trace) and S100B-SEN829 
complex titrated with TRTK12 in the 1:2:1 ratio (magenta). Very low intensity peaks 
are below the displayed threshold in some of the spectra. 
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2.5.3. Protein crystallography 
 
The structure of S100B-SEN205A complex has been determined by X-ray 
crystallography by the research group of Mangani from Siena, using a reflection data set 
collected at the EMBL X11 beamline c/o DESY, Hamburg. The structure has been 
easily solved by molecular replacement and clearly shows the presence of a S100B 
homodimer in the crystal asymmetric unit. The refined model consists of two S100B 
independent subunits where only the last 2 residues at the C-terminus are missing in 
chain A and the last residue is missing in chain B. The final model consists of 179 
residues (Met0 to Glu89 (His90 in chain B)), 4 calcium ions and 96 water molecules. 
The Ramachandran plot shows that 91.7% residues are in preferred regions, 8.3% in 
allowed regions and none in the disallowed regions. 
The electron density in the cavity delimited by helices III and IV (Fig. 2.17) in 
both subunits is consistent with the dimensions of the SEN205A fragment. The region 
appearing as the SEN205A binding site is not involved in any crystal contacts so that 
the molecule binding is not influenced by lattice interactions. 
 
 
 
Figure 2.17. Electron density maps of the fragment in the two protein subunits. 
Protein maps are in cyan, ligand maps are in green. Positive map peaks of the protein 
refined without the ligand are represented in magenta. 
 
Ligand fitting to the density, followed by refinement of the complex, showed a 
well defined orientation of the fragment within the binding site.  
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The orientations of SEN205A appear to be different between the two S100B 
subunits (Fig. 2.18).  
 
 
Figure 2.18. Different fragment orientation present in the crystal structure. The 
two S100B monomers with bound fragments (chain A, in pale yellow, chain B in light 
pink and bound fragments in yellow and magenta, respectively) are overlaid on 
backbone atoms, showing two different orientation of compound SEN205A within the 
same binding site of the two subunits. 
 
A cross-check with NMR experimental data highlighted that the location of 
residues showing NH-chemical shift variations is consistent with the binding mode 
determined for chain B interaction site. The hydrophobic moiety of SEN205A fits with 
a good shape complementarity into the hydrophobic pocket determined by residues 
Leu32, Ile36, Leu44, Ile47, Val52, Leu60 and Phe76. In particular, the rotation of 
Met79 side chain opens a small cavity where the chlorine substituent of the phenyl is 
placed. The piperidine ring protrudes toward the protein residues of the flexible hinge 
loop, which is mainly composed of polar residues.   
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2.6. Discussion  
 
Analysis of S100B complexes with binding peptides highlighted that the calcium-
dependent S100B-protein interaction is characterized by a wide contact surface with a 
hydrophobic central region and polar surrounding residues (Fig. 2.10). This kind of PPI 
between an amphypatic α-helix on a protein and a hydrophobic cleft on its partner is 
similar to other therapeutically relevant interactions such as Bcl-xL-Bak (See section 
3.2.4). 
Small molecule modulation of PPIs for therapeutic intervention represents a 
challenging task. Fesik et al. have recently reported
79
 the discovery of a potent inhibitor 
of the anti-apoptotic protein Bcl-xL via a fragment-based SAR by NMR approach. 
Identification of fragment targeting hot spot has thus proved to be a successful strategy 
for developing PPI inhibitors. Moreover molecular fragments would adapt more easily 
to the intrinsic flexibility of protein-protein interface. 
The virtual screening method allowed the selection of a relatively small number of 
virtual hits to be submitted to biophysical screening, by rationally sampling a set of 280 
fragments from a large library of 123,000 compounds. The 5 most active compounds  
originated from our in vitro approaches represents the 2% of the screened library, thus 
confirming the validity/effectiveness of NMR-based screening approach.  
It can be observed that compounds SEN683A, SEN684A and SEN728A are close 
analogues (Table 2.2).  
It is worth noting that 4 out of the 5 compounds identified originated from models 
based on the S100B structure bound to the most potent ligand TRTK-12. Analysis of 
S100B complexes showed that, although the C-terminal part of p53 and TRTK-12 
peptides interacts with S100B broadly in the same binding site, an induced fit effect is 
evident and S100B conformation varies following specific peptide binding (Fig. 2.9). 
TRTK-12 shows a higher shape complementarity to S100B surface. NMR-estimated Kd 
and ligand efficiency values for the identified molecules are low. However, the five 
binders identified by NMR really target the TRTK-12 binding site and show 
potentialities for future optimization. 
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2.7. Experimental section  
 
2.7.1. Protein samples and organic molecules 
 
All materials were obtained from commercial suppliers and used without further 
purification. Unlabelled and 
15
N-enriched human S100B for NMR and X-ray studies 
was purchase from ProtEra srl. Potential ligands selected by virtual screening for further 
biophysical characterization were purchased from Asinex, Chembridge, ChemDiv, 
Enamine and Specs.; the TRTK-12 peptide was purchased from Mimotopes Pty Ltd. 
 
 
2.7.2. NMR experiments 
 
Unlabelled and 
15
N-enriched S100B samples were prepared in acetate buffer 20 
mM pH 6.0, and 20 mM CaCl2. Samples for WaterLOGSY (Water Ligand Observed via 
Gradient SpectroscopY)
68
 experiments were 20 M in protein monomer concentration 
and 800 M in candidate ligand concentration. Samples for 15N-HSQC72 and 15N 
NOESY-HSQC
80
 spectra were 300 M in monomeric protein concentration. NMR 
spectra were recorded at 298 K. WaterLOGSY experiments were run on a Bruker 
AVANCE 700 MHz spectrometer equipped with a 5 mm triple-resonance TXI, Z-
gradient probe, and an automatic sample changer. For each compound, a reference 1D 
WaterLOGSY spectrum of the compound alone and a 1D WaterLOGSY spectrum in 
the presence of the protein were recorded. The initial set up of the WaterLOGSY 
experiment was performed on pentamidine, a molecule known to bind S100B at the p53 
site with high affinity
81
; this provided us an internal control of the reliability of our 
methodological approach. WaterLOGSY NMR experiments employed a 2 ms selective 
rectangular 180° pulse at the water signal frequency and a NOE mixing time of 2 s. 
15
N 
HSQC and 3D 
15
N NOESY-HSQC (mixing time of 110 ms) experiments were acquired 
on a Bruker AVANCE 800 MHz spectrometer, equipped with a cryoprobe. The 
acquisition parameters for these NMR spectra are provided as Supporting Information 
(Table 2.3). 
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Experiments Dimension of acquired data 
(nucleus) 
Spectral width 
(ppm) 
         t1                      t2                  t3        F1                F2                 F3 
WaterLOGSY
a 
16384(
1
H)    12.0   
1
H-
15
N-HSQC
b 
100(
15
N) 1024(
1
H)  14.3 40.0  
15
N-edited [
1
H-
1
H]-NOESY
b 
256(
1
H) 40(
15
N) 1024(
1
H) 16.0 40.0 16.0 
a
 Data acquired on a 700 MHz spectrometer. 
b
 Data acquired on a 800 MHz spectrometer equipped with a cryo-probe  (TXI, 5-mm)  
All the spectra were processed using the standard Bruker software (XWINNMR) and analyzed by  the 
CARA program. 
 
Table 2.3. Acquisition parameters for the NMR experiments, acquired at 298 K. 
 
The chemical shift change (in ppm) of the individual amide pairs was defined as 
the weighted average 
1
H and 
15
N chemical shift variations, according to the equation 
(2.1). 
Kd values in the case of fast exchange between free and bound forms were 
calculated by plotting the weighted average 
1
H and 
15
N chemical shifts of affected 
residues as a function of fragment concentration during the titration and fitted 
considering the one site binding mode. Kd values in the case of slow exchange between 
free and bound forms were calculated by plotting the decrease in intensity of the 
resonances of the free form as a function of peptide concentration and fitted considering 
the one site binding mode.
82
 The ligand efficiency (LE) was also calculated on the basis 
of the identified Kd values through the following equation (2.3):
76,83
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2.8. Conclusion 
 
Starting from an in silico screening, preformed by Siena Biotech, that lead to the 
identification of a library of 280 fragments that targets the p53-S100B binding interface, 
we performed an in vitro NMR screening that confirmed 5 selective binders. The 
estimated Kd is in the range of 0.1-1.4 mM and the ligand efficiency in the range of 
0.19-0.26 kcal mol
-1
. Although weak binders, these molecules target the binding site of 
TRTK-12 peptide, thus validating the reliability of the approach.  
These results are currently being utilized to develop the fragments into potent lead 
compounds via structure-based optimization. 
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Structural model for  
Bcl-xL-cytochrome c complex  
 
3. Summary 
 
In this chapter will be presented a NMR-derived model structure of the adduct 
between the human anti-apoptotic protein Bcl-xL and the human cytochrome c. Both 
proteins are involved in the programmed cell death called apoptosis. During the 
apoptotis mediated by mitochondria, cytochrome c is released into the cytosol where it 
initiates reactions that lead to the cell death.
1
 In vitro studies shown that cytochrome c 
interacts specifically with Bcl-xL, thus making the protein unable to perform this death 
reaction cascade and blocking apotosis.
2
 The model structure of the adduct, reported in 
the present study, provides insights at the atomic level on the mechanism by which 
cytochrome c translocated to cytosol can be intercepted, such that the apoptosome is not 
assembled. Moreover, this model allows the definition of the protein-protein interaction 
surface and reveals key intermolecular contacts that identify new potentially druggable 
spots on cytochrome c and Bcl-xL. 
 
 
3.1. Apoptosis 
 
The life and death of cells must be balanced if tissue homeostasis has to be 
maintained. Cell death is responsible of the maintenance of the cell populations in 
tissues of multicellular organisms upon physiological and pathological conditions. Cells 
have an intrinsic mechanism of self destruction called programmed cell death or 
apoptosis. The term programmed cell death was introduced to propose that cell death is 
not accidental but follows a sequence of controlled steps leading to self-destruction.  
Apoptosis (a greek term having the meaning "falling off or dropping off" in analogy to 
leaves falling off trees or petals dropping off flowers) had been coined in 1972 in order 
to describe the morphological processes leading to controlled cellular self-destruction.
3
 
Apoptosis is also called "clean death". In fact, during this process the cell is fragmented 
into compact membrane-enclosed structures, called apoptotic bodies that are engulfed 
Chapter 
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by macrophages and thus are removed from the tissue without damaging the 
surrounding cells or causing an inflammatory response, as occurs in necrosis (Fig. 3.1).
4
 
Apoptosis has a central role in maintaining tissue homeostasis, in the nervous 
system development, in the elimination of the old cells and in the immune system. 
Defect in apoptosis can result in cancer, autoimmune diseases and spreading of viral 
infections, while neurodegenerative diseases are caused or enhanced by excessive 
apoptosis.
5
 
 
 
 
Figure 3.1. Hallmarks of the apoptotic and necrotic cell death process.
6
  
 
 
3.1.1. Molecular mechanisms of apoptosis signaling pathways 
 
In principle, two alternative pathways that initiate apoptosis exist: one, called 
extrinsic pathway, is mediated by death receptors on the cell surface, the other is 
mediated by mitochondria and is known as the intrinsic pathway. In both pathways, 
specific proteases, called caspases, are activated leading to the biochemical and 
morphological changes that are characteristic of apoptosis (Fig. 3.2).  
In the intrinsic pathway the death receptors, activated by their natural death 
ligands, form a death-inducing signaling complex that activates the initiator 
procaspases-8 by autocatalytic cleavage (Fig. 3.2). In some type of cells, the signal 
coming from the activated death receptor does not generate a caspase signaling cascade 
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strong enough for execution of cell death. In this case, the signal needs to be amplified 
via mitochondria-dependent apoptotic pathways. The link between the caspase signaling 
cascade and the mitochondria is provided by BID, a Bcl-2 family member. BID is 
cleaved by caspase-8 and in its truncated form (tBID) translocates to the mitochondria 
where it induces the release of cytochrome c and other mitochondrial pro-apoptotic 
factors into the cytosol (Fig. 3.2).
7
  
 
 
 
Figure 3.2. The two main apoptotic signaling pathways. 
 
 
 
 
 
 
Protein-protein interaction 
55 
In the extrinsic pathway, death at the mitochondrial level is initiated by 
stimulation of the mitochondrial membrane, and proceeds via release of cytochrome c 
and other apoptogenic factors from the intermembranous space of mitochondria (Fig. 
3.2). In the cytosol, cytochrome c forms a complex with Apoptotic Protease Activating 
Factor-1 (Apaf-1), ATP and the inactive initiator caspase procaspase-9. Within this 
complex, known as the apoptosome, caspase-9 is activated (Fig. 3.3).
8
 Activated 
caspase-9 subsequently initiates a caspase cascade involving downstream executioner 
caspases ultimately resulting in cell death (Fig. 3.2).
9
 
 
 
 
Figure 3.3. Mitochondrial pathway of caspase activation and apoptosome 
formation. 
 
 
3.1.2. Extrinsic pathway: regulatory mechanisms in apoptosis  
 
How cytochrome c manages to cross the mitochondrial outer membrane is not yet 
exactly known, but is known that the Bcl-2 family is involved in the regulation of this 
process. For example, addition of pro-apoptotic Bcl-2 family members to isolated 
mitochondria is sufficient to induce cytochrome c release.
10,11
 Several hypotheses have 
been advanced but none of them has been proven definitively.
10,12
 There are three basic 
models that describes this regulation process (Fig. 3.4).  
1) Pro-apoptotic Bcl-2 members form channels that facilitate protein transport. 
Based on the structural similarity of Bcl-xL to the pore-forming subunit of bacterial 
toxin, it has been suggested that Bcl-2 proteins might form channels into the outer 
mitochondrial membrane by inserting and following conformational changes
13
 Bcl-2 
family members indeed can insert into synthetic lipid bilayers, oligomerize, and form 
channels with discrete conductance.
14
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2) Pro-apoptotic Bcl-2 family members interact with other mitochondrion proteins 
(as the Voltage Dependent Anion Channel (VDAC)) either to generate a pore or to 
modulate mitochondrial homeostasis.
15
 
3) Pro- and anti-apoptitic Bcl-2 family members heterodimerize to form channels.  
 
 
 
Figure 3.4. Possible mechanisms of action of Bcl-2 family members. 
 
How can this processes occur? Central to this question are Bax and Bak. Bax is a 
cytosolic monomer that during apoptosis changes its conformation, integrates into the 
outer mitochondrial membrane and oligomerizes, forming channels on the outer 
mitochondrial membrane.
16
 
In contrast, anti-apoptotic Bcl-2 members sequester pro-apoptotic Bcl-2 proteins 
by binding to their BH3 domains and thereby ultimately prevent Bax or Bak activation/ 
oligomerization and consequently inhibit mitochondrial pro-apoptotic events. The 
balance between the expression of anti- and pro-apoptotic Bcl-2 family members 
determines the cell death or survive. 
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3.2. Bcl-xL 
 
Human Bcl-xL is a member of the Bcl-2 family proteins. The founder of this 
family is the BCL-2 proto-oncogene found in the human cells affected from B type 
Leukemia called B Cell Leukemia-2. From these cells was isolated the first gene 
codifying for an apoptotic protein.
17
 The Bcl-2 family plays a central role in the 
regulation of apoptotic cell death. At least 15 Bcl-2 family members have been 
identified in mammalian cells and several others in viruses.
18
 They can be divided in 
pro-apoptotic and anti-apoptotic proteins according to their function. All members show 
α-helical secondary structure and present high structural homology; they possess up to 
four conserved motifs BH1, BH2, BH3 and BH4 known as Bcl-2 homology (BH) 
domains. Between the anti-apoptotic members two main groups can be distinguished: 
one contains at least BH1 and BH2 domains (A1, Mcl-1), the other one has all four BH 
domains (Bcl-2, Bcl-xL, Bcl-w). Similarly, the pro-apoptotic proteins can be divided in 
two subfamilies: Bax, Bak and Bok, which contain BH1, BH2 and BH3 resembling Bcl-
2 family closely, while the seven other known mammalian killers (Bik, Blk, Hrk, 
BNIP3, BimL, Bad, Bid) possess only the central short BH3 domain (Fig. 3.5) and they 
are unrelated to any other known proteins.  
 
 
 
Figure 3.5. The Bcl-2 family: structural homology schematization. 
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Deletion and mutagenesis studies argue that the amphipathic -helical BH3 
domain serves as critical death domain. These BH3 domain proteins may well represent 
the physiological antagonist of the anti-apoptotic proteins. These proteins are able to 
interact forming homo- and hetero-dimeric complexes. The ratio of pro- and anti-
apoptotic proteins modulate the sensitivity of a cell to apoptosis.  
During the last few years the interest with respect to Bcl-xL has incredibly grown 
because it plays a central role in the studies focused on the apoptosis mechanism 
comprehension.  
 
 
3.2.1. Structure 
 
The 3D structure of human Bcl-xL was determined by both X-ray crystallography 
and NMR in 1996.
13
 The structure consists in two central hydrophobic α-helices (α5 e 
α6) which are about 30 Å in length, flanked on one side by α3 and α4, and on the other 
by α1, α2 and α7 (Fig. 3.6).  
 
 
Figure 3.6. Three dimensional structure of human Bcl-xL (PDB code 1LXL). 
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The two central helices containing predominantly hydrophobic residues, are arranged in 
an antiparallel fashion, with a crossing angle 23°. Helix 6 contains Pro180 responsible 
of the helix direction. The C-terminal end contains hydrophobic residues that makes the 
protein able to anchor to the mitochondrial membrane. The helix α7 is connected to α6 
by an irregular turn composed of two glycines (Gly186 e Gly187), which are largely 
conserves in the Bcl-2 family. The N-terminal helix forms hydrophobic interactions 
with α2, α5 and α6 and seems to be important for stabilizing the protein structure. A 
flexible loop of 52 residues (Ser28-Val80), connects helices α1 and α2. It's a low 
homology structure region in the Bcl-2 family and was found to be not essential for the 
anti-apoptotic activity.
19
 The three functionally important Bcl-2 homology regions 
(BH1, BH2 e BH3) are in close spatial proximity and form an elongated hydrophobic 
cleft that may represent the binding site for other Bcl-2 family members. It has been 
demonstrated that the first two domains are essential for the anti-apoptotic activity of 
Bcl-xL; mutations within these regions abrogate the pro-survival activity blocking the 
heterodimerization with other members of the Bcl-2 family (for example Bad e Bak) 
that promote the programmed death.
20
 While BH3 has been found to be essential for the 
killer activity of the death-promoting proteins.
21
 Here reported the aminoacidic 
sequence of human Bcl-xL where the BH1, BH2 and BH3 domains are colored 
respectively in yellow, red and green (Fig. 3.7). 
 
 
 
Figure 3.7. Aminoacidic sequence of the human Bcl-xL. 
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A three dimensional structure is here reported  to show that these domains are in 
close spatial proximity (Fig. 3.8) and form an elongated hydrophobic cleft in the protein 
able to interact with pro-apoptotic proteins as Bak as reported in the following 
paragraph. 
 
 
Figure 3.8. BH1, BH2 and BH3 domains are displaced forming an hydrophobic 
pocket. 
 
Indeed, mutations of a highly conserved glycine (Gly138), part of this 
hydrophobic region, inhibit the death-repressor activity of Bcl-xL and block binding to 
Bax.
22
 This could be due to amino acids with bulkier side chain that can potentially 
block the access to this pocket.  
 
 
3.2.3. Function  
 
Bcl-xL occupies a central role in the cellular programmed death regulation with an 
anti-apoptotic function, it is over expressed in tumors, it contributes to the cancerogenic 
cells growth and it is responsible of the cancer resistance to the therapy.
23
  
Moreover, Bcl-xL resembles the membrane insertion domain found in bacterial 
toxin
24
 where these membrane insertions domains contain two central helices consisting 
of polar residues, surrounded by five amphypathic helices able to form pores in the 
Protein-protein interaction 
61 
membranes where they localize.
25
 By analogy Bcl-xL, as all the Bcl-2 family members, 
should be able to form pores in the membranes where it localize.  
It has been shown that Bcl-xL is able to form functional ion channels when added 
to synthetic membranes in vitro.
26
 However, the properties of these channels vary 
considerably among the family members. Bcl-xL may form small conductance channels 
in mitochondrial membranes that counterbalance the effect of Bax by maintaining 
electrical homeostasis and membrane integrity or, alternatively, their presence may 
prevent channel formation by Bax.
27
 
 
 
3.2.3. Interaction: Bcl-xL-Bak  
 
As discussed above Bcl-xL inhibits programmed cell death, while Bak promotes 
apoptosis. Interactions between these two proteins modulate the sensitivity of a cell to 
apoptosis (3, 4). Bcl-xL and Bak are anchored to the mitochondrial membrane as shown 
in Figure 3.9. 
 
 
Figure 3.9. Model for Bcl-xL-Bak interaction. 
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To understand how Bcl-xL interacts with Bak inhibiting its ability to promote cell 
death, the solution NMR structure of Bcl-xL complexed with a 16-residue peptide 
derived from the BH3 region of Bak is reported (residues 72-87).
28
The Bak peptide 
binds in a hydrophobic cleft formed by the BH1, BH2, and BH3 
regions of Bcl-xL (Fig. 3.10). 
 
 
 
Figure 3.10. Ribbon representation of the 3D structure for the complex. The BH1, 
BH2, and BH3 regions of Bcl-xL are shown in yellow, red, and green, respectively. The 
Bak peptide is shown in magenta.  
 
The NH2-terminal residues of the peptide interacts with the BH1 region of Bcl-xL 
(Val126, Glu129, Leu130, and Phe146), whereas the C-terminal portion of the Bak 
peptide interacts  predominantly with residues in the BH2 and BH3 regions (Phe97, 
Arg100, Tyr101, and Phe105). The hydrophobic side chains of the peptide (Val74, 
Leu78, Ile81, and Ile85) point into a hydrophobic cleft of Bcl-xL (Fig. 3.11) and 
stabilize  complex formation. In addition to these hydrophobic interactions, the charged 
side chains of the Bak peptide (Arg76, Asp83, and Asp84) are close to oppositely 
charged residues of Bcl-xL (Glu129, Arg139, and Arg100, respectively) (Fig. 3.11).  
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Figure 3.11. Binding pocket representation of Bcl-xL bound to the Bak peptide. 
Protein and peptide side chains are in yellow and green respectively. 
 
In summary the molecular interactions that stabilize the Bcl-xL–Bak peptide 
complex likely reflect the important interactions that occur between the full-length 
proteins. Only the BH3 region of Bcl-xL is critical for the ability to inhibit pro-apoptotic 
generation,
21,29
 while several regions of the death-inhibiting proteins participate in their 
antiapoptotic activity and heterodimerization.  
 
 
3.3. Cytochrome c  
 
Cytochromes are among the most studied and popular protein among biochemists 
and biophysicists.
30
 This is due to their red color, which makes protein purification 
easier, their small size and their high solubility. Moreover, their relatively high 
thermodynamic stability together with high helical content and the presence of the heme 
cofactor have allowed cytochromes to be studied through a variety of spectroscopic 
techniques.  
In the early 1920s, David Keilin discovered cytochromes becoming intrigues by 
the changing distribution of color in tissue of the larval form of a fly that lives in the 
stomach of the horse. The larva carries a considerable amount of a hemoglobin like 
pigments that confer it a red color. During metamorphosis the red color disappears from 
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the young fly reappearing in the flight muscles of the adult. The absorption spectrum of 
the flight muscles gives four bands: three bands at 604, 566 and 550 nm already known 
from the hemocromes spectra, and the fourth at 520 nm. The proteins responsible of this 
absorption spectra were termed cytochrome for cellular pigment and were shown to 
undergo oxidation and reduction followed by a change in the protein color. On the basis 
of the different cytochromes absorption spectra three type of cytochromes were 
identified as a, b and c type. I will take into account the cytochrome c type. Among 
those, four types of cytochromes c were classified by sequence, three dimensional 
structures, number and type of hemes, position of the axial iron ligands, and redox 
potential.
31
 In the present work I'll focus the attention on the mithocondrial cytochrome 
c that belongs to the type 1.  
Type 1 cytochrome c are usually small proteins (8-20 kDa), generally water-
soluble with a single heme, although multi-heme proteins are also included in this 
family. In the type 1 cytochrome c  the prosthetic group is constituted by a type c heme 
defined by the presence of a single Cys-Xaa-Xaa-Cys-His (CXXCH) signature for heme 
attachment.  
Heme is a rigid almost planar molecule comprising four pyrrole groups linked by 
methene bridges to form a tetrapyrrole ring (Fig. 3.12).  
  
 
 
Figure 3.12. Structure of heme c of c-type cytochromes. 
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The cytochrome c is covalently bound to the polypeptide backbone of the 
molecule trough thioether linkages at the vinyl side chains to cysteins 14 and 17 in the 
polypeptide chain. The prosthetic group contains one iron ion esa-coordinated by four 
nitrogen of the heme tetrapyrrole ring and with two axial protein residues. For 
mitochondrial cytochrome c this ligands are His18 and Met80  (Fig. 3.13). The ion iron 
is able to accept and release electrons cycling between the oxidized and reduced state, 
thus conferring to the protein an electron transport activity. A series of observations 
highlighted chemical and physiochemical differences between the oxidized and reduced 
states of cytochrome c suggesting that the structure of the ferrocytochrome c was 
stronger than that of ferricytochrome c. This was attributed to an oxidation-state 
dependent dynamics change that precisely regulates the thermodynamic and the kinetic 
of the redox reaction. 
 
 
 
Figure 3.13. Cytochrome c covalently bound to the heme prosthetic group, shown 
as red sticks, through cysteins 14 and 17. The iron atom, shown as a red ball, is axially 
coordinated by Met80 and His18. 
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3.3.1. Structure of mithocondrial cytochrome c 
 
The first three-dimensional structure of cytochrome c has been solved in the 1962. 
Several additional structures appeared during the later years as the one of mitochondrial 
cytochrome c in the 1970s.
32
 Three structural elements are found in all cytochrome c 
experimental structures: the N- and C-terminal -helices (respectively, helix 1 and 5 
in mitochondrial cytochromes), as well as the long helix (helix 3, also called the 60’s 
helix in mitochondrial cytochromes) preceding the short helix and the loop containing 
the second axial ligand to the heme iron, which is always a methionine
33-35
. The 
structure is stabilized by hydrogen bonds formed between heme-propionate and Arg38, 
Tyr48 and Trp59 and by other propionate and Ser49 Asp50 and Thr78. A number of 
conserved basic residues have been shown to be important to function, namely Lys8, 
13, 25, 27, 72, 73, 79, 86 and 87. The nine basic residues surround the heme edge where 
electron transfer usually takes place. 
 
 
3.3.2. Function of mithocondrial cytochrome c 
 
Cytochrome c is loosely associated with the inner membrane of the mithocondrion 
and is an essential component of the electron transport chain. Cytochrome c has several 
functions: it is essentially an electron transfer protein, mainly involved in aerobic as 
well as anaerobic respiration, in mammalian cells, it is involved in apoptosis
36
 (see 
paragraph 3.1 for details) and it can catalyze several reactions as hydroxilation, aromatic 
oxidation and shows peroxidase activity, in particular, it is not uncommon that 
cytochrome c is fused to redox enzymes and constitutes an entry/exit point for electrons 
in the catalytic cycle of the enzyme.
37
 
 
 
3.3.2.1. Cytochrome c: an electron transport protein 
 
The electron transport chain is the most important process to generate energy in 
mitochondria and many prokaryotes. Energy is derived from the transfer of electrons 
through a series of membrane-bound enzyme complexes and conserved as a 
transmembrane proton gradient, which is eventually used for the ATP synthesis. In 
Protein-protein interaction 
67 
particular electrons move from an electron donor (NADH or QH2) to a terminal electron 
acceptor (O2) via a series of redox reactions. These reactions are coupled to the creation 
of a proton gradient across the mitochondrial inner membrane mediated by proton 
pumps. The resulting transmembrane proton gradient is used to synthesize ATP trough 
the ATP synthase.  
The electron transport chain is constituted by four complexes embedded in the 
inner mitochondrial membrane (Fig.3.14). 
    
 
 
Figure 3.14. Schematic picture of the enzymes of the mitochondrial inner 
membrane involved in the terminal steps of aerobic respiration. 
 
In complex I, called NADH Ubiquinone Oxidoreductase, two electrons are 
removed from NADH and transferred to a lipid-soluble carrier, Ubiquinone (Q) and 
four protons (H
+
) are pumped across the membrane.  
In Complex II, called Succinate Dehydrogenase, additional electrons originating 
from succinate are delivered into the quinone pool. 
In Complex III, called cytochrome bc1 complex, two electrons are removed from 
ubiquinol (QH2) and transferred to two molecules of cytochrome c located within the 
intermembrane space. At the same time, four protons are translocated across the 
membrane, contributing to the proton gradient. 
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QH2 + 2cytochrome c (Fe
3+
) + H
+
IN → Q + 2cytochrome c (Fe
2+
)  + 4H
+
OUT  
 
In Complex IV, called cytochrome c oxidase (CCO) four electrons are removed 
from four molecules of cytochrome c and transferred to molecular oxygen O2, 
producing two molecules of water. At the same time, four protons are translocated 
across the membrane, contributing to the proton gradient.  
 
4cytochrome c (Fe
2+
) + O2 + 8H
+
IN → 4cytochrome c (Fe
3+
) + 2H2O + 4H
+
OUT 
 
The electron transfer coupled to the generation of a electrochemical gradient 
across the membrane drives ATP synthesis by the ATP synthase complex.
38
  
 
 
3.3.3. Interactions 
 
Efficient electron transfer between cytochrome c and its counterparts in the 
respiratory chain requires rapid adduct formation and rapid product dissociation as well 
as the achievement of proper orientation of the partner proteins in the transient adduct to 
optimize the electron transfer rate. Such requirements are reflected in the nature of key 
interactions involving surface residues surrounding the heme crevice of cytochrome c. 
The optimal interfacial arrangement is tuned by hydrophobic interactions among short 
range contacts. The transient nature of the complexs is assured by the possibility to 
switch on and off the potential electrostatic interactions among residues of different sign 
surrounding the contact central region on the two proteins. Long-range recognition of 
the partners is driven by non-specific electrostatic interactions that rely on the presence 
of large patches of different sign on the two protein surfaces. 
 
 cytochrome c and cytochrome bc1 
 
In the crystal structure of the complex between cytchrome c and 
cytochrome bc1 from Saccharomyces cerevisiae (Fig. 3.15A) the 
interaction with the soluble domain cytochrome c1 of the enzyme is 
mainly mediated by non polar contacts involving residues Thr12, Arg13, 
Val28 and Ala81 on cytochrome c from Saccharomyces cerevisiae. Weak 
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polar interaction involving Lys79 and Lys86 are present, while additional 
electrostatic interactions (involving for example cytochrome c Lys87) 
have been proposed to modulate intermediate states and the unbinding step 
(pdb code 1KYO).
39
 The soluble domain of cytochrome c1 is negatively 
charged at neutral pH, thus complementary to the positively charged 
soluble cytochrome c. However, the structure of the complex suggests that 
despite the high electrostatic charge present on both proteins and the good 
complementary character in this respect between the two partners, the 
most stable configuration of the adduct is predominantly determined by 
non polar contacts.  
 
 cytochrome c and CCO 
 
Cytochrome c interacts with subunit II of CCO, which is composed of two 
transmembrane helices and a β-barrel globular domain facing the 
intermembrane or periplasmic space, and contains the catalytic group 
composed by two electronically coupled copper ions so called CuA site. A 
structural model of the adduct between cytochrome c-552 and the CuA 
subunit of CCO from Paracoccus denitrificans has been proposed (Fig. 
3.15B) (pdb code 1ZYY).
40
  In the various conformers of the complex 
common hydrpophobic patches are found, while different networks of 
electrostatic intermolecular interactions are established within negatively 
charged residues of CCO and the positively charged of cytochrome c-522. 
In particular, the hydrophobic interactions involve residues Ala16, Val26, 
Ala79, Phe80, and Ala81 on  the cytochrome c-522, while the 
electrostatic interactions involve Asp and Glu contiguous to the CCO's 
central hydrophobic surface area and Lys residues (namely Lys13, Lys15, 
Lys19, Lys70, Lys74 and Lys77) surrounding the heme crevice on the 
cytochrome c-522.
41
 
 
 
 
 
 
Protein-protein interaction 
70 
 cytochrome c and cytochrome c peroxidase (CCP) 
 
A three-dimensional structure of the adduct between yeast-iso-1-
cytochrome c and CCP is available (pdb code 2pcb).
42
 The region of 
cytochrome c in direct contact with CCP is relatively similar to that 
involved in the interaction with cytochrome c1 subunit of the cytochrome 
bc1, described above. Also in the CCP-cytochrome c complex, 
hydrophobic interactions are the predominant forces holding the complex 
together (Fig. 3.15C). On the side of cytochrome c they  involve residues  
Leu9, Arg13, Gln16, Cys17, Ala81, Phe82, Gly83 and Lys86. The side 
chains of Asn70, Lys73 and Lys87 are potentially involved in hydrogen 
bonds and/or salt bridges. 
 
 
 
Figure 3.15. (A) Residues in S. cerevisiae cytochrome c involved in the 
interaction with cytochrome bc1 involved in hydrophobic contacts are represented as 
blue spheres, those giving rise to electrostatic interactions are red spheres, whereas 
Lys87, proposed as potentially involved in salt bridges of transient states, is shown in 
cyan; (B) Residues in cytochrome c522 involved in hydrophobic contacts with CCO are 
shown as blue sphere, while the surrounding Lys potentially involved in alternating 
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electrostatic interactions are red spheres; (C) Residues of interest for the interaction 
between yeast iso-1-cytochrome c and cytochrome c peroxidase; (D) Residues in human 
cytochrome c involved in hydrophobic contacts with Bcl-xL are shown as blue spheres, 
while the amino acids involved in electrostatic/H-bond interactions are represented as 
red spheres; the colour coding is the same as for panel (A). In the four panels, 
cytochrome c is represented with an orientation where the “loop face” points towards 
the observer. 
 
In all the adducts presented above both electrostatic and hydrophobic interactions 
play an important role in the complex formation. The initial recognition it's supposed to 
be driven by the shape and the potential of the negative cluster, and would work long-
range, whereas the hydrophobic interaction acting short-range would fine-adjust the 
redox partners for optimal electron transfer.  
Moreover, cytochrome c exposes to all its partners a common area that coincides 
with the solved exposed porphyrin ring. This region is the most suitable contact surface 
where an electron can be transferred to an acceptor.  
No structural information exist on the interactions between cytocrome c and 
proteins involved in the apoptosis process. 
 
 
3.4. Aim of the project 
 
Apoptosis normally eliminates cells with damaged DNA or aberrant cell cycle. 
Pro-survival proteins are therefore potentially oncogenic. Clarifying how the Bcl-2 
family governs apoptosis might provide the ability to control the apoptotic threshold.  
Conventional cytotoxic therapy indirectly induces apoptosis, but more effective 
outcomes should be achieved by direct activation of the apoptotic machinery. Promising 
approaches include impairing expression of pro-survival proteins or identifying drugs 
that inhibits their action. The identification of interfaces between partner molecules 
provides targets for pharmacological intervention: the protein-protein interaction surface 
between Bcl-xL and cytochrome c here identified may offer one of these targets. 
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3.5. Methods 
 
Nuclear magnetic resonance (NMR) spectroscopy is unique among the methods 
available for three-dimensional structure determination of proteins at atomic resolution. 
Since proteins perform their physiological functions biological fluids, knowledge of the 
molecular structures in solution is highly relevant. In the NMR experiments, solution 
conditions such as the temperature, pH and salt concentration can be adjusted close to 
physiological conditions.  
In addition to protein structure determination, NMR applications include 
investigations of dynamic features, as well as structural studies of interactions between 
proteins supported also by molecular docking programs, such as HADDOCK (High 
Ambiguity Driven protein-protein DOCKing).
52
 
 
 
3.5.1. Resonance assignment: triple resonance expermients 
 
In the sequence-specific resonance assignment the use of multidimensional triple 
resonance NMR experiments for the protein resonance assignment has become 
standard.
43,44
 For proteins with less than  200 amino acids, triple resonance NMR data 
analysis is, in many cases, a routine task. The resonance assignment can be divided into 
two steps, i.e., backbone sequential assignment and side chain assignment. I will focus 
the attention on the former.  
Based on the primary sequence, the sequential assignment is usually achieved by 
comparing multidimensional NMR spectra providing the necessary correlations to 
identify spin systems within each amino acid (intra-residue) and then to link them in a 
sequence-specific manner (inter-residue). 
The information about intra- and inter-residual correlation is obtained using the 
triple resonance experiments uniformly 
13
C and 
15
N labelled proteins, based on well-
defined heteronuclear scalar couplings along the polypeptide chain (Fig.3.16).
45-48
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Figure 3.16. Spin system of the peptide backbone and the size of the 
1
J and 
2
J 
coupling constants that are used for magnetization transfer in 
13
C-, 
15
N-labelled 
proteins. 
 
The most popular sequential assignment strategy relies on a set of experiments 
HNCA and HN(CO)CA, (Fig. 3.17). The names of the experiments indicates all nuclear 
spins that are involved in the coherence transfer pathway exploiting scalar couplings 
and frequency labelling in the various dimensions of the experiments. 
 
 
 
Figure 3.17. Schematic representation of the 3D heteronuclear NMR spectra 
HNCA and HN(CO)CA. 
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The information about amino acid type is obtained from the combination of the 
C chemical shifts, which provide a  first indicator of the amino acid type and 
facilitates the sequential assignment.
49
 The HNCO 3D experiment can then be used to 
complete backbone assignment by the identification of the C' chemical shift such as 
HNCO and HN(CO)CA. 
The most important double- and triple-resonance experiments used for sequential 
and side-chain resonance assignment and the key correlations that can be detected in 
each experiment are summarized in Table 3.1. 
 
Experiment           Correlations 
CBCANH                Ci
 Ci
ii 
                                    Ci-1
 Ci-1
ii 
CBCA(CO)NH      Ci-1
 Ci-1
ii 
HNCA                   Ci
ii 
                                  Ci-1
ii   
HNCO                    Ci-1
'ii   
HN(CO)CA            Ci-1
ii 
HN(CA)CO            Ci
'ii 
                                  Ci-1
'ii   
 
Table 3.1: Correlations observed in the double and triple resonance experiments 
used for sequential and side chain assignment (
1
H approach). 
 
 
3.5.2. Molecular Docking for the study of protein-protein interaction 
 
The traditional approach to solve macromolecular complexes by NMR 
spectroscopy requires the collection of proton-proton nOes (nuclear Overhauser effects), 
which can be translated into distances. When the structures of the separate biomolecules 
are already known, a structure of the complex can be build up by selectively analyzing 
the intermolecular NOEs. In addition to these intermolecular NOEs, also orientational 
restraints like residual dipolar couplings (RDCs), heteronuclear relaxation rates, or 
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paramagnetic pseudo-contact shifts can be used, that precisely define the orientation of 
the two macromolecules in the complex. These methods require, however, extensive 
series of experiments and detailed analysis.  
Another way of studying complex formation by NMR is chemical shift 
perturbation mapping, where the chemical shifts changes of given atoms are monitored 
in the course of the formation of the complex (see Section 2.4.3.2). The information 
obtained by CSP analysis, however, is only qualitative; it does not allow to 
unambiguously identify pairs of atoms that are in contact in the complex and it does not 
provide precise distance or orientation information, and has therefore not been 
commonly used in structure calculations. 
For this reason, chemical shift perturbation are not directly used for structure 
calculations, but are combined with computational methods that predicts at a structural 
level the assembly of two separate biomolecules into their biologically relevant 
complex. HADDOCK
52
 is one example of computational methods that make use of 
biochemical and/or biophysical interaction data resulting from NMR titration 
experiments or mutagenesis data, introduced as Ambiguous Interaction Restraints 
(AIRs), to drive the docking process. After calculation, the structures are ranked 
according to their intermolecular energy, that is, sum of electrostatic, van der Waals, 
and AIR energy terms.  
HADDOCK protocol defines active and passive residues. The active residues are 
all residues showing a significant chemical shift perturbation after the formation of the 
complex, with a solvent accessibility higher than 50% in the free-form protein; the 
passive residues are those neighboring the active ones and have a solvent accessibility 
usually higher than 50%. 
The docking protocol consists of three consecutive steps: 
 rigid body minimization driven by interaction restraints, in which 1000 
structures of the complex are generated; 
 the best 200 structures in terms of total intermolecular energy are further 
submitted to the semi-flexible simulated annealing in which side-chains 
and backbone atoms of the interface residues are allowed to move; 
 final refinement in Cartesian space in water. 
Finally the 200 structures obtained are clustered using a threshold of 7.5 Å of 
RMSD among the structure of the cluster.  
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Clusters containing at least 4 structures were considered and analyzed on the basis 
of HADDOCK score value (HADDOCK score: 1.0 Evdw+0.2 Eelc+0.1 Edist+1.0 Esolv, 
where the four terms are respectively: van der Walls Energy, Electrostatic Energy, 
Distance Restrains Energy and Desolvation Energy), RMSD and Buried Surface Area. 
 
 
3.6. Results & Discussion 
 
Chemical shift changes provide a highly sensitive tool for identifying the residues 
that play a role in PPIs as already discussed for S100B. NMR chemical shift 
perturbations of backbone amides in Bcl-xL and cytochrome c reveal that the two 
proteins form detectable amounts of an adduct. The observed chemical shift variations 
are small (Fig. 3.18 and Fig. 3.19) but increase in a saturable manner upon titration (Fig. 
3.20).  
 
 
Figure 3.18. Plot of the chemical shift variation (Garrett values) of the backbone 
cytochrome c amide signals in the cytochrome c – Bcl-xL adduct.  
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Figure 3.19. Plot of the chemical shift variation (Garrett values) of the backbone 
Bcl-xL amide signals in the cytochrome c – Bcl-xL adduct.  
 
 
Figure 3.20. Fitting of the weighted average chemical shift variations of three 
perturbed residues (L90, G94, G200) of the 
15
N-enriched Bcl-xL as a function of the 
concentration of the unlabeled cytochrome c.  
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The interaction between cytochrome c and Bcl-xL has been reported to be strongly 
dependent on ionic strength:
2
 in 50 mM phosphate buffer, the Kd of 1.2 10
-7
 M at 80 
mM NaCl increases by nearly 12-fold in the presence of 600 mM NaCl. The relatively 
high concentrations required for the NMR experiments of these two heavily charged 
proteins (total charge: -14 for Bcl-xL and +9 for cytochrome c) contribute to the 
increase of the overall ionic strength of the solution, setting us farther from the optimal 
conditions for the complex formation. Consistently, the Kd values estimated from our 
chemical shift data (Fig. 3.20), although measured at 50 mM phosphate buffer and 150 
mM NaCl, are of the order of 1*10
-3
 M. The low affinity of the complex combined with 
the intrinsic low solubility of Bcl-xL prevented us from achieving protein concentrations 
in solution higher than 500 M for the anti-apoptotic protein, that would have provided 
larger amount of the of the bound state and therefore larger chemical shift perturbations. 
An overall increase in 
15
N transverse relaxation rate, R2, values is observed upon 
titration of Bcl-xL with cytochrome c, which is consistent with an increase in the overall 
tumbling correlation time upon complex formation.
50
 An accurate measure of 
15
N R2 in 
the complex, however, is hampered by the low stability of Bcl-xL caused by local 
sample heating associated to this type of measurements. 
Residues whose chemical shift values are affected by the presence of the partner 
molecule, when mapped on the proteins’ surface, result confined to well defined areas, 
suggesting the formation of a specific, albeit transient, complex. The restraints derived 
from the NMR experiments were used as input data for docking calculations on the 
human cytcochrome c - Bcl-xL system with the program HADDOCK and unequivocally 
define the docking face for both proteins.  
The obtained ensemble of structural models is constituted by a well defined 
cluster (Table 3.2) of 128 conformers with BB RMSD of 0.8±0.5 Å from the overall 
lowest energy structure. The dominant contribution to the total interaction energy comes 
from the electrostatic term. This is consistent with the experimental finding that the 
interaction affinity is reduced by an increase in ionic strength.
2
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N ° of 
structures 
within the 
cluster 
van der 
Waals 
energy 
(kcal/mol)
 
Electrostatic 
energy 
(kcal/mol) 
Desolvatat
ion energy 
(kcal/mol) 
Restrains 
violations 
Overall 
RMSD 
(Å) 
Buried surface 
area 
(Å
2
) 
128 -59.68.4 -535.927.6 39.23.3 194.758.84 0.80.5 2040.181.5 
21 -39.55.7 -371.243.7 39.26.8 141.548.88 11.50.1 1599.6121.6 
6 -40.25.3 -371.731.8 45.010.4 116.744.73 11.80.1 1458.198.2 
11 -43.76.0 -291.434.4 40.710.0 114.252.48 8.90.2 1285.540.7 
 
Table 3.2. Structural statistics calculated over all structures for the 4 clusters 
obtained by HADDOCK. 
 
A buried surface area of the order of about 2,000 Å
2
 is identified, which contrasts 
with the short -lived nature of the complex, for which values < 1,200 Å
2
 would be 
expected. A similar situation has been already reported for the cytochrome c – CuA 
adduct and explained in terms of a biased picture resulting from the docking 
procedure;
40
 dense networks of intermolecular contacts are provided in the same 
structural model as if they could be contemporarily present whereas reasonably only a 
fraction of them is actually formed on average. Consistently with this view, the 
relatively large restraints violation energy hints that none of the calculated structures 
satisfies the experimental constraints altogether. Observed chemical shift perturbations 
in solution reflect the average effect of various interconverting adducts with slightly 
different binding contacts, as summarized in Table 3.3.  
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Bcl-xL Cyt Contacts Frequency 
Glu96 (O1, O2) Lys53 (H1,H2,H3) Hydrogen Bonds 141 
Arg100 (HH12, HH21, 
H22) 
Gly41 (CO) Hydrogen Bonds 64 
Tyr101 (HH) Ala43 (CO)  Hydrogen Bonds 31 
Tyr101 (C1,C,C) Ala43 (C,C)  Non Bond 195 
Asp133  (O2) Lys25 (H1,H2,H3) Hydrogen Bonds 87 
Asp133 (O1, O2) His26 (HN) Hydrogen Bonds 36 
Asn136 (H21, H22) His26 (CO) Hydrogen Bonds 44 
Asn136 (C,C) Tyr46 (C1) Non Bond 82 
Trp137 (C) Ser47 (C) Non Bond 43 
Gly138 (CO) Gly45 (CO) Non Bond 54 
Gly138 (C) Tyr46 (CO,C) Non Bond 128 
Thr190 (C2) Lys79 (C) Non Bond 42 
Phe191 (C1) Ser47 (C) Non Bond 32 
Leu194 (CO) Ala50 (NH) Hydrogen bond 47 
Leu194 Backbone (CO) Ala50 (C) Non Bond 32 
Tyr195 (OH) Lys53 (H1,H2,H3) Hydrogen Bonds 48 
Tyr 195 (C,C1) Ala50 (C) Non Bond 72 
Ser203 (H) Asn54 (O1) Hydrogen Bonds 45 
 
Table 3.3 Intermolecular contacts Non Bond and Hydrogen Bond calculated all 
the model structures of solutions obtained by HADDOCK and repetition frequency >30.  
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Considering all the identified contacts (Fig. 3.21), they define a large and flat 
contact area between the two partner proteins. 
 
 
 
Figure 3.21. Residues on cytochrome c (cyan) and Bcl-xL (pink) that are involved 
in intermolecular contacts in our structural model. They have been mapped on one of 
the lowest energy structure of our cluster of 128 conformers. 
 
Residues on human cytochrome c involved  in contacts with Bcl-xL are located on 
the  loop1, helix and loop 2 (Fig. 3.15A). Interestingly, the only known pro-
apoptotic mutant of cytochrome is G41S,
51
 i.e. a variant bearing a mutation on a residue 
of the -strand found to form an H-bond with Arg100 of Bcl-xL in 64 out of 128 
structures of our ensemble. In contrast, those on yeast cytochrome c or on cytochrome 
c522 in complex with the electron transfer partners are centered on the heme crevice 
defined by the two loops, where atoms of the porphyrin ring become partially exposed 
(Fig. 3.15B-D). Such differences might account for the different primary and secondary 
structures of the examined cytochromes as well as for the different cytochrome c 
functions. In fact, when cytochrome c acts as electron transfer protein needs to  have the 
porphyrin ring as close as possible to the redox partner. This is possible only from the 
porphyrin ring solvent exposed area. While the interaction of cytochrome c with Bcl-xL 
does not require any electron transfer, trailing off  the need of  the solvent exposed 
heme edge. For this reason cytochrome c in the anti-apoptotic complex shares only a 
few contact residues with the electron transport adducts. Indeed the core interactions are 
here centered on the left side (according to the view of Fig. 3.15A) of the heme crevice. 
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Involvement of the loops probably still reflects the need of conformational adaptability 
to facilitate an induced fit.  
The structure of Bcl-xL consists of  seven helices (Fig. 3.6) and a long flexible 
loop, spanning residues 45 to 84.
13,28
 The C-terminal part contains a hydrophobic tail 
proposed to constituted the anchoring point in the membrane bound form. At the basis 
of this short tail the protein fold forms a large and flat surface (Fig. 3.22), that in the 
membrane-bound form should be oriented towards the mitochondrion. Residues in 
contact with cytochrome c are all located in this area. In particular: Glu96 and Tyr101 
are on helix-3; Glu129 and Arg139 are the second-last and the first residue, 
respectively, of helix-4 and helix-5, which are antiparallel to each other and 
perpendicular to helix-3; residues 133-138 are on the loop connecting helix-4 to helix-5; 
Trp181, Glu184 and Asn185 are on helix-7 and Thr190, Glu193 and Leu194 on helix-8, 
two short helices roughly parallel to helix-3; finally, the last two residues forming 
contacts are Tyr195, immediately after helix-7 and Ser203 at the basis of the C-term 
tail.  
 
Figure 3.22. Ribbon representation of the structure of Bcl-xL: the putative 
transmembrane hydrophobic tail point towards the bottom part of the picture. Residues 
involved in contacts with cytochrome c are displayed using a spacefill representation. 
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The Bak peptide is shown in magenta and its interaction area  has only a few contact 
points with that defined for cytochrome c. 
Their spatial location with respect to the anchoring tail suggests that cytochrome c 
is captured by the protein just at its entrance into the cytosolic space. 
Arg139, whose mutation into Glu has been reported to inhibit the antiapoptotic 
activity of Bcl-xL,
28
 is involved in the interaction with cytochrome c and also with the 
Bak peptide; otherwise the contact surfaces residues of Bcl-xL with the two counterparts 
do not coincide. Complexation of Bcl-xL with the pro-apoptotic Bak peptide(s) has been 
reported to occur through an extended interaction with the hydrophobic cleft of Bcl-xL 
defined by helices 3 and 4; in addition a few charged side chains of opposite signs on 
the two partners are facing each other.
28
 
The non-coincidence of the contact surface areas in the two adducts may provide 
hints for differently targeting the pro-apoptotic and the anti-apoptotic protein-protein 
interactions.  
While our structural model seems reliable, one could question about the relevance 
of such a weak complex for blocking the apoptosome formation. In considering this 
aspect one should take into account the fact that in our NMR experiments both 
cytochrome c and Bcl-xL can free diffuse in three dimensions. 
The anti-apoptotic process of sequestration of cytochrome c by Bcl-xL can be seen 
as a baid and prey process, where Bcl-xL acts as baid when anchored to the external 
mitochondrial membrane and therefore has restrict motions. The prey cytochrome c is 
“fished” once released in the cytosol, where in principle it may still be a three 
dimensional diffusant, but the proximity of the mitochondrial membrane may still 
influence its diffusion modes.  Reducing the dimensionality of the recognition process 
between the two protein may lead to a sensible increase in binding efficiency.  
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3.7. Experimental part 
 
3.7.1. Protein samples 
 
Full length human cytochrome c was expressed and purified as reported in the 
literature
52
 in the unlabelled and 
15
N-labeled form. 
The Bcl-xL construct  used in our experiments contains residues 1-209 and lacks 
the C-terminal hydrophobic tail. The construct also has four additional N-term residues 
(numbers -3 to 0). 
Unlabelled, 
15
N-labelled and 
13
C,
15
N labeled forms of the protein were used for 
different NMR experiments. 
Typical protein concentrations for NMR experiments were in the 50 M to 5 mM 
range, in 50 mM sodium phosphate buffer at  pH 7.3, 150 mM NaCl, 1mM DTT and 
with 10% D2O for lock.  
 
 
3.7.2. NMR experiments 
 
All NMR spectra were acquired at 300 K using Bruker Advance spectrometers 
operating at proton frequencies of 500, 700, 800 and 900 MHz, all equipped with 
cryoprobes. Table 3.4 summarizes the NMR experiments performed.  
 
Experiments Dimension of acquired data (nucleus) 
 
Spectral width (ppm) 
 
t1 t2 t3 F1 F2 F3 
1
H-
15
N-HSQC
a 
200 or 256 (
15
N) 1024(
1
H) - 13.0 40.0 - 
HNCA
b 
200(
13
C) 40(
15
N) 1024(
1
H) 32.0 36.0 14.0 
HN(CO)CA
b 
200(
13
C) 40(
15
N) 1024(
1
H) 32.0 36.0 14.0 
15
N R2
c
 200(
15
N) 2048(
1
H)  32 14  
a
 Spectra acquired at 500, 800 or 900 MHz. All the spectrometers are equipped with cryo-probe (TXI 5-
mm). 
b
 Data acquired using a  700 MHz spectrometer equipped with a cryo-probe (TXI 5-mm)  
c
 Data acquired using a 500 MHz spectrometer equipped with a cryo-probe (TXI 5-mm)  
All the spectra were processed using the standard Bruker software (Topspin version 2.0) and analyzed by 
means of  the CARA program.
53
  
 
Table 3.4. Acquisition parameters for the NMR experiments; all spectra were 
recorded at 300 K. 
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3.7.3. Interaction studies 
 
Titrations of 
15
N human cytochrome c with unlabelled Bcl-xL and titrations of 
15
N-Bcl-xL with unlabelled cytochrome c were followed through 
1
H-
15
N HSQC. 
Looking at the 
15
N-enriched Bcl-xL the system was studied until a ratio of Bcl-
xL:cytochrome c 1:10. Looking at the 
15
N-enriched cytochrome c we could reach a 
cytochrome:Bcl-xL  ratio of 1:20. 
Assignment of Bcl-xL: Backbone resonance assignments of Bcl-xL were 
performed through conventional multidimensional NMR techniques based on triple 
resonance experiments, as summarized in Table 3.4. The assignment was carried out 
starting from the reported assignment on BMRB entry 6578,
54
 that refers to a dimeric 
form of the protein lacking the 45-84 flexible loop. We have accomplished 84 and 80% 
assignment of the C and HN backbone resonances, respectively.  
 
 
3.7.4. R2 measurements 
 
The generalized increase in 
15
N R2 relaxation rates of Bcl-xL was used to monitor 
the increase in average molecular size in the presence of  2-fold and 2-fold excess of 
cytochrome c. The experimental details are provided in Table 3.3. The local overheating 
typical of R2 measurements affects the stability of Bcl-xL, as revealed by 
1
H-
15
N HSQC 
experiments recorded in an interleaved manner during R2 experiments. The effect 
becomes more important in the presence of cytochrome c and is proportional to its 
concentration. Nevertheless an overall increase in R2, consistent with an increase in the 
correlation time for tumbling was observed. 
 
 
3.7.5. Chemical shift mapping 
 
The interaction between cytochrome c and Bcl-xL was monitored through 
chemical shift changes of the signals from the backbone amide moieties, whose 
magnitude increased upon increasing concentration of the titrant (Fig. 3.18 and Fig. 
3.19). The extent of the changes was quantified through the equation (2.1). 
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Kd were obtained by plotting the weighted average chemical shift variations of 
perturbed residues on the 
15
N-enriched Bcl-xL as a function of the concentration of the 
unlabeled partner cytochrome c (Fig. 3.20) and were found to be in the 1-3 mM range.  
 
 
3.7.6. Model structure calculations 
 
A structural model of the cytochrome c – Bcl-xL adduct was obtained using 
HADDOCK program.
55
 HADDOCK calculations were started with the coordinates of 
human cytochrome c (PDB id: 1J3S) and human Bcl-xL (PDB id: 1LXL). The starting 
structure for cytochrome c is actually the first member of an ensemble of  20 NMR 
conformers.  
The active residues defined for the present calculation are listed in Table 3.5.  
 
Bcl-xL cyt c
 
Q88, E129, D133, 
T190, F191
a
, G196  
Q16, V20, G24, H26, G29, 
G41,  A50, K79, M80, 
V83 
a The residue was considered active although it does not result  
solvent accessible from NACCESS calculations based on the  
solution structure 1LXL. 
 
Table 3.5. Haddock active residue of cytochrome c and Bcl-xL. 
 
The solvent accessibility has been calculated with the program NACCESS. 
Four clusters containing 128, 21, 6, and 11 structures, were obtained through the 
HADDOCK docking procedure. The structural statistics calculated over all structures of 
each cluster are shown in Table 3.2. Cluster 1 is by far the best in terms of RMSD and 
energy values. It unequivocally defines the docking face for both proteins and their 
relative orientations. 
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3.8. Conclusions 
 
Apoptosis normally eliminates cells with damaged DNA or aberrant cell cycle. 
Pro-survival proteins are therefore potentially oncogenic. Clarifying how the Bcl-2 
family governs apoptosis might provide the ability to control the apoptotic threshold.  
Conventional cytotoxic therapy indirectly induces apoptosis, but more effective 
outcomes should be achieved by direct activation of the apoptotic machinery. Promising 
approaches include impairing expression of pro-survival proteins or identifying drugs 
that inhibits their action. The identification of interfaces between partner molecules 
provides targets for pharmacological intervention: the protein-protein interaction surface 
between Bcl-xL and cytochrome c here identified may offer one of these targets.  
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Iron mineralization in ferritin 
 
4. Summary 
 
In this chapter the ferritin-iron interaction study as an 
example of the protein-metal interaction will be presented. Ferritins are multimeric 
nanocage proteins present in most living organisms throughout evolution. Ferritins are 
iron storage and detoxification proteins, since their role is to store a non-toxic, water-
soluble, yet bioavailable iron core and to release it whenever the cell needs. The 
biomineralization process that occurs inside the protein is a complicated multistep 
process long studied. The first step of the iron storage occurs at the ferritin catalytic 
ferroxidase site where two iron(II) ions react with dioxygen to form diferric species. 
These iron(III) complexes, once formed, migrate into the protein cavity where the iron 
nuclei of crystalline mineral form and aggregate to give the biomineral core. The 
structure of the iron(III) clusters as well as their pathway from the ferroxidase site to the 
central cavity, was still unknown and is subject of NMR studies at CERM. In addition, 
the crystal structure of ferritin with Fe(III) present in the active site, difficult to obtain 
because of the transient nature of substrate/enzyme interactions, was solved during this 
research study thanks to the collaboration between our research group and Mangani's 
group from the University of Siena. 
The large size of ferritin hampers the standard solution NMR experiments for 
sequence specific assignment described in Section 3.4. Immobilization of the protein in 
the solid crystals overcame the problems arising from the rapid transverse relaxation 
and Magic Angle Spinning (MAS) solid state NMR (ssNMR)
1
 provided spectra that 
allowed ferritin sequence specific assignment. 
 
 
4.1. The importance of iron for biological systems 
 
Iron approximately constitutes one third of our planet's mass and it is the fourth 
most abundant element in Earth's crust. Iron is an essential element for most organisms 
since serves as cofactor in several enzymes and is an important component of many 
cellular processes including respiration, electron transport processes, energy 
Chapter 
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metabolism, DNA synthesis and gene regulation. Despite its abundance, in 
physiological conditions it is poorly available. This is due to the fact that the stable 
oxidation state of the metal is Fe(III), that at neutral pH values forms insoluble hydroxy-
aquo-complexes that are in equilibrium with a free Fe(III) concentration around 10
-18
 M. 
Some organisms need higher iron concentration, bacteria, for example, need iron 
concentrations of 10
−7
 M for growth. Moreover, free iron in the presence of oxygen can 
cause the one electron reduction of the lattice resulting in the formation of superoxide 
radical (equation 4.1) which can accept another electron and two protons to produce 
hydrogen peroxide (equation 4.2). On the other hand, Fe(II) can react with hydrogen 
peroxide to generate the hydroxyl radical that's a very reactive and damaging species.  
 
Fe(II) + O2 → Fe(III) + O2
•−
     (4.1) 
2O2
•−
 + 2H
+ → H2O2 + O2     (4.2) 
H2O2 + Fe(II) → 
•
OH + OH
−
 + Fe(III)   (4.3) 
 
The sum of the last two equations produces the hydroxyl anion, the hydroxyl 
radical and O2 (equation 4.4). This reaction occurs in the presence of a catalytic amount 
of iron.
2
 
 
H2O2 + O2
•−
 → OH− + O2    (4.4) 
 
This hydroxyl radicals can damage a number of cellular components, like DNA, 
proteins and membrane lipids. Aerobic organisms, therefore, have developed strategies 
for iron uptake delivering and storage that protect cells from the potentially toxic effect 
of free iron and radical chemistry. There are three general mechanisms adopted in 
nature to acquire, to solubilize and store iron in a non toxic form: chelation, reduction 
and acidification. The most common chelating agent are called siderophores. They 
have high affinity for iron due to their multidentate ligand character. In addition they 
have high affinity for Fe(III) over other metals such that siderophores are very efficient 
in specifically mobilize iron even in the presence of other metal ions. The second 
strategy for solubilizing iron
 
is its reduction to Fe(II) generically mediated by a class of 
enzymes called ferrireductase. This represents the mechanism that mammalian cells 
use for iron uptake. Once reduced, iron is transported into the cell by Fe
2+
 specific 
transporters. The third strategy is acidification of the extracellular environment that 
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cause an increase of iron concentration. This strategy is commonly used by plants in 
case of iron deficiency.  
 
 
4.1.1. Cellular iron uptake in mammalian 
 
Mammalian cells can uptake iron as heme-iron or nonheme-iron. Uptake of 
nonheme-iron from the lumen if the mammalian intestine is mediated by a Fe(II) uptake 
system. Iron is first reduced by cell surface ferrireductases or by natural reductants and 
then taken into the intestinal epithelial cells. Once in the epithelial cells, the iron is 
exported across their membrane into the blood by ferroportin. Before its release into 
the serum, iron is oxidized and then bound by transferrin (Kd = 10
-22
), that delivers 
Fe(III) to the cells of most tissue in the body. Iron uptake from transferrin into other 
cells types combine the three strategies discussed before as summarized in Figure 4.1. 
Once inside the cell Fe(III) is reduced by a ferrireductase and transported into the 
cytoplasm where it reaches its cellular targets (Fig. 4.1). Intracellular iron pathways are 
not fully understood. 
 
 
Figure 4.1. Mammalian iron uptake and storage. 
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4.1.2. Intracellular iron storage and biomineralization in mammalian 
 
Organisms posses an efficient storage mechanism for iron accumulation. More in 
general, storing a metal ion inside a protein has the benefit to concentrate it without the 
toxic consequences that the accumulation of minerals might otherwise entail. Indeed, 
many of the storing mechanisms of metal ions also play a role in detoxifying toxic 
metals. The primary site of iron storage found in vertebrates, plants, some fungi and 
bacteria is ferritin.  
 
 
4.2. Ferritins 
 
Ferritins are members of the broad superfamily of iron storage and detoxification 
proteins found ubiquitariously in nature.
3
 They have highly conserved supramolecular 
nanostructures designed to sequester thousands of iron atoms in a mineralized and 
biologically available form and to release them in a controlled manner. In the process of 
uptaking and storing iron, ferritins catalyze the contemporary oxidation of two Fe(II) 
trough a single dioxygen/hydrogen peroxide molecule by a mechanism that avoids the 
odd electron oxidation of iron(II) and the associated production of superoxide and 
hydroxyl radicals harmful to the cell.
2,4
 The dioxygen/hydrogen peroxide molecules 
migrate into the cavity where biomineralization reaction occurs (equation 4.5): 
 
2Fe(II) + O2 + (H2O)x+3 → Fe2O3(H2O)x + 4H
+
 + H2O2   (4.5) 
 
Thus, the ferritins are not only able to efficiently harvest and accumulate iron, but 
they also help to protect the cell against oxidative stress minimizing “free iron” which 
contributes to the generation of reactive oxygen species.
5
 Another important property of 
ferritin is the protection of DNA from oxidative damage.
6
 
In this respect, the importance of ferritin is illustrated by embryonic lethality of 
gene deletion in mammals
7
 and resistance to oxidants in animals, plants, bacteria and 
archea.
8
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4.2.1. Mini and maxi ferritins 
 
Ferritins are formed by the self-assembling of multiple -helix bundle subunits 
oriented almost parallel to the protein surface and forming a ring around a cage that 
occupies about 30% of the total protein volume.
9
 It has been shown that they use 
oxygen to make the iron concentrates.
10
  
Ferritins are generally classified in two sub-families called maxi- and mini-
ferritins (Fig. 4.2).  
 
 
 
Figure 4.2. Maxiferritin (right) and mini-ferritin (left) ribbon representation. 
 
Maxi-ferritins of animals, plants, and bacteria are constituted by 24 subunits of 20 
kDa each assembled in a supramolecular complex of 480 kDa able to host 4500 iron 
atoms. The cage has an external diameter of 12 nm and a diameter cavity of 8 nm. Mini-
ferritins of bacteria and archaea are formed by 12 subunits that form a protein cage of 
240 kDa able to host up to 500 iron atoms. The nanocage has an external diameter of 9 
nm and an internal one of 5 nm. They were first discovered during starvation and named 
Dps (DNA protection during starvation) proteins. In contrast to maxiferritins where 
dioxygen is used to concentrate iron, the miniferritins use iron to detoxify dioxygen or 
peroxide and protect DNA from damage.
11,12
 I will focus my attention on the maxi-
ferritins. 
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4.2.2. Ferritin: type of chains 
 
The single ferritin subunits are four-helix bundles which typically consist of four 
-helices packed in a coiled-coil arrangement. The four  -helices that run parallel and 
antiparallel one to another, are designated as A, B, C, and D. A long loop connects the 
B to the C  -helix, while two short loops connect the others.13 The long loop and the 
helices A and C are solvent exposed, while B and D helices flank the inner cavity. In 
maxi-ferritins, a short fifth helix forms a turn with an axes of about 60° with respect to 
the four-helix bundle axis; it is the most phylogenetically variable part of the sequence 
(Fig. 4.3).   
 
 
 
Figure 4.3. Ribbon diagram of the bull frog M ferritin (pdb code 1MFR) showing 
the relationship between the helices A, B, C, D and E, inclined at ∼60° to the four-helix 
bundle axes and the BC loop. 
 
The single subunit can be constituted by a number of amino acid in the 154-185 
range. Plant and bacterial ferritins are homopolymers, whereas mammalian ferritins are 
composed of two subunit types, the H (heavy ≈ 21 kDa)  and L (light ≈ 19 kDa) chains 
where the first is a few residues longer than the second one. The H chain contains the 
forroxidase site responsible for the iron oxidation, while the L chain does not show 
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ferroxidase activity but is contributes to the iron incorporation inside the iron core 
exposing carboxyl groups into the cavity.
14
 In mammals both subunits co-assemble in 
different proportions in a tissue-specific manner.
15,16
 Human H- and L-chains are of 
similar size (182 and 174 residues respectively) and share 55% amino acid sequence 
identity. Beyond the H and L chains, a so-called M (middle) subunit type exists. Its 
molecular weight is just in the middle between the H and the L subunit and it presents 
ferroxidase activity.    
H and M subunits contain a set of residues that is highly conserved in the majority 
of ferritins. These residues constitute the catalytic oxidoreductase (ferroxidase) sites that 
is situated in the center of each of the four-helix bundles (Fig. 4.15A). At the catalytic 
site two Fe(II) once bound, are oxidized by dioxygen to form diferric oxo complexs 
precursors of the hydrated ferric oxide mineral. 
 
 
4.2.3. Ferritin shell: axes and channels 
 
Within the single subunits, a big network of interactions involving both 
hydrophobic and hydrophilic interactions are established. Moreover, ferritin subunits 
self-assemble to form a symmetrical and extremely stable ferritin spherical shell. The 
outcome of the assembly of 24 subunits, is a shell that has the approximate geometry of 
a rhombic  dodecahedron, the faces of which consist of two subunits related by a 2-fold 
symmetry axis at its centre (e.g., I and II or III and VI Fig. 4.4).  
 
     
 
 
Figure 4.4. (a) Schematic diagram illustrating the relation between symmetry 
related subunits. (b) Assembled ferritin viewed from the fourfold axis. 
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Beyond the six 2-fold axes, eight 3-fold axes and six 4-fold axes are present (Fig. 
4.5). The long side of subunit I interacts with the ends of subunits III and VI, while the 
two ends of subunit I also interact with subunits IV and VII. Most of the intersubunit 
interactions, involving both hydrophobic and hydrophilic interactions, lie within these 
interfaces, between the 3-fold and 4-fold axes. 
This wide network of inter- and intra- subunit interactions explains the extremely 
high ferritin stability. Indeed ferritin can be safely heated up to 80 °C,
17
 stands 6 M 
guanidine at neutral pH
18
 and allows pH variation from 3 to 11 without unfolding. 
Moreover, intersubunit and intrasubunit interactions are so similar
19
 that subunit 
dissociation and subunit unfolding usually coincide.  
There are two clearly discernable channels leading from the outside to the inside 
of the protein shell along the 4-fold and 3-fold axes of symmetry. The six channels 
along the 4-fold axes (Fig. 4.5B) are constituted by four helices of four neighboring 
subunits. This gives a long apolar channel, 12.5 Å in length, and relatively narrow  it is 
accessible to a 2 Å diameter probe.
20
 The eight 3-fold axes (Fig. 4.5C) are funnel-
shaped with a wider entrance at the outside of the molecule and a narrow passage (3.4 Å 
wide and about 6 Å depth). The amino acid residues which neighbor and line these 
channels include residues from the C-terminus of helix C and those of the N-terminus of 
helix D. These hydrophilic residues (117–137) are highly conserved in all ferritins. 
Most data indicate that iron enters and exits the cavity of animal ferritins via these 3-
fold channels
4
 while the hydrophobic channels are thought to be involved in diffusion of 
oxygen and hydrogen peroxide. 
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Figure 4.5. Full ferritin shell (left panel) and expanded views (right panel) of 
three channel types: (A) 4-fold, (B) 3-fold, and (C) 2-fold channels with key residues 
indicated. The rotation symmetry related subunits is highlighted in blue in the left 
panels.  
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4.3. Iron storage in maxi-ferritins 
 
Thousands (up to 4500) of iron atoms can be accommodated in ferritin minerals 
inside the protein cage. A large number of studies were carried out to understand the 
mechanism of iron uptake and deposition in ferritin. It has been proposed a multistep 
mechanism:
21
 
1) two iron(II) ions bind at the protein oxidoreductase (ferroxidase) sites followed 
by a rapid oxidation trough dioxygen to form diferric peroxo products (equation 4.6) 
that immediately evolve in diferric oxo complexes (equation 4.7); 
2) the resulting diferric oxo complexes migrates into the protein cavity following 
a pathway that since now was unknown; 
3) in the protein cavity, a stable nucleus of crystalline mineral (ferrihydrite 
Fe2O3(H2O)x) starts to form (equation 4.8); the growing mineral core provides 
additional nucleation sites onto which incoming Fe(II) can be further deposited and 
oxidized.   
 
2Fe
2+
 + O2 
 →  [Fe(III)-O-O-Fe(III)]      (4.6) 
[Fe(III)-O-O-Fe(III)] + H2O 
 →  H2O2 + [Fe(III)-O-Fe(III)]   (4.7) 
[Fe(III)-O-Fe(III)] + (H2O)x+2 → Fe2O3(H2O)x + 4H
+  
(4.8) 
 
2Fe(II) + O2 + (H2O)x+3 → Fe2O3(H2O)x + 4H
+
 + H2O2  (4.5) 
 
In accordance with equation 4.6, stopped-flow kinetics, resonance Raman 
spectroscopy, Mössbauer spectroscopy, and EXAFS have established that diferric 
peroxo product are formed during the first 50 ms after Fe(II) oxidation by O2 at the 
ferroxidase site
22
 and are 1,2- peroxo di Fe(III) intermediate having an unusually short 
Fe-Fe distance of 2.54 Å. This first intermediate subsequently decays within 150 ms to 
one or more diferric oxo intermediate(s) and small clusters whereupon H2O2 is produced 
in a stoichiometric amount and released into solution. Finally, the diferric oxo dimers 
and clusters migrate into the protein cavity where they lead to the formation of large 
polynuclear aggregates and the mineral core itself (equation 4.8). This reaction in vitro 
requires from days to months. This can be due to the slow kinetic of the mineral 
aggregation reaction that involves formation and breaking of bonds between iron 
products and protein residues. 
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Once a central metal core is formed into the protein cavity (up to 200 iron atoms), 
the iron oxidation occurs directly on the mineral surface as stopped-flow absorption 
spectrometry, UV spectrometry, and electrode oximetry revealed.
21
  
What about the two sub-products H
+ 
and H2O2? From the overall reaction shown 
in equation 4.5 is clear that for each Fe(II) 2H
+
 are produced. Protons have to diffuse 
out of the protein in order to avoid fast pH decreasing and hydrolysis of peptide bonds. 
Concerning H2O2 it has been shown that it leaves only partly the ferritin shell, while the 
other part migrates inside the cavity where it reacts with Fe(II) helping the mineral 
formation (equation 4.9).
23
  
 
2Fe
2+
 + H2O2 + 2H2O → 2FeOOH(core) + 4H
+
                 (4.9) 
 
 
4.3.1. Active site 
 
As the first X-ray structures of ferritins began to appear, it became clear that 
ferritins were members of the larger family of binuclear non-heme iron enzymes. 
Indeed, the ligand set of iron in ferritins, as well as the mechanism of iron oxidation, 
oxygen activation and the diferric peroxo intermediate formation,
24-26
 are similar to 
those found in other binuclear non-heme iron enzymes.
27
 
Binuclear non-heme iron enzymes catalyze a variety of reactions using a largely 
conserved ligand set at the active site. Among these, the most studied are ribonucleotide 
reductase (R2), which converts ribonucleotide into deoxyribonucleotides, Δ9-desaturase 
(Δ9d), which inserts a double bond into a fatty acid chain, and methane monooxygenase 
(MMO), which catalyzes the oxidation of methane to methanol.  
A crystal structure of ferritin with Fe(II) present in the active site is difficult to 
obtain because of the transient nature of substrate/enzyme interactions. However, a 
considerable number of ferritins X-ray structures co-crystallized with metal ion 
homologues for Fe(II) (e.g. with Mg(II),
28
 Ca(II)
20
 or Zn(II)
29
) are available, permitting 
comparisons with the diiron cofactor proteins.  
In frog M ferritin, Mg(II) (Fig. 4.6A) has a the same ligand motif to that of the 
corresponding Fe(II) in Δ9d or R2 (Fig. 4.6C), consisting of two carboxylate and one 
histidine ligand-EEH and a quite similar on with respect to the MMO (Fig. 4.6B) that 
presents a two carboxylate and one histidine ligand-DEH motif. For most diiron 
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proteins this motif is generally repeated at the second iron site, while for ferritin such 
ligands are substantially different and consist of two glutamates (one is the Glu58 
bridge), a glutamine, and an aspartate residue–EQD. Here, the histidine is replaced with 
a weaker aspartate ligand, and the unusual presence of the glutamine ligand prevents the 
formation of a second carboxylate bridge between the metals, a structural feature thus 
far present in all other nonheme diiron sites.  
 
 
 
Figure 4.6. Crystal structures of the active sites (A) M ferritin crystallized with 
Mg(II) (pdb code 1MFR); (B) methane monooxygenase (pdb code 1FYZ) crystallized 
with Fe(II); (C) Ribonucleotide Reductase (pdb code 1PFR) crystallized with Fe(II). 
 
This structural catalytic site differences reflect the diverse fate of the diferric 
species in ferritin versus non-heme iron enzymes. As reported  in the Figure 4.7 in 
ferritin (left), the  peroxodiferric complex decays to diferric oxo or hydroxo precursors 
that are translocated from the catalytic to the biomineralization sites and hydrogen 
peroxide is released. In diiron proteins the resting state has to be restored without any 
uptake of new iron. Rapid freeze-quench (RFQ) EPR, and Magnetic Circular Dichroism 
(MCD) studies shown that the peroxodiferric complex evolves into a tyrosyl radical that 
it's not released from the catalytic site.
30
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Figure 4.7. Left: proposed reaction pathway for M ferritin resulting in release of 
ferric-oxo mineral precursor from the active site, assuming equal rates of dioxygen 
binding and ET for all the types of diiron sites. The two bound waters may provide the 
protons necessary for formation of hydrogen peroxide. The water derived bridge present 
in the peroxo species may exist as a hydroxo or aquo bridge.
25,31
 Right: reaction 
pathway for R2 ribonucleotide reductase leading to a high valent intermediate and 
generation of a stable tyrosyl radical (Y122•).30 
 
In conclusion, the key differences between the diferrous substrates in ferritin and 
the diferrous cofactor sites in MMO, R2 and Δ9d are: 1) the single glutamate bridge 
between the bound Fe (II) atoms, 2) two water ligands, one coordinated to each Fe(II), 
3) the weaker ligand field, and 4) the concerted Fe(II) binding mechanism and 
cooperativity. 
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4.3.2. Nucleation site 
 
Once the diferric oxo complexes are formed, they migrate into the protein cavity 
where the iron (III) biomineral (ferrihydrite) starts to form (equation 4.8). It has been 
shown that the mineralization step occurs in the inner surface of the protein shell where 
the nucleation sites are localized. These mineralization centers are made up of the 
highly conserved diamond cluster of carboxylate residues clustered at the subunit dimer 
interfaces.
32,33
  
The ferritin core is a hydrated ferric oxide mineral phase (ferrihydrite) of variable 
crystallinity and composition. The structural and magnetic properties of the iron-core 
have been investigated in detail by high-resolution transmission electron microscopy, 
Extended X-ray absorption fine structure (EXAFS), electron diffraction and Mossbauer 
spectroscopy.
34
  
The iron core appears as a nanoparticle of 8 nm of diameter encapsulated in the 
protein shell. Each iron atom is surrounded by 6 oxygen atoms at an average distance 2 
Å which are likely in a distorted octahedral (Fig. 4.8a) or hexagonal (Fig. 4.8b) 
arrangement and also it has 7 iron neighbors at an average distance of 3 Å. Depending 
from the composition and the rate of growing, the structure for the iron core is more or 
less ordered.
35
  
 
 
 
Figure 4.8. Two proposed structural models for the arrangement of iron 
(grey/green) and oxygen (brown) in ferrihydrite. (a) Double-hexagonal component:
36
 Fe 
atoms randomly occupy 50% of the octahedral sites with the constraint that neighboring 
Fe sites are not occupied simultaneously. (b) Hexagonal unit cell:
37
 Partially filled 
circles represent 40–45% vacancies in the Fe2 (octahedral) and Fe3 (tetrahedral) sites. 
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4.3.3. Iron uptake 
 
When iron concentration in cells is high, ferritin acts also as an iron scavenger by 
sequestering excess cellular iron. The mechanism by which cytosolic iron is delivered to 
ferritin is still unknown. However, two years ago it has been found that human poly 
(rC)-binding protein (PCBP1) increased the amount of iron loaded into ferritin when 
expressed in yeast. Thus, PCBP1 may function as a cytosolic iron chaperone in the 
delivery of iron to ferritin.
38
  
Moreover, recent electrostatic potential energy calculations, molecular diffusion, 
and thermodynamic and kinetics measurements of animal ferritin support the proposal 
that Fe(II) uses the threefold channels for entry.
39,40,40
 The negative outer entrance  (Fig. 
4.9) is surrounded by patches of positive potential, and this arrangement leads to 
electrostatic fields directing cations towards the channel entrance, the 3-fold route. The 
region of negative potential extends through the 3-fold channel to the interior of the 
molecule, such that Fe
2+
 translocation through the channel would be driven by an 
electrostatic gradient. Alterations of the conserved amino acid residues that line these 
channels (Fig. 4.5B) decreased the capacity of H-chain ferritins to bind and oxidize 
Fe(II), documenting the role of the 3-fold channel in the entry of divalent cations into 
the interior of the protein. Inhibition kinetics experiments employing Zn(II) and Tb(III) 
as probes of Fe(II) oxidation indicated that the mechanism of inhibition occurs through 
blocking the passage of Fe(II) to the ferroxidase center, suggesting that the 3-fold 
channels are the main pathway of iron(II) entry in ferritin.
41
 Figure 4.9 illustrates the 
putative pathway into the protein via the 3-fold channel where residues Thr135, His136, 
and Tyr137 are proposed to be involved in guiding iron from the inner opening of the 
channel to the ferroxidase centers of the protein. 
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Figure 4.9. Internal view of the three-fold channel of ferritin (left panel). The 
right panel shows a putative Fe(II) pathway from the three-fold channel to the 
ferroxidase center of the protein. 
 
 
4.3.4. Iron release 
 
Ferritin releases iron in a controlled fashion. In response to decreasing cytosolic 
iron concentration, ferritin receives external signals that promote the immediate 
dissolution of the iron biomineral.  
The mechanism of iron release from ferritin is still unknown. Two models are 
proposed for recovering ferritin iron in vivo. In the first model, cytoplasmic ferritin is 
incorporated into the lysosome, followed by protein degradation, iron mineral 
dissolution, and iron export to the cytoplasm.
42
 It's still not clear how ferritin enters 
lysosomes and how iron crosses the lysosome membrane. The second model is based on 
the reversible unfolding/folding of ferritin pores that regulates the access of reductant 
and chelating agents allowing Fe(II) release from ferritin.
43,44
 Ferritin pores are formed 
from six helices and present four highly conserved amino acids (Figure 4.10). that can 
be seen as analogous to the gated channels formed by membranes proteins involved in 
the control of ion flow.
42,45
 Selective destabilization of the ferritin pore structure, 
independently of global ferritin structure, was observed by crystallography, site-direct 
mutagenesis and Circular Dichroism (CD) spectroscopy. Ferritin pores unfolding has 
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been observed at 56 °C, at millimolar concentration of urea or guanidine and after 
mutation of some residues in proximity to the pore. In particular, it has been shown that 
the  substitution of the set of conserved residues increases mineral chelation rates. These 
residues are an interhelix (C-D) leucine-leucine pair, an interloop (C/D-B/C) aspartate-
asparagine ion pair, and a short C-D loop.  
It is possible that biological regulators recognize the pore gates and/or the 
folded/unfolded states to protect the ferric iron mineral from cellular reductants until the 
iron is needed for synthesis of iron cofactors. 
 
 
 
Figure 4.10. A) closed pores, B) open pores gates and unfolded pores. 
 
  
4.4. Aim of the project 
 
Here is reported the study of the iron(III) pathway from the ferroxidase site to the 
central cavity of the protein. To manage the investigation of such a big system a new 
NMR strategy was developed. The strategy is based on 
13
C-
13
C solution NOESY 
experiments combined with solid state proton driven 
13
C-
13
C spin diffusion and 3D 
coherence transfer experiments. In this way 75% of amino acids were recognized and 
35% sequence specific assigned. Paramagnetic broadening, induced by iron(III) species 
in solution 
13
C-
13
C NOESY spectra, localized the iron within each subunit and traced 
the progression to the central cavity. Moreover, the crystal structure of iron-loaded 
ferritin has been solved. 
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4.5. Methods 
 
1
H direct-detection NMR experiments are at the basis of the solution structure 
determination for many proteins and biological complexes. Complete structure 
determinations by solution NMR have generally been restricted to proteins of relatively 
low molecular weight (< 30 kDa). The approach fails for large protein (MW > 30 kDa) 
or paramagnetic proteins, proteins regions affected by exchange processes or unfolded 
proteins. While in the last case, a “solution structure” does not exist, in the other 
situations the method fails because of the short transverse relaxation times (T2) that 
characterize these systems. Indeed, relaxation rates (T2
-1
 or R2) and thus signal 
linewidths (Δν), increase with the size of the macromolecule: Δν½ = 1/(πT2), broadening 
signals beyond detection. 
For proteins of < 100 kDa,
46
 novel techniques using cross-correlated relaxation 
between dipole-dipole interactions and chemical shift anisotropy (CSA) have overcome 
the limitations imposed by transverse relaxation, allowing the detection of some sets of 
signals.
47
 Nevertheless, for systems larger than 100 kDa, the use of 
1
H–15N triple 
resonance experiments fails, because the coherence transfer relying on scalar couplings 
suffers for the reduced transverse relaxation times. Examples are transverse relaxation-
optimised spectroscopy (TROSY),
48
 cross-correlated relaxation-enhanced polarization 
transfer (CRINEPT),
49
 that in combination with extensive protein deuteration, have 
successfully been used for the detection of amide resonances in systems up to 900 
kDa,Fiaux, 2002 12702 /id} but do not allow assigning proteins. 
 
 
4.5.1. Carbon detection experiments in solution NMR 
 
Beside 
1
H-detected NMR, 
13
C-direct detection experiments, have been developed 
with significant results.
50-52
 These experiments take advantage of the lower 
gyromagnetic ration of 
13
C with respect to 
1
H, which reflects in less efficient relaxation 
mechanisms and therefore longer T2 values.
53
  
On the other hand, 
13
C-
13
C NOESY-type experiments are not influenced by the 
negative effect of the molecular size. Indeed, the magnetization transfer phenomena at 
the basis of NOESY experiments occur when the magnetization is along the z-axis, and 
are therefore not affected by  transverse relaxation.
54
 During the NOESY mixing time 
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two processes are operative: the cross-relaxation, that is responsible of the 
magnetization transfer through dipolar coupling, and the longitudinal relaxation which 
restores the magnetization to the equilibrium values. The longitudinal relaxation times 
are substantially longer than transverse relaxation times in large proteins. The cross 
relaxation increases with molecular weight, being directly proportional to the rotational 
correlation time of the molecule.
55
 Therefore the NOESY intensities in high molecular 
weight systems gain from both processes.  
Nevertheless, 
13
C-
13
C NOESY-type experiments do not allow the sequence-
specific assignment because sequential C-C connectivities are usually too long to be 
observed while those between carbonyls and carbonyls and C of sequential amino 
acids, which are as short as 2.4-2.9 Å, at the current stage of spectral resolution could 
not be determined with certainty given the large linewidth of carbonyl resonances. For 
this reason it has been necessary to develop new techniques, such as solid state NMR, 
that permit the assign of such a big system.  
 
 
4.5.2. Magic Angle Spinning Solid State NMR 
 
Over the last decades, solid-state NMR spectroscopy (ssNMR) has emerged as a 
key technique for chemical analysis, structure determination and dynamic investigation 
of organic, inorganic and biological systems.
56
 This rapid development is mainly due to 
advances in instrument hardware design, stable magnets, sample isotope labeling and 
novel experimental methodologies. In the past, ssNMR revealed structural details of 
materials such as polymers, cement, petroleum, coal, glasses, organometallic 
compounds, catalysts, and many more,
57
 not accessible by other spectroscopic methods. 
Today, a major challenge is to characterize at an atomic resolution the three dimensional 
structure and dynamics of biomolecules such as insoluble proteins, immobilized 
biological assemblies, membrane-embedded proteins,
58
 fibrillar aggregates
59
 or intact 
viruses.
60
 
In solution, molecules tumble quickly enough to average out the orientationally 
dependent anisotropic interactions (such as Chemical Shift Anisotropy (CSA), 
heteronuclear and homonuclear dipolar couplings and, for spin with S > 1/2, 
quadrupolar couplings) giving spectra with relatively sharp transitions. By contrast, 
solids do not tumble enough and anisotropic or orientation-dependent interactions are 
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observed in the spectrum. Thus anisotropic general approaches for obtaining high 
resolution ssNMR spectra have been developed: the use of oriented samples and the 
MAS technique. In the latter, the sample is spun around an axis tilted at an angle of 
54.73° (the magic angle) with respect to the static magnetic field
61
. In this work, we 
have focused on MAS methods for structural studies. MAS gives sufficiently resolved 
spectra and allows the detection of the isotropic chemical shifts making the 
implementation of the well-established solution NMR strategies for resonance 
assignment possible. Moreover, the ssNMR assignment can be exploited to obtain 
information about secondary structure motifs, as common in solution  NMR.  
 
 
4.5.2.1. Basic tools in solid-state MAS NMR  
 
The anisotropic nuclear interactions that are of interest in solid-state NMR 
spectroscopy can be described by second-rank tensors which couple the nuclear 
magnetic moment to the pertinent field and together form the nuclear spin Hamiltonian 
H: 
H = HZ + HRF + HCS + HD + HJ + HQ  (4.10)  
 
HZ is the Zeeman term, which describes the interaction between a nuclear spin I and the 
external field B0: 
 
HZ = I Z B0     (4.11) 
 
where I and B0 are represented by vectors and Z is a second-ranked tensor. 
Transitions between the Zeeman states are induced by an oscillating field B1 and 
are described by the HRF term: 
 
HRF = I Z B1     (4.12) 
 
where the B1 field is generally thousand times smaller than the B0 field. 
The remaining terms of the Hamiltonian give rise to the characteristic features of 
an NMR spectrum. These are the chemical shift Hamiltonian HCS, the dipolar 
Protein-metal ion interaction 
112 
Hamiltonian HD, the J-coupling Hamiltonian HJ and the quadrupolar coupling 
Hamiltonian HQ. The chemical shift Hamiltonian HCS can be written as: 
 
HCS =  I  B0     (4.13) 
 
where is the shielding tensor and describes the effect of the electron distribution 
around the nuclear spin. Because the electron distribution is not uniform, the chemical 
shift interaction depends on the orientation of the nucleus with respect to B0. In a first-
order perturbation theory, the truncated chemical shift Hamiltonian HCS for a single spin 
becomes: 
HCS =  Iz zz
LF
 B0    (4.14) 
 
The index LF indicates that zz
LF
 is the zz element of the matrix in its 
laboratory-frame (LF) representation. 
The dipolar Hamiltonian HD describes the through-space coupling between two 
nuclear spins I
I
 and I
J
: 
 
HD = I
I 
D I
J
    (4.15) 
 
where D is the dipolar coupling tensor, which describes how the field due to the spin I 
varies with the orientation of the I-J internuclear vector in the applied field (IJ). The 
dipolar coupling has also an r
-3
 distance dependence, which is source of distance 
restraints in NMR. The truncated dipolar Hamiltonian is: 
 
HD = - (0/4 )  IJ (
I J /rIJ
3 
) * (1/2) * (3cos
2 
(IJ) -1) 2*Iz
I 
Iz
J
  (4.16) 
 
J-couplings are dipolar couplings that are mediated through bonds by the electrons.
62
 In 
the solid-state J-couplings are much smaller than the dipolar interactions, nevertheless 
solid state NMR experiments have recently been presented, which utilize J-couplings to 
establish homonuclear
63,64
 and heteronuclear
65
 correlations.  
The quadrupolar coupling Hamiltonian HQ is non-zero only for nuclei with spins 
greater than 1/2 and is proportional to the electric-field gradient tensor V. The chemical 
shift tensor  the dipolar interaction tensor D and the electric-field gradient tensor V 
contain all a (3cos
2–1) orientation dependence factor. Consequently, in a MAS NMR 
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experiment, chemical shift anisotropy, dipolar and quadrupolar interactions can be 
averaged by mechanically spinning the sample about an axis aligned at 54.7º with 
respect to the external magnetic field, as depicted in Figure 4.11. When the sample is at 
the magic-angle, the anisotropic factor vanishes and under fast rotation the anisotropic 
broadening is removed. The isotropic shift interactions and the isotropic J couplings are 
left and high-resolution NMR spectra can be recorded, as in solution NMR.  
 
 
 
Figure 4.11. Schematic representation of the magic-angle spinning (MAS) 
technique. The rotor, that contains the sample, is tilted at 54.7º respect to the external 
magnetic field. By the combined application of bearing and driving pressures, the 
sample rotates around itself, at the desired frequency.  
 
 
4.5.2.2. Cross Polarization transfer (CP) 
 
Proton would be in principle the best nucleus to be studied in ssNMR due to its 
large gyromagnetic ratio (H) and its high natural abundance. In an NMR experiment, 
the sensitivity, i.e. the signal-to-noise ratio (S/N), depends on both these parameters 
and, of all naturally occurring nuclei, the proton has the best sensitivity. In solution 
NMR, indeed, proton detected experiments are used to define protein structure, as 
discussed in the previous chapter. However, a large H implicates large homonuclear 
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dipolar 
1
H-
1
H couplings and gives a homogenously broadened spectrum unsuitable also 
for line narrowing techniques such as MAS and homonuclear dipolar decoupling. Under 
the best homonuclear decoupling sequence, the proton resonances in solid are at least an 
order of magnitude broader than in solution. Different techniques have been developed 
to overcome this problem.  
Up to now the most adopted method consists in heteronuclear detection. So far, all 
standard ssNMR experiments have relied on 
13
C and 
15
N detection. Low-  nuclei 
detection in the presence of MAS and high power proton decoupling gives high 
resolution spectra. The sensitivity can be improved chemically using isotope enrichment 
and with spectroscopic tools using Cross-Polarization (CP). CP transfers magnetization 
from proton to the low- nuclei (13C or 15N) as shown in Figure 4.12. 
 
 
 
Figure 4.12. Pulse program for a 
1
H-
13
C CP with dipolar coupling during the 
acquisition time. 
 
The signal enhancement resulting from CP is due to two factors. First, the larger 
gyromagnetic ratio of protons (e.g.  H is 4 times bigger than C) creates a larger 
1
H 
polarization which is transferred to the low- nucleus. Second, the repetition time of the 
experiment is determined by the shorter 
1
H relaxation time relative to low- spins and 
hence the experiment repetition rate can be increased. For typical 
1
H-
13
C CP 
experiment, these two factors can easily result in a 10-fold increase in sensitivity. In a 
CP experiment, the field strengths in the rotating frame are set to the Hartmann-Hahn 
condition, as depicted in Figure 4.13. 
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Figure 4.13. The classic Hartmann-Hahn matching condition for a non-spinning 
sample, that allows transfer of polarization from 
1
H to low-nuclei, such as 13C. For a 
spinning sample, the MAS frequency has to be taken into account and the matching 
condition becomes: 1H -13C = ±n r. 
 
The standard pulse program  for ssNMR protein resonance assignment starts with 
a 
1
H excitation 90º-pulse and then magnetization is transferred from protons to the low  
frequency channel (e.g. 
13
C) by the matched pair of CP pulses. 
 
 
4.5.2.3. Assignment strategy 
 
In ssNMR the common protein resonance assignment procedure established in the 
last few years consists in the identification of the amino acid spin systems and of the 
intraresidue backbone amide nitrogen, followed by the linking of the different spin 
systems for the sequential assignments. The three-dimensional chemical shift 
correlation experiments used for this purpose are the dipolar assisted rotational 
resonance (DARR),
64
 the NCACX, the NCOCX and the CANCO.
65,66
 The DARR 
experiment is based on the spin diffusion effects along amino acids side chains making 
the identification of the side chains of each amino acid possible. In the NCACX 
experiment it is possible to link each spin systems to its nitrogen, while in the NCOCX 
experiment each side chain is connected with the nitrogen of the following residue. 
Finally, the CANCO experiment links the carbonyl of each residue to the C and 
nitrogen of the following residue. In particular, a peak in the NCACX resonates at the 
frequencies Ni-Ci-CXi, where CXi can be one of the 
13
C nuclear spins of residue i (Ci, 
Ci, Ci etc.) as shown in Figure 4.14. A peak in the NCOCX resonates at the 
frequencies of Ni+1-Ci-CXi. A peak in the CANCO resonates at the frequencies of 
Ci+1-Ni+1-Ci. Therefore, a strip at a given 
15
N frequency in the NCACX permits the 
identification of intraresidue (residue i) C, Cand C. Comparison with the NCOCX 
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strip allows the identification of the backbone 
15
N frequency for the following amino 
acid (i+1). With this 
15
N frequency, in the CANCO we can identify the C of the (i+1) 
residue (Fig. 4.14). 
 
 
 
Figure 4.14. Schematic representation of the possible connectivities detected in the 3D 
experiments NCACX (red), NCOCX (blue) and CANCO (green) used for the sequential 
assignment at the solid state. Independently of the acquisition dimension, the 3D spectra 
are oriented with the 
15
N dimension along the x axis. Each strip is a portion of a 
13
C-
13
C 
plane (y, z), centered at the 
13
C frequency reported in the bottom of each spectrum, 
extracted from a plane at a 
15
N frequency. The vertical strips are then visualized next to 
one another and allow to build-up sequential patterns.  
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4.6. Results  
 
The pathway of the ferroxidase products to the mineralization site into the protein 
cavity was so far unknown. Simple inspection of the protein cage does not show an 
obvious path from the active site to the mineralization cavity. Therefore, we sought the 
path by solution NMR spectroscopy by taking advantage of the paramagnetic effects 
induced by the iron(III) species released at the catalytic site, on the resonances of 
nearby residues. The unequivocal identification of the signals of amino acids to be used 
as probes for the paramagnetic effects required the development of a new NMR 
approach because of the high molecular weight of the assembled protein (480 kDa). 
Indeed, the large size of ferritin causes slow tumbling of the molecule in solution and 
prevents 
1
H NMR signal detection. We applied 
13
C-
13
C NOESY in solution for the 
identification of about 75% of amino acid spin systems.
67
 On the other hand slow 
molecular tumbling induces rapid transverse relaxation and hampers solution NMR 
experiments for sequence specific assignment based on coherence transfer. 
Immobilization of the protein in the solid state overcomes the problems arising from the 
rapid transverse relaxation, and magic angle spinning (MAS) solid state NMR
1,68
 
provided relatively well resolved spectra (Fig. 4.15A).  
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Figure 4.15. Structure of the 24-mer bullfrog ferritin (A). The primary and 
secondary structures (taken from PDB 1MFR) of bullfrog M ferritin subunits are shown 
in panel (B). Residues belonging to the ferroxidase site are indicated by magenta 
characters. Residues whose resonances are sequence specifically assigned are indicated 
in blue. 
 
We used the protein resonance assignment procedure for ssNMR described in 
Section 4.1.4, that provides direct connectivities between these backbone atoms on 
adjacent residues (Figs. 4.16-4.17).  
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Figure 4.16. An example of a sequential walk for residues 40-43 through strips 
constructed from NCACX (red traces), NCOCX (blue traces), and CANCO (green 
traces) experiments. The type of spectrum from which strips are extracted is reported on 
the top of each strip, together with the 
15
N frequency of the plane from which they are 
extracted. Each strip is centered at the 
13
C frequency reported on the bottom. Strips in 
the CANCO and NCACX with the same 
15
N chemical shift and containing the same Cα 
allow the sequential assignment through the C'. Peaks in the NCOCX connected to 
those of CANCO through dashed lines are sometimes observed, as reported by 
Oschkinat and coworkers.
69
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Figure 4.17. Examples of the sequential walk connecting residues 71-78 (A), 89-
93 (B), and 144-147 (C). The representation is the same as in Figure 4.16, but for sake 
of clarity, only the NCOCX and CANCO strips are shown. 
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As a result, 59 residues, distributed throughout each subunit, were sequence-
specific assigned (Fig. 4.15A/B). The chemical shift index is consistent with their 
location on the expected secondary structure elements, while the use of ferritin 
expressed in [2-
13
C]-labeled glycerol confirmed the chemical nature of the assigned 
residues.
69
 The transfer of sequence-specific assignments derived from solid state data 
to the solution 
13
C-
13
C NOESY is relatively straightforward if one takes into account the 
deuterium isotope shift
70-72
 and overlays the spectra searching for the best 
superimposition of the aliphatic region (Fig. 4.18), which is characterized by a good 
resolution both in solution and in the solid state.  
 
 
 
Figure 4.18. Superimposition of the aliphatic region of the ferritin 
13
C-
13
C 
NOESY spectrum acquired in solution (blue trace) and of the solid state 
13
C-
13
C DARR 
spectrum (red trace) permits the transfer of the solid-state assignments to solution data 
and vice versa. The two 2D maps were overlaid by looking for the best superimposition 
of the aliphatic part. 
 
Our strategy is based on the recognition of side chain spin patterns. The several 
factors that affect the completeness of the assignment are i) the intrinsically low 
chemical shift dispersion related to the four-helix bundle structure of the monomers,
73
 
ii) the primary sequence of ferritin (Fig. 4.15A) that has large numbers of residues of 
the same type (the most abundant amino acids are Leu19, Glu18, Lys13, and Asp13, 
and account for 36% of the total amino acids); iii) the extremely narrow distribution in 
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13
C chemical shifts within each of the most abundant amino acids, and within the 
Lys/Leu and Glu/Asp groups; iv) the difficulty in discriminating between Glu and Gln 
and between Asp and Asn. More extensive assignments will require repetition of the 
experiments using samples prepared with selective „unlabelling‟ of different amino 
acids,
74
 and is beyond the scope of this report. Nevertheless, the present results 
represent a large step forward in the assignment of big molecular complexes.  
The location of the assigned residues on different structural elements (Fig. 
4.15A/B) makes the group of 59 identified residues structurally representative. Many of 
the assigned residues (62%) are on protein loops, because of the intrinsically lower 
chemical shift dispersion characteristic of amino acids located on the -helices.73 
However residues assigned on -helices are distributed throughout the subunit: helix 1 - 
residues 10, 11, 14-16, 26, 27, 31, 32, helix 3 - 117, 118, 119; helix 4- 141, 144-146, 
148-151, and helix 5 -, 161, 163, 167-169. The set of signals for the sequence assigned 
amino acids was used to monitor the fate of the iron(III) products in solution after 
iron(II) is added and reacts with dioxygen at the active sites.  
When iron(II) and oxygen substrates are converted to ferric species in ferritin, 
selective changes are observed of the 
13
C-
13
C solution NOESY (Fig. 4.19).  
 
 
Figure 4.19. Superimposition of the aliphatic region of the ferritin 
13
C-
13
C 
NOESY spectra acquired in solution before (blue) and after (green) the addition of 1 
equivalent of iron (II) (2 iron(II)/active site; 48 iron(II)/nanocage); resonances 
disappearing upon formation of iron (III) products are labeled. 
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The titration used saturating amounts of ferrous substrate for each catalytic cycle, 
beginning with the addition of 48 atoms of iron(II) per ferritin nanocage, i.e., 2 iron(II) 
ions per ferroxidase site. The iron(II) ions and oxygen substrates are immediately 
converted into iron(III) species, which is accompanied by the disappearance of some 
resonances in well resolved spectral regions, well outside the noise level in the spectrum 
of the apoprotein. This behavior is consistent with the presence of paramagnetic species 
that cause broadening beyond detection of resonances of nearby residues.
75
 Except for 
the  disappearance of a few cross peaks, the 
13
C-
13
C NOESY spectra are identical with 
and without iron(III), indicating localized paramagnetic effects. Good indicators of the 
location of the product are provided by the well resolved side chain peaks of isoleucine 
residues; all four of the isoleucines present in ferritin are assigned. Among the four 
isoleucine residues, only the resonances of the side chain of Ile144 disappeared at this 
stage of the titration, indicating that the ferric products leave the catalytic site and 
migrate towards a new site close to Ile144, which has a side chain protruding towards 
the interior of the helix bundle. Ile141, by contrast, adjacent to the ferroxidase site and 
unaffected at this stage of the titration, has a side chain directed towards the exterior of 
the bundle, towards the internal cavity of the cage. Paramagnetic broadening is also 
induced in Ala26, another residue near the active site with a side chain pointing toward 
the interior of the bundle. These effects suggest that the ferric products leave the 
catalytic site and move inside the 4-helix bundle, from the ferroxidase site towards the 
short fifth helix at the C-terminus of each subunit (Fig. 4.20A). Addition of another two 
iron ions per active site for a total of 96 per nanocage, affects a larger number of 
residues. Besides Ile144 and Ala26, Trp89, Thr92, Ile148, Leu156 are also broadened 
beyond detection (Fig. 4.20A).  
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Figure 4.20. Tracing the iron channel in ferritin by paramagnetic effects. (A) 
NMR resonances that disappear in 
13
C-
13
C NOESY solution spectra, as the  iron:protein 
ratio increases, are mapped onto the ribbon structure of a ferritin subunit as colored 
spheres (1 equivalent of iron = 2 iron(II)∕active site = 48 iron(II)∕nanocage). 1 
equivalent: light blue, 2 equivalents: blue, 4 equivalents: dark blue. (B) View of the 
internal surface of the ferritin protein cage showing the relative spatial relationship near 
channel exits into the cavity; iron(III) products emerging from the channel of the red 
subunit have paramagnetic effects on residue Val42 in the blue subunit and on Arg72 
and Gly74 in the green subunit, after 4 equivalents of iron are added. Paramagnetically 
broadened residues are shown as spheres. (C) Ferritin channel exits in four adjacent 
subunits surround the 4-fold axes of the ferritin protein cage: Val42 (blue spheres); 
Ile148, Thr149, Leu154, and Leu156 (red spheres). (D) Effective magnetic moments per 
subunit (μeff, red bars) and average magnetic moment per iron atom (μeff∕iron atom, blue 
bars) obtained by Evans measurements at increasing concentrations of iron. 
 
 
Protein-metal ion interaction 
125 
The side chains of these residues, as for Ala26 and Ile144, are located inside the 
helix-bundle, but farther from the ferroxidase site. Adding a total of four more iron ions 
per active site, in two additions, for a total of 192 iron atoms per nanocage, results in the 
disappearance of additional resonances, e.g. Thr149 and Leu154 (Fig. 4.20A). These 
residues, however, are located outside the helix bundle at the junction of the channel 
with the inner surface of the mineralization cavity and probably represent the gate for 
iron exit from the channel into the internal protein cavity. Thr149 and Leu154 are also 
at interfaces with other subunits, and, at this level of the titration, other residues in close 
contact to iron(III) complexes are in different subunits. For example the resonances of 
Val42 in one subunit, which is almost in contact with Thr149 on a perpendicular subunit 
(Fig. 4.20B), disappear. The relative position of the subunits in the protein architecture 
is such that multiple exits are close enough to nucleate mineralization inside the central 
compartment through fusion of the emerging products (Fig. 4.20C).  
The first addition of iron (48/nanocage; 2/active site) causes no hyperfine shift in 
any of the resolved resonances, consistent with the presence of iron(III) species 
characterized by low anisotropy, which are incapable of influencing nuclei at distances 
larger than those broadened beyond detection. With 96-192 iron atoms a few resonances 
experience small chemical shifts (≤ 0.2 ppm). These signals belong to amino acids that 
have some signals broadened by paramagnetic effects or that are close in space to amino 
acids with signals broadened beyond detection.  
To explore the aggregation state of the ferric products in ferritin after oxidation of 
iron(II), bulk magnetic susceptibility in solution, was measured at different steps in the 
iron titration (Fig. 4.20D, Table 4.1), by the Evans method. 
76,77
 
 
N° of iron atoms per 
ferritin subunit 
M (m
3
 mol
-1
) µeff (µB) µeff per iron 
atom (µB) 
2 1.12 ± 0.11 10
-7
 4.49 ± 0.22 2.24 ± 0.11 
4 1.75 ± 0.18 10
-7
 5.61 ± 0.28 1.40 ± 0.07 
6 2.61 ± 0.26 10
-7
 6.85 ± 0.34 1.14 ± 0.06 
8 3.43 ± 0.35 10
-7
 7.85 ± 0.39 0.98 ± 0.05 
10 4.38 ± 0.44 10
-7
 8.87 ± 0.45 0.89 ± 0.04 
12 5.32 ± 0.54 10
-7
 9.78 ± 0.49 0.81 ± 0.04 
14 6.40 ± 0.65 10
-7
 10.70 ± 0.54 0.76 ± 0.04 
16 7.37 ± 0.74 10
-7
 11.50 ± 0.58 0.72 ± 0.03 
 
Table 4.1. Magnetic properties (per subunit) of iron-loaded ferritin at different 
degrees of metallation, as deduced from Evans measurements at 298 K. 
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The species formed upon addition of the first two irons per active site has an 
effective magnetic moment eff of 4.49 ± 0.22 B i.e., significantly lower than expected 
for two non-coupled high-spin iron(III) centers (4.5 B vs. 8.3 B) and indicative of the 
presence of an antiferromagnetically coupled dimer,
78,79
 as also observed by Mössbauer 
spectroscopy.
31
 The small magnetic susceptibility is consistent with a -oxo complex.78 
This species accounts for the observed paramagnetic line broadening on nearby residues 
(estimated to be within 5-6 Å). Addition of the second two irons per active site is 
associated with a eff of 5.61  ± 0.28 B i.e., an average eff of 1.4 ± 0.07 B per iron. 
The decrease in the average eff per iron atom from 2.24 ± 0.11 B to 1.40 ± 0.07 B 
suggests the presence of a four-iron(III) cluster with antiferromagnetically coupled 
metal ions. The presence of four iron ions induces paramagnetic line broadening of a 
greater number of amino acids, as observed in Figure 4.20A. Further additions of pairs 
of iron atoms per active site are accompanied by a continual increase in total eff and 
decrease in the average eff per iron atom, as expected for antiferromagnetically coupled 
clusters of increasing nuclearity. The eff of 7.85 ± 0.39 B obtained with 8 iron/subunit 
is comparable to the value reported for the Fe8(4-O)4 cluster.
80
 
Insights on the kinetics of products formation could be obtained with Evans 
measurements as a function of time. The magnetic moments in Figure 4.20D are 
equilibrium values (Table 4.2).  
 
N° of iron atoms 
per ferritin subunit 
tstab (hours) µeff per iron 
atom (µB) t=0 
µeff per iron 
atom (µB) t=tstab 
2 1.5 2.36 ± 0.12 2.24 ± 0.11 
4 24 1.56 ±0.08 1.40 ± 0.07 
6 24 1.24 ± 0.06 1.14 ± 0.06 
8 24 1.05 ± 0.05 0.98 ± 0.05 
10 24 0.93 ± 0.05 0.89 ± 0.04 
12 24 0.85 ± 0.04 0.81 ± 0.04 
14 24 0.78 ±0.04 0.76 ± 0.04 
16 24 0.74 ± 0.04 0.72 ± 0.03 
 
Table 4.2. Time-dependence of the µeff values per iron atom of iron-loaded 
ferritin at different degrees of metallation, observed by Evans measurements at 298 K. 
 
Equilibration of the dimeric ferric products produced by the first equivalent of 
iron is fast (about 1.5 hours). As more iron(II) is added, there is an initial increase in 
magnetic susceptibility attributable to the formation of a new dimer, followed by a slow 
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decrease until a stable value is reached in about 24 hours. This behavior suggests that 
the first product at the catalytic site is always a dimer, which then interacts with other 
products already present within the 4-helix bundle channel.  
 
 
4.7. Discussion 
 
The 4-helix bundle structure of the ferritin subunits provides the scaffold that 
hosts the ferroxidase sites and also guides the catalytic products towards the 
mineralization site. Based on the observed paramagnetic effects on residues lining the 
internal face of the 4-helix bundle, the functional channel corresponds to the interior of 
the  4-helix bundle. Iron catalytic products proceed along the 20 Å –long path inside the 
4-helix bundle of each subunit, roughly parallel to the protein surface, until they reach 
the C-terminal edge, where the short fifth helix, angled about 60° from the axes of the 
bundle, creates a kink that may guide the iron(III) clusters into the mineralization 
cavity. The iron channel we observed is much longer than current models which predict 
a short hop across the protein cage, between the active site and the cavity. 
Formation and migration of ferric products at the active sites of the 24 subunits 
appear to be synchronized in all the subunits at all titration steps. After the first catalytic 
turnover (2Fe/catalytic center), the iron(III) complexes have only moved a few 
angstroms into the channel from the active centers. Two Ile residues are close to the 
active site, Ile141 and Ile144, with Ile141 closer to the metal ions at the catalytic center. 
(Distances between the metal ion coordinated to Asp140/Gln137/Glu103 and Ile141 
nuclei are C 7.7 Å, C 8.0 Å, C1 7.6 Å, C1 7.1 Å, whereas distances between the 
same metal ion and I144 are C 10.2 Å, C 9.2 Å, C1 7.1 Å, C1 8.2 Å; PDB 1MFR). 
If the iron(III) ions produced at the catalytic site maintained the same coordination of 
the ferrous substrate, Ile141 should be more affected by the paramagnetic effects. 
However, resonances of Ile141 are unchanged while those of Ile144, further from the 
active site, are broadened beyond detection. A possible driving force for the change in 
the coordination environment of the iron upon oxidation may be interaction with Tyr30 
and His54; distances between the metal ion coordinated to Asp140/Gln137/Glu103 in 
the active site and potential donor atoms of these residues are: Tyr30 O5.9 Å; His54 
N1 4.8 Å and N2 6.1Å (PDB 1MFR). Migration of the iron(III) products from the 
active site, which as we now know is into the long channel of each subunit, is required 
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to complete turnover at the active site. In the channel, a coordination site with different 
affinities for substrate ferrous (lower than the active site) and ferric product (higher than 
the active site) is needed for the migration of the diferric species. This mechanism is 
consistent with the reported tenfold reduction in iron oxidation rate upon substitution of 
Tyr with Phe at position 30.
81
 When a second equivalent of iron(II) is added (2 
irons/active site), NMR showed paramagnetic species penetrating further into the 
subunit channels. In addition, the resonances of Ala26 and Ile144 remained broadened 
beyond detection suggesting that the second cycle of diferric products are at the same 
site of the diferric products from the first catalytic cycle. The ferritin iron channels 
contain the products of up to 4 catalytic turnovers, before iron reaches the central cavity. 
Equilibrium among different coordination states, with comparable and possibly 
increasingly lower affinity, is needed for the migration of the iron(III) species, when 
new diferric products are formed and released at the active site. 
The magnetic susceptibility data suggest interactions between diferric reaction 
products in the protein channels, and indicate iron aggregation in the protein cage. 
Newly formed iron(III) dimers from the active site, upon addition of more iron(II) 
equivalents, react with earlier iron(III) products, on a time scale of the order of several 
hours, possibly by hydrolysis of water coordinated to ferric ions. The time required may 
reflect the slow kinetics of ligand exchange typical of iron(III), and may be ascribed to 
the establishment of interactions, although weak, between the ferric products  and the 
several potential ligands present in the channel. In addition to the already discussed 
Tyr30 and His54, other potential ligands are Met33, Thr92, Met96, Glu163, and Ser170.  
The exits of the ferritin channels, where iron(III) catalytic products migrate from 
active sites to the cavity are close enough, one to the other, to promote fusion/hydrolysis 
of the emerging multimeric iron(III) complexes into larger biomineral. The multisubunit 
structure of ferritin and the symmetry properties of the protein nanocage, thus, are 
essential elements for the concentration of iron products in the nanocage cavity.  
By flash-freezing ferritin crystals after 30‟ of soaking in concentrated solutions of 
iron(II) under aerobic conditions, we have been able to detect iron(III) product-dimers 
inside the 4-helix bundle channel. Crystallographic data collected at the Zn-edge 
resulted in a 2.7 Å resolution structure. Anomalous difference electron density maps 
acquired on such crystals invariably and clearly present two iron(III) ions in a 
coordination environment similar, but not identical, to that for the magnesium-bound 
form (Fig. 4.21). 
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Figure 4.21. Ferroxidase sites of BF M-ferritin with Mg (left) and Fe (right). 
 
As summarized in Table 4.3, each magnesium ion in the Mg2-ferritin is bound to 
four donor atoms from protein residues. For the so-called Mg(1) they are O1 and O2 
of Glu23 (which acts a bidentate), the N1 of His61, and the O1 of Glu58. The latter 
residue bridges the two magnesium ions, coordinating Mg(2) through its O2 atom. 
Mg(2) also binds to Asp140 O2, Glu103 O1, and Gln137 O1. No solvent molecules 
are reported inside the 4-helix bundle channel, although most probably water molecules 
should complete the coordination sphere of the two magnesium ions. 
In the 30‟-ferric-ferritin, Fe(1) binds to O1 of Glu23 (which acts a monodentate 
ligand), to N1 of His61, and to O1 of Glu58, which is again acting as a bridging 
ligand between the two metal ions; Fe(2) binds to O2 of Glu58, and to Glu103, which 
now becomes an asymmetric bidentate ligand. On the other hand distances with Gln137 
O1 and Asp140 O2 and O1 are all too long for coordination bonds. In the first 
coordination sphere of the iron ions a bridging oxygen is present in 23 out of 24 
subunits, and apical oxygen atoms on both Fe(1) and Fe(2) are found in 15 subunits and 
in 24 subunits, respectively. The metric Gln137 O1 is at a distance which is too long to 
give rise to a coordination bond (3.4 Å) and too short to imply a H-bonded water 
molecule. Analogous considerations applies to Asp140, whose Oδ2 is within H-bonding 
distance from the apical water bound to Fe(2)( 2.5 ± 0.9 Å).  
No further ligands are detected in the present structure, although expected to 
achieve the hexacoordination typical for iron(III). In addition, spectroscopic data 
indicate that an oxo/hydroxo bridge should be present in the ferric dimers products. 
These consideration can be reconciled with the present structural data according to the 
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two following hypothesys: (i) the bridging oxygen belongs to an hydroxide and Gln137 
acts as a loosely bound bridging ligand in trans position with respect to the bridging 
Glu58 or (ii) a -oxo-bridging ligand is present but not detectable with the actual 
resolution. The observed iron-iron distance of 3.2 Å is typical for (-oxo)bis(-
carboxylato)diiron(III) compounds.  
The six coordination sphere assumed by the two iron ions described above would 
account for the detachment from the Glu23 O2 (for Fe(1)) and Asp140 O2 and 
possibly Gln137 O1 (for Fe(2)), which are the protein ligands of magnesium.  
In any case, the Fe(2) ion is systematically and significantly displaced with 
respect to Mg(2) by more than 1.2 Å. These changes in coordination bonds translate 
into a movement of the dimetal center away from helix 4 and towards helices 1 and 
2.  
These structural data are fully consistent with the published solution NMR results. 
Ile141, adjacent to the Mg(2) ligands Gln137 and Asp140, is not affected by any 
paramagnetic broadening in the NMR spectra of the diiron species. On the other hand, 
the resonances of the side chain of Ile144, which is farther from the magnesium ions, 
disappear at this stage of the titration. This observation lead us to propose that the 
iron(III) ions produced at the catalytic site should have a different coordination with 
respect to the magnesium structure. If iron(III) would simply replace magnesium(II), 
indeed, Ile141 should be more affected by the paramagnetic effects. On the contrary, 
resonances of Ile141 are unchanged while those of Ile144, farther away from the 
magnesium binding site, are broadened beyond detection. 
We propose here that this situation represents the ferroxidase site in the product 
conformation, where the ferric dimers are found in a coordination geometry that is 
better suited for their higher oxidation state.  
The main differences between the reagent and the product conformation are 
mainly due to a translation of Fe(2) that, in its movement, gets closer to Tyr30 (Fe(2)-
Tyr30 O about 5 Å vs. Mg(2)-Tyr30 O about 6 Å), a residue proposed to play a key 
role for the kinetics of the iron oxidation. This movement is accompanied by some 
reorientation of the side chain of Asp140, which also shows different conformation is 
the different subunits (see in Table 4.3 the larger errors with respect to the other amino 
acids for the distances measured from the two iron ions). On the other hand the protein 
backbone structure is essentially identical in the Mg2 and Fe2 structures (RMSD of 0.38 
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Å superimposing the 24-mer and 0.26 ± 0.01 Å superimposing the single subunits). This 
movement may provide room for the incoming new iron(II) substrates. 
 
 Mg(1) Mg(2) Fe(1) Fe(2) 
Glu23 O1 2.4  2.30.2  
Glu23 O2 2.5  3.20.2  
Glu58 O1 2.0 3.7 2.10.1 3.30.1 
Glu58 O2 3.7 2.5 3.40.2 2.00.1 
His61 N1 2.7 4.7 2.80.1 4.50.1 
Glu103 O1  2.9  2.50.2 
Glu103 O2  3.2  2.40.2 
Gln137 O1 3.3 2.7 3.40.1 3.40.1 
Asp140 O2  2.5  3.70.4 
     
Fe-oxygen 
bridging 
OH/H2O 
  2.80.2 2.70.2 
Fe-oxygen 
H2O(1) 
  2.90.5  
Fe-oxygen 
H2O(2) 
   2.90.4 
Mg(1)-Mg(2) 4.0    
Fe(1)-Fe(2)   3.20.1  
 
Table 4.3. Summary of the main structural features of the Mg2 and Fe2 bound 
forms of M ferritin: distances (Å) from potential donor atoms and inter-metal distances 
(Å) are reported for the magnesium and iron ions in the two crystal structures. The 
reported errors provide a measure of the differences within the 24 subunits of the Fe2 
structure. The Mg2 structure consists of 24 identical subunits. 
 
Crystal structures of the diferric products of crystal obtained with different 
soaking times (30‟, 60‟, 90‟, 120‟ before flash freezing) were solved and refined, 
although at lower resolution (3.7-4.1 Å). However, anomalous difference maps clearly 
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show the ferroxidase site always occupied by two iron ions. Although they reasonably 
represents different stages of catalytic turnover process leading to the production of 
increasing amounts of oxidation products, the features of the coordination environment 
of this pair of iron(III) ions are very similar and  invariably indicate the translation of 
the diferric center towards the 1 and 2 helices. 
 
 
4.8. Experimental section 
 
4.8.1. Protein expression and purification 
 
Frog (R. catesbieana) M ferritin protein was expressed from a pET3a plasmid.
81
 
Uniformly 
13
C, 
15
N-labelled protein for solid state, and 
2
H,
 13
C, 
15
N-labelled protein 
(deuteration > 90%) for solution studies were expressed in minimal medium with label 
algal hydrolysate as described in.
67
 Unlabelled protein was used for Evans magnetic 
susceptibility measurements. A ([2-
13
C] glycerol, 
15
N) ferritin sample was prepared 
according to the published procedure.
64
 The crystals were grown by the sitting drop 
method: 2 l of a 14 mg/ml protein solution was mixed with an equal volume of 3 M Na 
formate. The drop was equilibrated with 3 M Na formate at 18 °C. Trigonal crystals 
formed within a week. 
 
 
4.8.2. Protein crystallization for solid state NMR 
 
A reaction tube was filled with 1 mL of a solution of PEG 3350 at 25% w/v in 
Na2CO3 100 mM pH 6.5. A 0.2 mL drop of 40 mg/mL ferritin was deposited on the 
upper surface of this solution. The solution was kept at room temperature for 24 hours 
before the precipitate was separated by centrifugation. In this form, about 50 mg protein 
was transferred into a 4-mm MAS rotor. 
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4.8.3. Protein crystallization for X-ray crystallography 
 
Anomalous diffraction data have been collected at ESRF beamline BM14-1. 
Before data collection Bull frog (BF)-ferritin crystals have been soaked on a solution at 
pH 6.5 containing 10 mM FeSO4, 3 M Na formate under aerobic conditions and flash 
frozen in liquid nitrogen after 30-60-90-120 minutes soaking time. Anomalous 
diffraction data on each crystal have been collected both at the Fe K-edge (white line at 
1.737 Angstrom) and below the Fe K-edge (at 1.759 Å) in order to exclude any other 
anomalous scatterer besides Fe. Each crystal provided a complete dataset to 3.7 Å 
resolution. 
Datasets at 2.7 Å resolution have been collected on ESRF beamline ID14-4 at the 
Zn K-edge (1.292 Å). All structures have been solved by molecular replacement in the 
trigonal space group P31 2 1 (space group n. 152, cell parameters: a=210.23,  b=210.23, 
c=320.76), manually rebuilt and refined with REFMAC5 (CCP4 suite).  The crystal 
asymmetric unit contains a whole BF-ferritin molecule (24 subunits), thus allowing us 
the analysis of 24 independent subunits for each crystal.  
Anomalous difference maps computed with the refined phases, unambigously 
show the presence of the Fe ions bound to BF-ferritin at different sites. 
Iron(II) at the catalytic site of ferritin is immediately oxidized to iron(III), 
producing a colored protein form with a typical electronic absorption spectrum. The 
same color was observed in our crystals. However, photoreduction of ferric ions due to 
synchrotron radiation is always possible. The effect of the synchrotron radiation at the 
Zn K-edge on ferric ions bound at the catalytic site of the protein was checked acquiring 
EXAFS data at ESRF beamline ID14-4 at the Zn K-edge. 
 
 
4.8.4. Solid state MAS NMR spectra 
 
All the NMR experiments were performed at a field of 16.4 T (700 MHz 
1
H 
Larmor frequency, 176.0 MHz 
13
C Larmor frequency) on a Bruker Avance 700 wide-
bore spectrometer equipped of a 4 mm CP-MAS probe. All the experiments were 
acquired at MAS frequency of 9 kHz. Accurate determination of sample temperatures in 
solid state NMR with MAS is known to be problematic, mainly due to frictional and RF 
heating that make the internal sample temperature significantly different from the 
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measured temperature outside the MAS rotor.
82
 In order to define the best temperature 
for our measurements we acquired preliminary data over the 273-298 K range of 
measured temperature values outside the MAS rotor. The best resolution, signal to 
noise, and agreement with solution chemical shift values occurred for data acquired at a 
measured temperature of 298 K. Standard sequences were used. In all experiments a 
ramped cross polarization (CP) from protons was used.
65
 The relaxation delays were of 
3-4 s. Acquisition times in the direct dimension were in the range of 15-35 ms. For 2D
 
13
C-
13
C correlation experiments, PDSD and DARR were employed for 
13
C-
13
C 
mixing.
83,84
 For the 
15
N-
13
C correlation experiments (NCO providing NiCi-1 correlations 
and NCA providing NiCi correlations) a double CP 
85
 sequence was utilized, in which 
the 
15
N-
13
C transfer was achieved using the TAM pulse on 
13
C channel. The above 
mentioned building blocks (NCO or NCA and DARR) were combined to obtain the 3D 
Ni-Ci-CXi (NCACX) and 3D Ni-Ci-1-CXi-1 (NCOCX) experiments
66
 Finally a 3D 
Ci+1- Ni+1-C'i (CANCO) experiment
66
 was acquired. For 2D DARR experiments, 
mixing times of 20 and 40 ms were used. The 
1
H radiofrequency field strength during 
mixing was matched to the MAS speed to satisfy the n=1 condition. Each 2D 
13
C-
13
C 
spectrum was acquired with 32 scans, 3744 points in the direct dimension, and 1024 
experiments in the indirect dimension and spectral widths of 305 × 305 ppm. The 2D 
NCO and NCA experiments were acquired with 256 scans, 512 points in the direct 
dimension, and 160-256 experiments in the indirect dimension and spectral widths of 
149 × 141 ppm respectively. The 3D NCACX and 3D NCOCX were recorded with 32 
scans, 2710 points in the direct dimension, 80 experiments in the 
15
N indirect 
dimension, and 64 in the 
13
C indirect dimension (spectral widths of 354 × 45 × 20 ppm). 
Both were acquired with a 22 ms DARR mixing time. The 3D CANCO was recorded 
with 128 scans for each experiment, 2710 points in the direct dimension, 32 
experiments in the 
15
N dimension and 54 in the 
13
C indirect (spectral widths of 354 × 45 
× 30 ppm). All pulse sequences were implemented with 100 kHz spinal64 
1
H 
decoupling 
84
 during indirect evolution and acquisition periods. 
Spectra were processed with the program TopSpin (Bruker). The 2D and 3D maps 
were analyzed with the CARA program.
86
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4.8.5. Solution NMR spectra 
 
13
C-
13
C NOESY. Ferritin solutions, 3 mM in subunits (125 µM in nanocages) in 
100 mM MOPS, pH 7.0, were used to acquire 
13
C-
13
C NOESY maps
54,67
 at increasing 
iron concentrations. Freshly prepared solutions of ferrous sulfate in 1 mM HCl were 
added to the protein solution at a ratio of 2 iron atoms/active site (48 iron atoms/protein 
nanocage). The conditions were comparable to those used previously for solution 
Mössbauer and EXAFS spectroscopies
24,25
 which showed complete and fast oxidation 
of iron. In order to facilitate homogenous diffusion of iron and oxygen, protein samples 
were titrated according to the following procedure: i) taking out the sample from the 
NMR tube; ii) adding the iron(II) solution and gently pipetting up and down the entire 
solution; iii) spinning the solution. EXAFS data (to be published) confirmed that the 
iron products obtained with this procedure were all in the iron(III) oxidation state. Our 
samples were incubated at 298 K for 2 days before collecting the 
13
C-
13
C NOESY 
spectra. After measurements were made on the sample with 48 iron atoms/nanocage, a 
second aliquot of 2 iron atoms/active site was added and the process repeated until 192 
iron atoms/nanocage were analyzed through the 
13
C-
13
C NOESY. The 
13
C-
13
C NOESY 
maps at each step of the titration were acquired on a 16.4 T Bruker AVANCE 700 
spectrometer equipped with a triple-resonance TXO cryoprobe optimized for 
13
C direct-
detection, at 298 K, using two different mixing times: 500 ms on the full spectral width 
(200 ppm), for 18 h, and 150 ms on the aliphatic region (90 ppm) in order to increase 
resolution, for 16 h to achieve good signal-to-noise ratios.  
 
 
4.8.6. Magnetic susceptibility measurements 
 
The magnetic susceptibility of ferritin with increasing amounts of iron was 
measured by the modified Evans method
76,77
 as previously reported.
87
 Coaxial NMR 
tubes were used with tert-butyl alcohol and 1,4-dioxane as internal references. The 
paramagnetic and diamagnetic protein samples were prepared from the same stock 
solution i.e., 320 µM in subunit monomer (13.3 µM in protein nanocages) in 100 mM 
MOPS, pH 7 with 5 mM ter-butyl alcohol and 5 mM 1,4-dioxane. The protein solution 
was split into two aliquots. The inner capillary contained the diamagnetic apoferritin 
solution. Freshly prepared solutions of ferrous sulfate in 1 mM HCl were added to the 
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second aliquot of ferritin in steps of 2 iron/active site (48 iron atoms /protein nanocage) 
in the outer tube. Addition of iron to the protein solution followed the procedure 
described for the 
13
C-
13
C NOESY. Ten additions of two  iron(II)/subunit (up to a total 
of 20 iron atoms/subunit) were analyzed. The shifts of the proton signals of the two 
reference molecules were measured at on the 16.4 T Bruker AVANCE 700 
spectrometer (the same used for 
13
C-
13
C NOESY) at 298 K. The set of Evans 
measurements was repeated twice. An additional set was measured on the 18.7 Bruker 
AVANCE 800 spectrometer. The inner-outer tube peak separation (expressed in 
ppm) for each standard was measured and assigned to the bulk susceptibility shift. The 
paramagnetic contribution to the molar susceptibility of the solute (M
PARA
) was related 
to the bulk susceptibility shift  as indicated in the following equation:  
 CM χM
PARA  
/ 3       (4.17) 
in which CM is the mM concentration of the protein and χM
PARA
 is given in m
3
 
mol
-1
. The magnetic moment in solution (eff) was then calculated according to equation 
(4.18): 
²eff = χM
PARA 
3 k T / NA 0      (4.18) 
where k is the Boltzman constant, T is absolute temperature, NA is Avogadro‟s 
number, and 0 is the vacuum permeability.  
 
 
4.9. Conclusion 
 
NMR revealed functional iron channels in ferritin that facilitate hydrolysis and 
guide the multinuclear ferric mineral precursors to the biomineralization cavity. 
The NMR approach of combining solid state experiments for sequence specific 
assignment of key residues and solution 
13
C-
13
C NOESY is a strategy that can provide 
chemical information at atomic resolution on the mechanism of action of other large 
molecular assemblies, in addition to the ferritin nanocage. 
The X-ray structure of ferritin iron loaded showed the ferroxidase site in the 
product conformation.  
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5. Summary 
 
In this chapter will be discussed a novel high- resolution magic-angle spinning 
(MAS) solid-state-NMR (ssNMMR) method to improve protein assignment.  
Up to now 
13
C-detection experiments represent the common strategy for ssNMR 
protein assignment resulting in complete structure elucidation of several peptides and 
small proteins.
1-3
 However, this technique is still limited by problems of broad 
resonances, due to the 
13
C-
13
C scalar coupling, resolution due to possible signal overlay 
in proteins beyond 8 kDa and to the limited chemical shift range typical of 
13
C 
resonances, and low sensitivity, that intrinsically characterize heteronuclear (the low- 
nuclei) detection spectroscopy.  
In the past few years, two methodologies have been proposed to overcome these 
problems. One is based on proton detection, the other one on deuterium spectroscopy 
in perdeuterated proteins. In both techniques resolution and sensitivity are improved 
with respect to the carbon detection experiments. 
We now propose two new 3D ssNMR experiments, namely DCC and DCH, as a 
new strategy for protein assignment, counting the advantages of proton detection 
methods.  
 
 
5.1. Introduction 
 
Until now, all standard ssNMR experiments have relied on heteronuclear 
detection (
13
C), as discussed previously (Section 4.5.3.4.). Proton, which is widely used 
in solution NMR because of its high natural abundance and high gyromagnetic ratio 
(H), does not play a big role in solid-state NMR. In conventional solid-state NMR, 
indeed, 
1
H detection is usually less favorable, as large dipolar couplings lead to 
substantial line broadening. So far, the most used technique for protein assignment was 
based on correlation between heteronuclei like 
13
C or 
15
N, employing NCACX, 
Chapter 
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NCOCX and CANCO type experiments (Section 4.5.3.4.). The assignment of proteins 
beyond 8 kDa fails with this procedure mainly due to the broad resonances caused by 
13
C-
13
C scalar coupling. 
Recently, two main approaches have been developed to overcome these problems. 
The first one is a 
13
C spin dilution technique based on carbon detection experiments that 
solves the resolution and overlap problems. It consists in a reduced labeling scheme 
achieved by using [1,3-
13
C]glycerol or [2-
13
C]glycerol as carbon source for protein 
expression.
1
 In this way, the bonded carbons are not simultaneously labeled and a lower 
number of connectivities is observed. Therefore, the carbon spectra are less crowded 
and the assignment is simplified. Moreover the carbon lines are significantly narrower 
with respect to spectra recorded on uniformly 
13
C enriched samples because the carbon 
dilution suppresses or completely removes line-broadening due to 
13
C-
13
C scalar-
couplings. Another advantage consists in the detection of weak couplings that contain 
structural information, thanks to the reduction of the number of strong dipolar couplings 
between connected nuclei. 
The second approach consists in the development of proton detected 
experiments with 
1
H narrow line. Currently, there are three general ways to destroy 
homogeneous interactions in MAS solid-state NMR. The first approach is based on 
quenching the proton dipolar coupling by spinning the sample at very high rotation 
frequencies around the magic angle. Improvements in MAS technology have made high 
frequency (≈ 70 kHz) sample spinning possible.4,5 A second spectroscopic approach 
involves the design of homonuclear decoupling sequences which allows the 
achievement of proton line widths in the order of 170–200 Hz.6-8 The third approach 
involves dilution of the strongly coupled proton spin systems by deuteration. I will 
focus the attention on this last method. 
 
 
5.1.1. Proton detected experiments in perdeuterated proteins  
 
Suppression of strong 
1
H-
1
H dipolar couplings can be achieved chemically by 
perdeuteration. With this approach, all non-exchangeable proton sites are occupied by 
deuterium atoms while exchangeable sites are back substituted with protons. Deuterium 
has a gyromagnetic ratio that is a factor of 6.5 smaller compared to the proton one. 
Correspondingly, all 
1
H,
 1
H dipolar couplings are scaled by a factor of 6.5. Deuterated 
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samples in conjunction with fast MAS and very weak decoupling quench cross-
relaxation from protons, show narrower resonances compared to their protonated 
analogues acquired with high power homonuclear decoupling  and allow recording of 
multi-dimensional spectra for assignment. 
During this year a systematic study of the effect of the level of exchangeable 
protons on the observed amide proton line width obtained in perdeuterated proteins has 
been conducted in Oschkinat's research group. It has been shown that a decreased 
amount of amide deuterium in perdeuterated proteins from 90% to 0%, gave a 4-fold 
increase in line width for both 
1
H and 
15
N resonances.
9
 At the same time, decreasing the 
D2O concentration from 90 to 60% , a sensitivity gain of 3.8 has been obtained for the 
CP based experiments 
1
H detected. In conclusion, it has been demonstrated that the best 
compromise between the line width and the signal to noise ratio in CP experiments is 
represented by perdeuterated proteins 40% back exchanged with water.
9
 
In 2006 Reif's group conducted a study on 
1
H-
15
N proton detected correlation 
spectra in MAS ssNMR using deuterated proteins back exchanged with a crystallization 
buffer prepared in 1:9 H2O:D2O solvent.
10
 The protein used for this study is the α-
spectrin SH3 domain, a 62 amino acid protein whose ssNMR assignment is known,
11
 
that is largely used as standard protein for ssNMR methodological studies. A 
1
H line 
width on the order of 30 Hz has been observed for proton detected experiments at 
spinning frequencies of 13 kHz without homonuclear decoupling (Fig. 5.1A). While the 
line widths obtained in the same conditions with deuterated SH3, 100% 
1
H at labile 
proton positions, if protons are evolved in an indirect dimension (
15
N detection) are of 
ca. 100 Hz. In addition, avoiding of decoupling reduces sample heating and is beneficial 
for sample stability (Fig. 5.1B).  
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Figure 5.1. (A) 
1
H-detected 2D 
15
N–1H correlation spectra of the deuterated SH3, 
10% 
1
H at labile proton positions recorded at 600 MHz. (B) 
15
N detected 2D 
15
N–1H 
correlation experiments for deuterated SH3, 100% 
1
H at labile proton positions recorded 
at 600 MHz.  
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5.1.2. Deuterium spectroscopy in perdeuterated proteins  
 
Since in perdeuterated proteins protons are no longer available, a significant 
amount of information is compromised. In the last two years the use of deuterium CP 
has been proposed as an alternative to proton CP in perdeuterated proteins. The use of 
deuterium combined with 
13
C detection opens new fields for correlation and dynamic 
spectroscopy. 
Reif's group shown that the deuterons can be used to probe chemical environment 
similarly to protons, and that the accessibility of deuterium quadrupolar tensors can 
reveal dynamic information. In particular it was demonstrated that the best way to 
obtain high-resolution deuterium ssNMR spectra is through Double-Quantum (DQ) 
deuterium-carbon experiments where the observed deuterium resonances are narrower 
than the ones observed in solution. Moreover, an sensitivity improvement by a factor of 
2.46 ± 0.82 of the 
2
H,
13
C correlation experiment compared to the 
1
H,
13
C correlation was 
obtained.
12
  
 
 
5.2. Aim of the project 
 
Taking into account the sensitivity improvement of the 
2
H-
13
C DQ CP versus the 
1
H-
13
C CP and the better resolution of proton detected experiments in comparison with 
the carbon detected one, a novel strategy for protein assignment in ssNMR is in this 
work. The use of deuterium double quantum chemical shifts for separating carbon-
carbon correlations into a third dimension, and thereby generating a starting point for a 
suite of pulse sequences for sequential assignment procedures that involve deuterium 
double quantum (equivalent to 2 times proton), and carbon chemical shifts is here 
reported. A solution-like concept for assigning side chain resonances was tested by 2D 
and 3D deuterium-carbon correlations of 
2
H,
13
C,
15
N-labelled ubiquitin employing 
deuterium double quantum generation prior to heteronuclear cross polarization. 
Moreover, considering the advantages derived from proton detection experiments, a 
DCH three dimensional correlation spectrum has been thought in order to achieve the 
sequential assignment. 
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5.3. Methods 
 
5.3.1. Deuterium  
 
Deuterium is a nucleus with I=1. A quadrupolar moment is associated with spins 
having a spin quantum number > 1/2. The quadrupolar moment interacts with the 
electric field surrounding it, created by the electron clouds around the nucleus in 
question. The large quadrupolar moment in combination with isotropic tumbling of 
molecules induces large quadrupolar relaxation and makes the direct observation of 
deuterons in solution disadvantageous. Typically, deuterium line widths in the order of 
100-200 Hz are observed in solution.
13-15
. What about deuterium line width in ssNMR? 
In the  solid-state, narrow 
2
H resonance lines can in principle be achieved for two 
reasons: i) quadrupolar couplings inhomogeneous in nature can be completely averaged 
out under MAS; ii) the absence of molecular tumbling in solids eliminates the additional 
quadrupolar relaxation caused by tumbling. 
 
 
5.3.2. Deuterium-Carbon Cross-Polarization 
 
It is well known that deuterium gyromagnetic ratio is approximately 1.6 times 
smaller than the 
13
C one and that 
2
H has I=1 while 
13
C has I=1/2. Is the CP 
magnetization transfer from deuterium to carbon convenient? Comparing deuterium and 
carbon nuclear magnetic moments (X) is possible to calculate the gain in sensitivity: 
 
cII
II D
CC
DD
C 



)1(
)1(D


  = 1.02  (5.1) 
 
replacing 
6.1
1

c
D


, ID = 1 and IC = 1/2. ID and IC are deuterium and carbon spin 
quantum numbers respectively and D, C are the gyromagnetic ratios of deuterium and 
carbon respectively. It comes out that the magnetization transfer from deuterium to 
carbon is not inconvenient. In addition, deuterium being a quadrupolar nucleus, has an 
associated efficient quadrupolar relaxation mechanism which makes the spin-lattice 
relaxation times faster than proton
16,17
 thus allowing fast repetition rates and therefore 
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the acquisition of a large number of scans for the same unit time. Moreover, deuterium 
is more abundant than protons in perdeuterated proteins.  
In JACS 2009 Agarwal showed a resolution increase in the 
2
H-
13
C DQ CP 
experiment with respect to the 
2
H-
13
C SQ CP experiment.  
He also found that 
2
H-
13
C CP matching conditions for deuterons having different 
quadrupolar couplings (methyl groups and the D-C/ D-C) is different. During a 
CP spin lock pulse, deuterium spins are simultaneously exposed to two orthogonal 
fields: the constant Zeeman field created by r.f. and the electric gradient field of the 
quadrupolar nuclei.
18
 The electric gradient field is continuously modulated in the z-
direction parallel to the static magnetic field by spinning of the rotor. Thus, the 
modulation of size and direction of quadrupolar coupling is larger for nuclei having 
larger quadrupolar tensors. The time required for optimum 
2
H-DQ excitation is 
inversely proportional to the size of the quadrupolar coupling. Short DQ excitation and 
reconversion times (1 s) yield exclusively correlations for C-D deuterons associated 
with large quadrupolar couplings (e
2
qQ/h  =165 kHz), whereas a longer delay (9 s) is 
necessary to observe correlations involving methyl deuterons associated with a smaller 
quadrupolar coupling (e
2
qQ/h  = 55 kHz). An improvement by a factor of 2.46±0.82 
of the 
2
H-
13
C correlation experiment compared to the 
1
H-
13
C correlation was observed. 
The 
2
H line widths were on the order of (38±14) Hz for methyls and of (30±9) Hz for 
carbon alpha.
19
 
 
 
5.3.3. Double Quantum (DQ) 
2
H-
13
C correlation experiment 
 
Two hard 90° pulses separated by a delay  constitute the simplest pulse sequence 
for generation the DQ coherence. The first 90° creates a transverse magnetization that 
evolves to an antiphase state under the influence of quadrupolar couplings during the 
delay . With the second 90° pulse this antyphase state is converted to a DQ coherence. 
The first and the second pulse should be both applied with the same phase. The DQ 
coherence evolves in the t1 dimension. After evolution of DQ coherence in t1, a time 
reversal approach is adopted to convert the DQ coherence back to SQ transverse 
magnetization. A fourth 90° pulse flips the deuterium magnetization along the z-axis. A 
z-filter of duration  of 2 s was used to remove any residual transverse magnetization. 
Further 
2
H 90° pulse combined with 
2
H-
13
C CP transfers magnetization to carbons for 
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detection. Proton decoupling was employed in the indirect dimension to remove the 
effect of long range heteronuclear dipolar coupling to deuterons. 
For maximum efficiency of the sequence double-quantum excitation-evolution-
reconversion period for the first t1-increment is equal to one rotor period: R = 3*90° + 
2* + t1(0), where90° = 
2
H 90° pulses,180° = 
13
C 180° pulse,  = free evolution period 
and t1(0) = deuterium evolution period for the first increment. All increments in the 
indirect dimension were adjusted as multiple of the rotor period: t1 = 2n* tR with n as 
integer number to avoid Multiple Quantum spinning side bands.  
 
 
 
Figure 5.2. Pulse sequence for 
2
H, 
13
C Double Quantum (DQ) correlation 
experiment. The double quantum excitation-evolution-reconversion period for the first 
t1 point was equal to a rotor period. Phase cycling: 1 = (x, y, -x, -y); 2 = (-y); 3 = (x); 
4 = (4(x), 4(-y)); 5 = (y); 6 = (8(x), 8(-x)); 7 = (16(x), 16(-x)); 8 = (2(x), 4(-x), 
2(x)); REC = (2(x, -x), 4(-x, x), 2(x, -x)). Phase sensitive detection in t1 is achieved 
using TPPI (on phase 1 and 4). 
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5.3.4. Double Quantum (DQ) 
2
H-
13
C-
13
C correlation experiment 
 
Adding a 
13
C-
13
C magnetization transfer after the 
2
H-
13
C DQ-CP, a 
2
H-
13
C-
13
C 
three dimensional correlation experiment has been performed. We used the DREAM 
adiabatic homonuclear recoupling magnetization transfer
20
 which is demonstrated to 
bring the general advantages of adiabatic pulse schemes such as a complete polarization 
transfer and robustness with respect to chemical shift differences and experimental 
imperfections like RF-field inhomogeneity.  
 
 
 
Figure 5.3. Pulse sequence for 
2
H-
13
C-
13
C Double Quantum (DQ) correlation 
experiment. Phase cycling: 1 = (x, y, -x, -y); 2 = (-y); 3 = (x); 4 = (4(x), 4(-x)); 5 = 
(y); 6 = (8(x), 8(-x)); 7 = (16(x), 16(-x)); 8 = (2(x), 4(-x), 2(x)); REC = (2(x, -x), 4(-x, 
x), 2(x, -x)). Phase sensitive detection in t1 was achieved using TPPI. 
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5.3.5. Double Quantum (DQ) 
2
H-
13
C-
1
H correlation experiment 
 
Adding a 
13
C-
1
H cross polarization transfer magnetization transfer after the 
2
H-
13
C 
DQ-CP, a 
2
H-
13
C-
1
H three dimensional correlation experiment has been performed. 
Before the last CP pulses a z filter 90° pulse is introduced and immediately after four 
water suppression pulses. With a second 90° 
13
C pulse, magnetization is recovered on 
the xy plane.
 
 
 
 
Figure 5.4. Pulse sequence for 
2
H-
13
C-
1
H Double Quantum (DQ) correlation 
experiment. Phase cycling: 1 = (x, y, -x, -y); 2 = (-y); 3 = (x); 4 = (4(x), 4(-x)); 5 = 
(y); 6 = (8(x), 8(-x)); 7 = (32(-y), 32(y)); 8 = (x); 9 = (y); 10 = (-x); 11 = (-y); 12 
=(16(y), 16(-y)); 13 = (x); 14 = (x); REC = (2(x, -x), 4(-x, x), 2(x, -x), 2(-x, x), 4(x, -x), 
4(-x, x), 4(x, -x), 2(-x, x), 2(x, -x), 4(-x, x), 2(x, -x)). Phase sensitive detection in t1 was 
achieved using TPPI. 
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5.4. Assignment strategy  
 
The aim of the novel experiments proposed in this section is to identify the amino 
acid spin systems trough 
13
C and D resonances and link the sequential spin systems 
via amide proton. The new three-dimensional chemical shift correlation experiments 
proposed for this purpose are the DCC and the DCH spectra. In Figure 5.4 is reported a 
scheme of the connectivities detected in the 3D DCC (blue) and DCH (green) 
experiments used for the sequential assignment. A peak in the DCC resonates at the 
frequencies of Di-Ci-CXi and Di-Ci-CXi where CXi can be one of the 
13
C nuclear 
side chain spins of residue i (Ci, Ci etc.). Therefore, a strip at a given 
2
H frequency in 
the DCC allows the identification of intraresidue (residue i) C, C etc.. A peak in the 
DCH resonates at the frequencies of Di-Ci-Hi,i+1. Hence, a strip at a given D 
frequency in the DCH allows the identification of the amide proton of residue i 
(intraresidue) and i+1 (following residue). When the strips are visualized as in Figure 
5.4 C it is possible to identify the intraresidue connectivities (residue i) C, Cetc. and 
the sequential connectivities via amide protons.  
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Figure 5.4. Schematic representation of the possible connectivities detected in the 
3D experiments DCC (blue) and DCH (green) experiments. In the DCC cube 
representation the positive diagonal peaks are shown in red and the negative cross peaks 
in blue.  
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5.5. Results & Discussion 
 
A 
2
H-
13
C double quantum correlation experiment of uniformly 
2
H-
13
C-
15
N labeled 
ubiquitin 20% back exchanged with water is reported in Fig. 5.5.  
 
 
 
Figure 5.5. DQ 
2
H-
13
C correlation spectrum. The spectrum was processed with a 
squared sine function with a sine bell shift of 5 in the indirect dimension while gauss-
lorentz function in the direct dimension was carried out using exponential line 
broadening of -40 Hz and a gaussian max of 0.1.  
 
The narrowest unscaled 
2
H DQ linewidth of approximately 36-37 Hz is observed 
for the D of A46. A list of DQ deuterium line width for different D groups is 
represented in Table 5.1.  
 
Amino acids 2H DQ LW (Hz) 
A46 36.5 
E64 40.3 
I30 40.9 
P38 38.6 
P19 38.7 
V26 42.0 
D32 47.0 
K63 39.9 
F4 47.5 
 
Table 5.1. List of DQ deuterium line width for different Dand Dgroups. 
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A cube representation of the DQ 
2
H-
13
C-
13
C correlation spectrum of uniformly 
2
H-
13
C-
15
N labeled ubiquitin 20% back exchanged with water is reported in Fig. 5.6. 
The spectrum was processed as the DC one. The typical 
2
H line widths for CDpeaks 
are about 170 Hz. 
 
Figure 5.6. Cube representation of the three dimensional DQ 
2
H-
13
C-
13
C 
correlation. 
 
The assignment was performed starting from carbon chemical shifts of crystal 
ubiquitin (BMRB 7111) that allowed the identification of the amino acid spin systems 
in the DREAM spectrum.
21
 Linking the  side chains of each amino acid in the DCC 
spectrum, was possible to assign almost all the Dcross peaks, 63% of the D and only 
a few C(Fig 5.4 and 5.7). This is due to the different DC CP matching conditions for 
deuterons having different quadrupolar couplings (methyl groups, C-D and C-
D).12 Recently, Reif and coworkers showed that the time required for optimum DC DQ 
excitation is inversely proportional to the size of the quadrupolar coupling constant: for 
C-D having a large quadrupolar coupling constant (e2qQ/h ≈ 170 kHz), a DQ 
excitation and reconversion time of 1 s is needed; for methyl deuterons with a smaller 
quadrupolar coupling (e
2qQ/h ≈ 57 kHz), is necessary a delay 9 s.12 
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Figure 5.7. Representative strip plots of the 3D DCC spectrum, showing 
intraresidues connectivities for residues V26, L43 and L69. Blue and red peaks are 
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negative cross peaks and positive diagonal peaks respectively. Each strip is extracted at 
the 
13
C frequency (3) reported on the right. The 
2
H DQ frequency of the plane from 
which strips are extracted is reported on the bottom. 
 
All the DCpairs could be identified, with the exception of the Met1. The 
63% of the D was here assigned. For the prolines it was possible to recognize the D-
C and the C-Dpairs but not the C-D and the C-Dpairs. On the other hand C 
and C could be identified as connectivities from  the D-C and D-C strips. For all 
the Gln and Glu (Gln2, Glu16, Glu18, Glu24, Gln31, Glu34, Gln40, Gln41, Gln49, 
Glu51, Gln58, Gln62, Glu64) the D was not detectable. The C was found from the 
D-C strip. Beside these, the D of Ile3, Lys48, Ser57, Tyr59 were not identified, 
most probably due to low S/N. In the DCC spectrum all the correlations DCX and 
DCX were recognized, provided the nuclei resonate between 75 an 15 ppm. In 
particular, for Leucines, Valines, Prolines, Threonines and Arginines all the cross peaks 
of the full pattern were observed, as well for the Isolucines, with the only exception of 
the C (that resonates around 14 ppm) and Lysines with the exception of the C(low 
S/N). For the aromatic amino acids (Phe, Tyr, His), only the C and C correlations are 
present in the spectrum.  
 
 
5.6. Experimental section 
 
5.6.1. Protein samples 
 
Uniformely 
2
H-
13
C-
15
N labeled human ubiquitin was expressed and purified as 
reported in literature.
22
 Protein microcrystal were grown at 4°C with the sitting drop 
method with a crystallization buffer containing 80% of D2O, following the procedure 
described by Igumenova.
23
 In this form, about 5 mg of protein were transferred in a 2.5 
mm rotor using an ultracentrifuge device.
24
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5.6.2. NMR spectroscopy 
 
NMR experiments on ubiquitin were performed in Zurich on a Bruker Avance 
600 wide-bore spectrometer operating at 14.09 T equipped of a Varian 2.5 Chemagnetic 
probe. The MAS frequency was set to 25 kHz. The sample was cooled at -15 °C.   
For the DQ 
2
H-
13
C correlation experiments the RF field amplitude for all hard 
pulses was adjusted to 100 kHz setting the RF carrier to 1.2 ppm and 100 ppm on 
2
H 
and 
13
C channels respectively. For 
2
H 
13
C CP the contact time was set to 1.4 ms. The 
2
H 
field during CP was ramped from 95 kHz to 105 kHz the 
13
C field was matched to the (-
1) Hartmann-Hahn condition (approximately 75 kHz). The delay  was set to 1 s to 
yield efficient DQ excitation for CD. The delay  was set to 2 s. The spectral width 
was 50 kHz and 3 kHz for the direct and indirect dimension. 4096 and 160 points 
corresponding to acquisition times of 41.0 ms and 25.6 ms were acquired in t1 and t2 
respectively. 1024 transient were acquired per t1 increment. The recycle delay was set to 
150 ms leading to an acquisition time of about 9 h. WALTZ-16 decoupling on the 
2
H 
and 
1
H channels was applied using a RF field strength of 3 kHz.  
The DQ 
2
H-
13
C-
13
C correlation experiments were recorded with the pulse 
sequence shown in Figure 5.3.. For 
2
H 
13
C CP was used a contact time of 1.5 ms. The 
2
H field during CP was ramped from 91 kHz to 101 kHz and the 
13
C field was matched 
to the (-1) Hartmann-Hahn condition (approximately 71 kHz). The WALTZ-16 
decoupling on the 
1
H and 
2
H channels during the evolution and the detection time was 
set to a field strength of 3 kHz. The RF amplitude during the 5 ms DREAM recoupling 
period was tangentially swept from 11.50 to 10.45 kHz. The spectral width was 50 kHz, 
18 kHz and 3 kHz for t3 (
13
C), t2 (
13
C) and t1 (
2
H) dimensions, respectively. 2048, 250 
and 32 points corresponding to acquisition times of 20.5 ms, 6.9 ms and 5.1 ms were 
acquired in t1, t2 and t3 respectively. 160 transient were acquired per t1 increment. The 
recycle delay was set to 150 ms leading to an acquisition time of about 3 days.  
Spectra were processed with the program TopSpin 2.0 (Bruker). The 2D and 3D 
maps were analyzed with the CARA 1.8.4.2 program.
25
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5.6.3. NMR assignment of human ubquitin 
 
Deuterium resonance assignments of ubiquitin was carried out starting from the 
reported assignment on BMRB entry 7111.
21
 
 
 
5.7. Conclusion 
 
Well-resolved 
1
H-
13
C-equivalent correlations of deuterated ubiquitin are obtained 
by exploiting the long life time of 
2
H double quantum states. Sufficient signal-to-noise 
was obtained due to short deuterium T1, allowing for high repetition rates and enabling 
3D experiments within a reasonable time. 3D DQ D-C-C correlations of ubiquitin were 
recorded within 3 days each, allowing the sequence-specific assignment of all D and 
of 63% of D This approach provides the basis for a general heteronuclear 3D MAS 
NMR assignment concept by including 
1
H-like chemical shifts.  
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6. Summary and conclusions 
The present work has focused on some important 
biological processes involving protein intermolecular 
interactions.  
Protein-small ligand studies have helped identifying new binders targeting the 
S100B-p53 interaction areas, that show potential for further optimization in a rational 
drug design process. Protein-protein interaction studies have provided the first structural 
model of cytochrome c binding to a Bcl-like protein, providing structural insights in 
cytochrome c dependent apoptosis. Both these activities relied on the use of well 
established NMR methodologies for ligand-screening and chemical shift perturbation 
mapping in the former case, and chemical shift perturbation mapping and data-driven 
docking in the latter. 
On the other hand, the characterization of the interaction between iron and ferritin 
required the preliminary development of an original approach based on the combined 
used of solid state NMR and solution 
13
C-direct detection NMR, which partially 
overcame the intrinsic difficulties associated to the assignment of a such large protein 
by NMR. Analysis of the paramagnetic line-broadening in solution spectra of ferritin 
permitted to trace the iron path from the catalytic site to the nanocavity: this represent 
the first structural, albeit low resolution, information on the pre-biomineralization path 
of the iron inside the protein. High-field revisiting of the old Evans measurements gave 
indications on the nuclearity of the precursors of the biomineral. 
Complementation between NMR and X-ray crystallography was used in some 
cases and resulted successful. 
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